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Abstract
Microfluidics combines principles of science and technology, and enables the user to han-
dle, process and manipulate fluids of very small volumes. This technology permits the
integration of multiple laboratory applications into one single microfabricated chip, re-
quires minimal manual user intervention and sample consumption, and allows enhanced
data analysis speed and precision. Due to these numerous advantages, the potential for
this technology to be applied in fundamental biophysical and biomedical research is vast.
The major aim of this thesis was to explore the capacities of microfluidics, particularly
droplet-based microfluidic technology in the following topics: 1) Mimicry of the immune
system cellular environment, with the ultimate goal of programing T cells for adoptive
T cell therapy; 2) Bottom-up assembly of minimal synthetic cells. Towards this end, a
novel approach to form gold-nanostructured and specifically biofunctionalized water-in-oil
droplets was developed. This thesis highlights the advanced properties of nanostructured
droplets to serve as 3D antigen presenting cell (APC) surrogates for T-cell stimulation.
The combination of flexible biofunctionalization and pliable physical droplet properties
work in tandem, providing a flexible and modular system that closely models in situ
APC-T cell interactions. The research within this thesis focused also on the dissection of
complex cellular sensory machinery implementing an automated droplet-based microflu-
idic approach. Towards this goal, nanostructured droplets as cell-sized compartments and
droplet-based pico-injection technology were used to achieve the bottom-up assembly of
the minimal number of proteins required for a “simple synthetic cell.” While the applied
methodology has a potential for assembly of a wide range of subcellular functional units,
the focus in this thesis was on the reconstitution of the actomyosin cortex. Successful
optimization of the biochemical and biophysical conditions within the droplets allowed to
achieve precise control over the actin polymerization and actomyosin network organization
by their linkage to the droplets periphery. These experimental steps were also necessary
to generate signaling events including myosin-driven droplet migration and self-propulsion
with reduced molecular complexity compared to living cells.
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Zusammenfassung
Mikrofluidik ist eine Technologie, die es ermöglicht mit sehr kleinen Flüssigkeitsvolumi-
na zu arbeiten, diese zu untersuchen und zu manipulieren. Die Miniaturisierung erlaubt
präzise und schnelle Datenanalyse, sowie die Integration unterschiedlichster Laborfunk-
tionen auf einem wenige Zentimeter großen Chip. Die zahlreichen Vorteile der Mikroflu-
idik Technologie eröffnen ein weites Feld von Anwendungen in der biophysikalischen
und medizinischen Forschung. Das wesentliche Ziel dieser Arbeit war es Mikrofluidik-
systeme, insbesondere Tropfen basierte Mikrofluidik, für die Anwendung in den folgenden
Forschungsaufgaben zu konfigurieren und zu optimieren: 1) Simulation der Zellumge-
bung des Immunsystems mit dem Ziel der Programmierung von T-Zellen für die adop-
tive T-Zelltherapie. 2) Systematischer Aufbau und Untersuchung minimaler synthetischer
Zellen. Hierzu wurde eine neue Methode zur Erzeugung gold-nanostrukturierter und spezi-
fisch biofunktionalisierter Wasser-in-Öl-Tropfen entwickelt. Diese Arbeit demonstriert das
Potential von gold-nanostrukturierten Tropfen als synthetische dreidimensionale antigen-
präsentierende Zellen (APCs) in der T-Zellstimulation zu fungieren. Die Verbindung von
präziser Biofunktionalisierung so wie die steuerbaren physikalischen Tropfeneigenschaften
bilden ein flexibles und modulares System, das die natürliche APC-T-Zell Wechselwirkung
realitätsnah nachbildet. Des Weiteren wurden komplexe zelluläre sensorische Mechanis-
men des Aktomyosin-Kortex untersucht. Hierzu wurden gold-nanostrukurierte Tropfen
als Zellbehältnisse verwendet und Pikoinjektions-Technologie zur nachträglichen Tropfen-
manipulation angewandt, um einfache "synthetische Zellen" mit der minimal benötigten
Anzahl an Proteinen zu erzeugen. Diese Methode ermöglicht die Erzeugung eines weiten
Spektrums von subzellulären Funktionseinheiten, die dann isoliert untersucht werden kön-
nen. In dieser Arbeit lag der Fokus auf der Nachbildung des Aktomyosin-Kortex. Die
Verbindung des Aktins zur Tropfenperipherie sowie die Optimierung der biochemischen
und biophysikalischen Bedingungen im Tropfen erlauben die Aktinpolymerisation und
die Organisation des Aktin-Netzwerks gezielt zu steuern. Diese experimentellen Schritte
waren notwendig, um Signalereignisse einschließlich Myosin-getriebener Tröpfchenmigra-
tion und Eigenantrieb mit eingeschränkter molekularer Komplexität im Vergleich zu leben-
den Zellen zu erzeugen.
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I. Introduction
1. Microfluidics
Microfluidics is a science and technology of systems that enable the user to handle, process
and manipulate fluids of very small volumes - down to less than picoliters - via micro
channels with diameters ranging from 0.1 to 100 µm. [1] Microfluidics permit the integration
of multiple laboratory functions into one single micro-fabricated chip with an average
dimension of few centimeters. This technology profits from minimized manual intervention
by the user, increased analysis speed, high data precision, less sample consumption and
minimal exposure to hazardous materials. Due to these numerous advantages,their is great
potential for this technology to be applied in biological, [2,3,4] chemical [5,6] and biomedical [7]
context. Despite the progress made in recent years, it still seems that this technology
remains in its first development stages. [8] To move it to the next stage, it has to become
successfully adapted to solve “real” end-user problems, rather than remain a field based
on proof-of-concept experiments.
The major aim of the research within this thesis was to bridge the gap between the
development of microfluidics, particularly droplet-based microfluidic technology, and its
application in fundamental biophysical and biomedical research with the goal to analyze
the reconstitution of actomyosin cortex units. Specifically, droplet-based microfluidics
was explored in the following topics: 1) Bottom-up assembly of minimal synthetic cells,
with the goal of actomyosin cortex constitution; and 2) mimicry of the immune system
cellular environment, with the goal of programing T cells.
1.1. Droplet Based Microfluidics
Micro-emulsions can offer various possibilities for chemical and biological research. The
potential of water-in-oil micro-emulsion droplets has already been described in 1954 by
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Joshua Lederberg. [9] Since successful implementation of microfluidic technology toward
controlled micro-emulsion creation - droplet-based microfluidics have emerged as new
scientific and technological field of research. [10]
Most droplet-based microfluidic devices are produced by standard photolithography and
the following softlithography methods in which polydimethylsiloxane (PDMS) is cast over
the wafer with desired positive relief (details Section III.2). [1,11] PDMS is the most common
material in microfluidic biological applications due to its low price, high transparency
(down to 280 nm), good permeability to gases and biocompatibility. [12]
Using flexible microfluidic devices, the formation speed and diameter size of monodis-
perse droplets can be controlled during their creation: the first may be varied from a slow
driping to over 1 MHz (mega hertz), [13] while the latter is variable upwards of 1 µm (dif-
ference in diameter < 1%). [14,15] The droplet diameter is controlled mostly by the channel
dimensions but can also be regulated by flow rates at the flow focusing junction where
the droplets are generated (detailed information see Section III.2.3). In the flow-focussing
junction an aqueous phase is cut by the stream of the oil phase (from both sides) and
droplets are generated by self-assembled accretion of surfactants at the interface between
water and oil. Figure I.1 shows three structures of the most common types of flow-
focusing junctions for droplets production. Following optimization, crossroad junction
structure (Figure I.1.C) was discovered as the most efficient for stable droplet production.
Therefore, in this research only the crossroad junction structure was used for droplet
production.
Figure I.1.: Representative structures of junctions in which the droplets are generated A) T-junctions,
B) Y-junctions and C) crossroad flow-focusing. Blue and red channels indicate aqueous and oil phases,
respectively.
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Besides the flow-focusing junction many other droplet-based microfluidic units have
been designed and implemented to manipulate and to analyze the droplets content (Figure
I.2). The most commonly used are:
A) Pico-injection unit (Figure I.2 A), in which an alternating electric field induces
surfactant poration and allows well-controlled injection of aqueous phase into
the droplets; [16]
B) Droplet storage chambers (Figure I.2 B), where the droplets can be stored in spe-
cially designed PDMS niches connected via narrow channels, which is mainly used
for time-lapses high-throughout analysis of the droplets content; [17]
C) Droplets sorter unit (Figure I.2 C), in which an electric field is triggered, based
on the microscopic readout of the droplet content (i.e., the expression level of spe-
cific markers) and deflect the droplets to the left arm of a Y-junction due to di-
electrophoretic force, otherwise the droplets will flow into the wider right arm, due
to lower hydraulic resistance; [18]
D) Mixing unit (Figure I.2 D), in which zig-zag channels are used to mix fluids inside
the droplets; [19]
E) Deformation chambers unit (Figure I.2 E). which offers a possibility to investigate
the dynamic surfactants accretion on the oil-water interface; [20]
F) Spiral inlet unit (Figure I.2 F), which is required for the Dean flow (De) regime,
allowing the separation of cells or particles by an inertial lift and viscous drag
force. [21]
Upon interest, these operating units can be integrated together into one single device
or composed for special experimental needs.
Figure I.2.: Summary of the most common droplet-based microfluidic units. Representative images of mi-
crofluidic units: (A) pico injection, (B) droplet storage, (C) droplet sorting, (D) mixing the content in
droplets, (E) droplet deformation and (F) spiral device.
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The soft and dynamic nature of biocompatible droplets, their ultra-fast generation and
well-controlled environment add up to a system that combines many necessary functions
of micro-compartments for various biochemical and biomedical applications. Therefore,
droplet-based microfluidic systems are commonly implemented as screening tools for high
throughput chemical and biological analysis. [22] They may home cells [4,23] and are used to
create biocompatible gels and polymer particles. [24] Moreover, droplet-based microfluidics
have been implemented as containers for PCR (polymerase chain reaction) [25] analysis
and for in vitro transcription and translation applications. [26]
1.2. Surfactants
Surfactants (surface active agents) are amphiphilic molecules, which are part of many
products used in our daily life e.g. shampoo, washing powder or cosmetics. The oldest
known surfactant is soap that was used already 2500 years B.C. in Egypt. [27] Surfactants
consist of hydrophobic and hydrophilic parts, variable in their number, length, molecular
weights and functional groups (Figure I.3).
Hydrophilic 
head group
Hydrophobic tails
Diblock surfactant
Triblock surfactant
Figure I.3.: Schematic representation of a diblock and triblock surfactant
The hydrophobic part consists mainly of hydrocarbon or (per)fluorinated-carbon chains
and is selected according to the chemical nature of the carrier oil. In general fluoro-based
surfactants are considered to be more effective in stabilizing droplets than hydrocarbon
surfactants with the same chain length and hydrophilic head groups. [28,29] This can be
explained by the larger difference in energy for transferring a -CF2- group from bulk to
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micellar state in comparison to -CH2- groups. [29] As hydrophilic head groups many polar
and non polar molecules have been tested. [30] In biological applications the most common
hydrophilic units are composed of polyethylene glycol (PEG) groups. PEG molecules
create a passivation layer and therefore minimize unspecific depositions of proteins from
e.g. the cell media or buffer to droplet´s inner surface. [15,30] Chemically modified surfac-
tants (see detailed description in Section III.5 and IV.4) can also act as defined adhesion
structures on the inner surface of the droplet. [4,31]
During droplet formation surfactants are organized by self-assembly at the oil-water
interface and decrease the interfacial tension by creation of a dense monolayer. This
monolayer also serves as a steric barrier against droplet coalescence. [32] Surfactant shield-
ing efficiency is mostly determined by the structure, length and chemical composition
of the hydrophobic part. To asses quantitatively the surfactant‘s ability to form stable
emulsion, the hydrophilic-lipophilic balance (HLB) has to be evaluated: [33,34,35]
HLB = 20
Hw
Hw + Lw
Where Hw and Lw are the molecular weights of the hydrophilic and hydrophobic parts
respectively. The HLB values are in the range of 0 to 20, where 0 represents a hydrophobic
and 20 a hydrophilic molecule. [28] For the formation of stable water-in-oil emulsion droplets
with surfactants dissolved in the oil phase the HLB-value for the surfactant needs to be
adjusted between 1 to 10. [29]
An additional factor to be considered for stable droplets creation is the critical micelle
concentration (CMC), which represents the lowest concentration of a surfactant at which
micelles are created. [36] Below the CMC, surfactants are dissolved in solution as monomers,
above the CMC the surfactants form aggregates like micelles or vesicles depending on
their hydrophobic to hydrophilic ratio and their structure, while the concentration of free
surfactants remains constant. [27] Micelles have no effect on the interfacial tension. Typical
CMC values for water-soluble surfactants at room temperature are in the range of 10-1
to 10-5 M. [36] The CMC value is affected by surfactant-dependent factors, for example its
constitution (diblock, triblock or else) and the structure of its hydrophilic and hydrophobic
moieties, but also by the temperature and the type of solvent (polar/apolar). Very stable
droplets can be obtained with surfactants having large fluorocarbon hydrophobic residues.
These surfactants closely overlap and form a dense layer with a thickness of about 10 nm
to 50 nm. [15] However, if the surfactants molecular weight exceed 20000 dalton their
5
1. Microfluidics
adsorption to the resultant droplet‘s interphase will be affected by slow diffusion in the
oil phase. [15] Therefore, it is important to consider the kinetics and diffusion rates of
surfactants as they have to accrete sufficiently at the generated droplet‘s interface prior
the droplets gets in contact with other droplets. Table I.1 presents the summary of the
physicochemical properties of hydrophobic and hydrophilic parts of the surfactant on the
CMC values. [37,38,39,40,41,42]
In this research the effectiveness of surfactants to reduce the interfacial tension as a
function of the concentration was assessed by two interfacial tension measurement meth-
ods: static mode, using pendant drop method as described in Section III.1.2, and dynamic
mode, using a droplet deformation microfluidic device (Section III.1.3).
Table I.1.: Summary of the physicochemical properties of the surfactants that influence
the CMC-values
CMC increase CMC decrease
- Trifluormethylene groups
Hydrophobic - Branches - Perfluorinated compounds
portion - Polar groups (O or OH) - Large number of C-atoms
- Doublebonds
- Several headgroups - Polar organic groups
Hydrophilic - Ionic groups e.g. OH or NH3
portion - Polar groups in the - Several binding sites
middle of the surfactant for counterions
In this thesis droplet-based microfluidics was explored in the following topics: 1)
mimicry of the immune system cellular environment, with the goal of programing T cells;
and 2) Bottom-up assembly of minimal synthetic cells, with the goal of actomyosin cortex
constitution
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2. Artificial Biointerfaces for Immunological
Applications
In immunology the two main players are antigen-presenting cells (APCs) and T lympho-
cytes (T stands here for thymus, the organ where T cells mature). APCs are pivotal
for the recognition and capturing of disease-causing antigens and their presentation to
lymphocytes in lymphoid organs. [43,44,45] T cells respond to the presented antigens and
perform actions that play a crucial role in orchestrating the body’s adaptive and in-
nate immune system response . [46,47,48,49,50] In patients who suffer from life-threatening
diseases like cancer, HIV, or autoimmune disorders the clinically beneficial T cell types
and/or APCs are found in low frequencies. To increase the disease-fighting capacity of a
patient’s T cells a new type of therapeutic strategy, the adoptive T cell therapy (ACT),
has recently been developed. [46,47,48,49,50] ACT aims to generate a large pool of engineered
T cells resulting in a potent immune response specific to antigens on the disease-causing
cells. However, despite the beneficial impact of engineered T cells, the road towards
broadly applicable ACT is still long and winding. Many clinical trials have been largely
disappointing because of a lack of highly proliferative engineered T cells, whether naive
or early memory phenotypes. [51] Activation, ex vivo expansion and differentiation of T
cells into an early memory subset are central steps in an effective ACT and represent a
challenge as it remains difficult to simulate the intimate cellular interactions between T
cells and APCs during their contact in peripheral lymphoid organs. [52,53]
2.1. Immunological Synapse
The fate of T cells is not solely regulated by the presence of certain molecules on the
surface of APCs but also by their density and spatial distribution on the micro- and
nanometric scales. [44,54] Moreover, mechanical properties of APCs and force-dependent
conformational changes during the formation of an immunological synapse (IS; a highly
organized supramolecular complex at the APC-T cell interface, see Figure I.4) play a
crucial role in T cell fate regulation. [43,55]
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Figure I.4.: APC T Cell interaction (A) Schematic representation of the direct interaction between a T cell and
an APC.An ideal APC surrogate must present recognition/stimulation signals delivered through a TCR
during interaction with the appropriate pMHC complex or antibodies (antiCD3), which bypasses signals
that normally must be provided from the natural antigen-presenting cell through close cell-cell contact: 1)
antigen recognition signal, 2) co-stimulation signal (provided mainly by B7 proteins, CD80 and CD86, as
well as antibodies (antiCD28) provided upon interaction with CD28 and adhesion molecules such as ICAM-
1). The third signal, termed cytokine priming, influences T cell activation, proliferation and differentiation.
(B) Crosssection representation of the IS. Signaling molecules are organized into the supra-molecular ac-
tivation clusters (SMACs) by actin-dependent motility: the central SMAC (cSMAC, yellow) is enriched
with stimulation and co-stimulation complexes, the peripheral SMAC (pSMAC, orange) is enriched with
adhesion complexes, and the distal SMAC (dSMAC, purple) is enriched with large and bulky molecules
such as CD43, CD44 and CD45. Adapted with permission from Ref. [43] Copyright 2013, Israel Journal of
Chemistry.
In this research the primary goal was to design and to implement nanopatterned and
specifically biofunctionalized water-in-oil droplets as APC surrogates for immunological
applications, with the intense to develop and implement antigen-presenting interfaces
that represent flexible and modular systems that closely model in situ APC-T cell inter-
actions.
A critical event in the initiation of the adaptive immune response is the activation of
T lymphocytes. This step is mediated by antigenic substances (short peptide fragments
of 10-15 amino acids), which are presented by major histocompatibility complex (MHC)
molecules on the APC membrane and recognized by T cell receptors (TCRs). [56] The
generation of productive T cell responses, such as proliferation and differentiation, requires
signal mediation by the TCR, but also the engagement of additional co-stimulatory signals
and adhesion complexes in the IS. [43]
The hallmark trait of an IS is the dynamically coordinated formation of micrometer-
scale spatial patterns of cellular surface molecules, the so-called supra-molecular activation
clusters (SMACs) (see figure I.4). Real-time imaging of T cell-APC interactions in vivo [57]
and in vitro [58] showed that synapse formation starts with TCRs-pMHC microclusters at
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the periphery of the contact zone and its dynamic recruitment by the actin cytoskeleton to
the center of the synapse. This creates a central SMAC (cSMAC) zone (Figure I.4), which
is surrounded by peripheral SMAC (pSMAC) that is enriched with adhesion microcluster.
Despite the fact that the supramolecular organization of the IS was described more than
fifteen years ago, understanding the mechanisms underlying SMACs formation and their
impact on T cell functions remains a challenge. Therefore, from the immunological point
of view it is imperative that the biophysical properties of artificial APCs must deliver
the critical functions of protein transport regulators, namely the cell membrane and the
dynamic actin cytoskeleton; both are essential for the signaling activity of single proteins
and whole cells. [59]
2.2. State of the Art Antigen-Presenting Interfaces
During the past twenty years much effort has been concentrated on the development of 2D
planar APC analogues as summarized in details in Platzman et al. [43] The most common
technology was based on supported lipid bilayers (SLBs), which provide a suitable model
system for mimicking the cell membrane (reduced from three to two dimensions), because
the lateral mobility of lipids and proteins partially resembles the in vivo situation. [60,61]
SLBs containing fluorescent-labeled APC ligands enabled the discovery of the IS, and
have since then been heralded as a powerful model for investigating the dynamically coor-
dinated SMACs formation. [62,63] Moreover, to better mimic membrane properties in vivo,
different semiconductor fabrication strategies have been implemented to define spatial
constraints within SLBs in order to alter the mobile fraction and the diffusion of incor-
porated proteins. [64,65,66] For example, TCR signaling can be controlled by maintaining
TCR in the periphery and preventing its dynamic recruitment to the center of the synapse,
by means of continuous linear barriers that increase TCR-associated phosphorylation, as
well as intracellular Ca2+ levels (Figure I.5 A). [66] Furthermore, DeMond et al. [64] used
electron-beam to create molecular mazes composed of short, periodic linear fences. It was
observed that TCR clusters were deflected by maze fences, when they encounter them,
but continued to move parallel to the fences, at speeds that scale with the relative angle
of motion to the preferred centripetal direction. Moreover, this study revealed that a
frictional drag force determined by the coupling chemistry (e.g., via talin) to the dynamic
actin cytoskeleton, drives the movement of protein microclusters. [67]
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Figure I.5.: Schematic representation of supported lipid bilayers in defined compartments and T cell
proliferation on soft substrates A) Schematic view of a patterned SLB surface and the hindered orga-
nization of SMACs. Adapted with permission from Ref. [43] Copyright 2013, Israel Journal of Chemistry.
B) Rigidity-dependent activation of mouse naive CD4+ T cells presented by IL-2 secretion and cell attach-
ment characterizations 6 hours after seeding. Adapted with permission from Ref. [68] Copyright 2012, The
Journal of Immunology.
As previously mentioned, IS formation upon interaction with APCs is also characterized
by a dynamic cytoskeleton, and adhesion proteins (e.g. integrin - LFA-1) interactions.
This suggests the involvement of mechanical forces in T cell activation. That is supported
by recent studies which showed that TCRs are sensitive to forces in the pN range. [69,70]
This indicates the important role of cytoskeleton contractility in APCs during T cell
activation. [69,70] Unlike cellular membranes, SLBs do not allow any pushing or pulling
force due to the supported rigid surfaces. Therefore, considering that T cells are unlikely
to encounter stimulatory surfaces with the stiffness of glass in vivo – much effort has been
put into the development of biocompatible APC supports that more closely mimic the
physiological elasticity ranges found in living organisms.
In attempt to provide answers to the question if T cells can sense the stiffness of the
antigen presenting surfaces O’Connor et al. [68] explored the impact of PDMS substrates
stiffness (EY < 2 MPa) on the ex vivo activation, proliferation and differentiation of
the primary human T cells (Figure I.5 B). It was shown that soft substrates (Young’s
modulus - EY < 100 kPa) on average support a 4-fold increase in overall T cell expansion
and greater IL-2 secretion than stiffer (EY = 2 MPa) substrates. Moreover, CD4+ T
cells expanding on soft substrates yield in an average 3-fold greater proportion of IFN-
producing type 1 helper (Th1) T cells, indicating that naive T cells expanding on soft
substrates can function more effectively following adoptive therapy in cancer. [71] These
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results depicted the important and afore unrecognized influence of the APC surrogate
mechanical properties on T cell proliferation and differentiation. In the case of clinical-
grade culture systems for in vitro T cell expansion such as bead-based APC analogs
(see the following paragraph), these findings could contribute to more rigorous material
selection, with an eye to mechanical property control.
Monodisperse, cell-sized polystyrene or magnetic iron oxide rigid beads endowed with
stimulatory and co-stimulatory antibodies were qualified as clinical-grade APCs systems
for T cell expansion in adoptive therapy (Figure I.6 A). [43] These beads have been highly
useful to define the optimal size of artificial 3D APCs as well as to determine the spa-
tial requirements and the minimal number of receptors (60 µm-2) to stimulate T cells
efficiently. [72,73] Bead-based APC surrogate systems provide good control over T cell acti-
vation and differentiation, but the approach has several limitations. The ability of these
systems to serve as an optimal APC analogues is mainly hindered by their inability to
dynamically remodel their protein composition, which is in stark contrast to the natural
IS. Additionally, the rigid nature of the bead material limits mechanosensing, which was
shown to be crucial for effective T cell activation control.
Figure I.6.: Schematic representation of T cell bead interactions and experimental results of bead medi-
ated T cell proliferation in µwell arrays A) Schematic sketch of A) latex and B) magnetic bead-based
APCs. Adapted with permission from Ref. [43] Copyright 2013, Israel Journal of Chemistry. B) Represen-
tative images of microwell-arrays with trapped beads and T cells. Adapted with permission from Ref. [74]
Copyright 2012, Lab on a Chip.
So far most T cell experiments described in literature were performed in suspension
mode. Unfortunately, this approach limits long-term dynamic analysis and control over
T cell processes using live-cell imaging. Firstly, primary naive T cells are non-adherent
11
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and become highly motile after stimulation - this means they escape rapidly out of the
field of view. Secondly, T cell differentiation is a relatively slow process (several days).
Thirdly, cell cytokine secretions become diluted. Lastly, T cell activation is considered to
be a stochastic process. Therefore, analyzing individual T cells and their most proximal
environment brings new insights of T cell response. [75] Recently, an experimental platform
which combines microwell arrays and bead-based APC, [74] as shown in Figure I.6, was used
for long-term monitoring of individual T cells. However, while this system was able to
provide a more controlled environment for long-term monitoring it failed to contribute to
a better design of synthetic 3D APC systems.
In this thesis a new APC analogue was designed overcoming the described drawbacks
by combining the afore mentioned advantages of 2D and 3D systems namely: [4]
- Control over identity and quantity of bio-ligands
- Dynamic organization of bio-ligands
- Allow T cells to exert forces in all three dimensions
- A well defined environment for long-term (up to 3 days) monitoring of individual
T cells over the course of their proliferation and differentiation.
3. Bottom-Up Assembly of Minimal Synthetic Cells
„What I cannot create, I do not understand.“ This quote by the American physicist Richard
Feynman can be also applied to biology. This way of thinking constituted a trigger or,
in other words, a catalyzer for a new biological field of research – i.e. synthetic biol-
ogy. [76] Traditionally, in biological research a complex bio-relevant matter is observed and
examined as it is normally found in nature. Therefore, a biological research generally
suffers from the fact that the systems to be technologically explored, such as tissues or
cells exhibit an enormous complexity. In an attempt to overcome this complexity, syn-
thetic biology thrives not only to observe the biological matter but also to generate it by
means of simple man-made devices that can be externally controlled to allow a bottom-up
assembly. [77,78] The aim of synthetic biology is not to replace the traditional biological re-
search, but to contribute synergistically by the implementation of the mechanical insights
gathered over decades of research in molecular biology to provide biomimetic systems for
better understanding of biological properties.
In this thesis, the primary goal was to explore the possibilities of droplet-based mi-
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crofluidics in the engineering of biomimetic micro-compartments for a bottom-up assem-
bly of sub-cellular units in vitro. Towards this end, water-in-oil nanostructured emulsion
droplets were used as cell-size compartments to achieve the functional bottom-up assembly
of the minimal number of proteins required for reconstitution of the actomyosin cortex.
3.1. Formation of Biomimetic Micro-Compartments
The main distinguishing feature of eukaryote cells is further compartmentalization –
the presence of lipid-membrane-enclosed compartments within the cell in which specific
metabolic activities take place. Therefore, in synthetic biology, especially in bottom-up
approach, it is imperative to create stable and well defined cell-sized compartments. An
important property of compartments is to provide boundaries in order to avoid diffusion
and dilution of biological components. Another important task of compartments is to
provide a connection with its surrounding. While keeping essential intercompartmental
functions, this connection can be provided by selective in and out material and/or signal
transport via biochemistry on the compartment interface. There are three main types of
functional micro-compartments in synthetic biology: 1) vesicles (lipid membrane-based
micro-compartments); 2) polymersomes (polymer-made synthetic membranes) and; 3)
droplets (water-in-oil emulsion micro-compartments).
3.2. Vesicles
Lipid membrane-based vesicles are the most traditional compartments in synthetic biol-
ogy. These compartments provide a suitable model system for mimicking the cell mem-
brane because the mobility of lipids and incorporated proteins closest resembles the in
vivo situation. [79] Nowadays, the most common method for the preparation of giant unil-
amellar vesicles (GUVs) is electroformation (Figure I.7) [80,81] or spontaneous swelling e.g.
hydrogels.
This method uses a thin lipid film on electrodes by deposition of a lipid solution and
evaporation of the organic solvent under a flow of nitrogen to inhibit lipid oxidation. Glass
slides coated with indium tin oxide (ITO), a transparent semiconductor, or platinum wires
are usually used as electrodes for the application of direct current (DC) or alternating
current (AC) electric fields. It was shown, that the upper boundaries for the AC electrical
field’s frequency and strength are 10 kHz and 10Vmm-1 respectively. [82] Despite the fact
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several theories tried to explain the growth of GUVs under electrical fields the exact
mechanism of GUVs generation is still unclear. [80,83,84]
Figure I.7.: Schematic representation of GUVs creation by electroformation Illustration of the elctroswelling
device consisting of two ITO-coated glasses, each connected with a copper electrode and isolated to the
other ITO glass to crate an else cortical field for electroswelling.
To achieve a higher yield of GUVs formation, electroformation method was combined
with the addition of high concentration of sodium ions. This is in contrast to the cytosol
of animal and human cells which exhibit a relatively small concentration of sodium and a
relatively large concentration of potassium. [85,86] Therefore, current studies elucidate the
mechanical properties of lipid vesicles exposed to physiological buffers with high potassium
concentration, which has a strong effect on the kinetics of enzymatic reactions and filament
polymerization.
In general, lipid vesicles demonstrate the potential advantages of using fluid membrane
compartments for synthetic biology applications. Nevertheless, several general challenges
for using GUVs for these types of applications exist. Mechanical instability of GUVs is
considered to be a main challenge in utilization of this micro-compartment system. Above
1 µm the mechanical stability of GUVs decreases with increasing size. [87] Furthermore, the
limited chemical stability of GUVs caused by oxidation processes of unsaturated fatty acids
and the hydrolysis of ester bonds are another drawback of this system, unless antioxidants
and chelating agents are added. [87] Moreover, the functional and controllable delivery of
protein complexes into the GUVs is time consuming, especially when their stability is
low. [88] Another drawback of this system is the uncontrolled orientation of incorporated
proteins. All this has led to research on other kinds of artificial micro-compartments that
possess advantages similar to those of lipid vesicles but have greater stability.
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3.3. Polymersomes
Vesicles made of amphiphilic copolymers have been used in synthetic biology applications
due to their increased stability, rigidity of their membranes and increased lifetime. [89,90]
In contrast to lipid vesicles, where lipid properties manipulation is limited, the thickness,
bending and stretching moduli, and the permeability of the polymeric membrane can
be easily tuned by changing the blockcopolymer molecular properties. In context of
controlled orientation of incorporated proteins polymersomes have also several advantages
in comparison to lipid vesicles. Directed insertion of membrane proteins into the synthetic
membrane can be achieved by orientation control of membrane proteins via tethering to
functional groups and/or antibodies. [91,92]
Nowadays, the most common methods for the preparation of the cell-sized polymer-
somes are electroformation (similar to lipid vesicles formation, see Section I.3.2) [80,93] and
double emulsion microfluidics as described in Figure I.8. [94] Polymersomes production
via electroformation generate polymersomes with poor control of size distribution and
a low efficiency of encapsulation as already discussed in the case of GUVs. [94] Narrow
polymersomes size distribution can be achieved by microfluidic approach using mixtures
of chloroform and hexane as hydrophobic phase which allows quick evaporation and the
creation of polymersomes with a double layer of polymers in the periphery. Nevertheless,
encapsulation and further manipulation of protein containing polymersomes still represent
big challenges. [95]
Figure I.8.: Schematic representation of double emuslion polymersome productrion Illustration of a microflu-
idic capillary device for W/O/W-double emulsion droplets stabilized by polymersomes. These devices con-
sist of pointed cylindrical capillaries in a square capillary. With the first cylindrical capillary the solution
for encapsulation is injected into the oil phase and the double emulsion droplets are collected by the second
capillary.
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These drawbacks are mainly due to complications related to controlled permeability of
the traditional polymersomes [96] and due to the lack of technological means that allow
precise and efficient injection of different biological components into polymersomes. To
overcome these obstacles, a new highly innovative and creative approach in bottom-up
synthetic biology had to be created, as described in the following section.
3.4. Droplets
Microfluidic block copolymers-stabilized water-in-oil droplets can also be classified as
polymersomes, but due to the continuous oil phase they are considered in the scientific
community as emulsion droplets. The advantages of water-in-oil emulsion droplets for
biological applications have been described in details in Section I.1.1. In the context of
bottom-up assembly of artificial cells droplet-based compartment systems represent the
advantages of the polymersomes, but can also be easily adapted to the droplet-based
microfluidic technologies for precise delivery of bio-relevant ingredients. The continuous
oil phase can play an important role in preserving the droplet material content (see Section
IV.3). Moreover, a continuous oil phase is required to control an injection (details see
Section I.1.1) of precise amounts of high-value biomaterials exclusively into the droplets
Figure I.9.
Figure I.9.: A droplet based pico-injection unit. (A) Shows a junction to control the spacing between the droplets
through addition of oil via the second oil channel. Figure (B) shows a injection channel and the electrodes
of an alternating electric field with 30kHz and 600V used to reduce the stability of the surfactants in the
droplet periphery for an aqueous injection of other cellular components (injection volume can range between
2 to 100 pL dependend on the applied pressure) from a pico-injection channel.
Due to the variety of required cellular components in the droplets the microfluidic device
with small and compact electric systems was integrated to apply electric fields in micro-
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channels. These electrical fields allow the destabilization (poration) of surfactants and
lipid bilayers towards controlled fusion (pico-injection) of solutions containing different
cellular components into the droplets. Figure I.9 (A) shows how the spacing between the
droplets carrying different cellular components is controlled through addition of oil via the
second oil channel. Figure I.9 (B) the injection unite where, an alternating electric field
with 30kHz and 600V reduces the stability of the surfactants in the droplet periphery for
an aqueous injection of other cellular components (injection volume can range between 2
to 100 pL depending on the applied pressure) from a pico-injection channel.
This thesis comprises a pioneering attempt to dissect the complex cellular sensory ma-
chinery by means of an automated droplet-based microfluidic approach. Towards this
end, water-in-oil nanostructured emulsion droplets (see Section IV.4) as cell-size com-
partments were used in combination with pico-injection technology to achieve a functional
bottom-up assembly of a minimal number of proteins required for “droplet-based minimal
synthetic cells”. While the applied methodology allows for the assembly of a wide range
of subcellular functional units, the main focus here was on actin cytoskeleton filament
organization.
4. In Vitro Reconstitution of Actin Cytoskeleton
network
The filamentous actin (F-actin) is one of the three main constituents of eukaryotic cy-
toskeleton. In vivo it is formed by the assembly of actin monomer units into filaments that
can be dynamically organized in a variety of ways, via recruitment of more than 130 dif-
ferent accessory proteins. [97] Some of these proteins affect F-actin assembly and disassem-
bly rates, others, like molecular motors, cross-linkers and nucleators generate mechanical
forces, crosslink, bundle and branch the filaments. These dynamic processes can self-
organize the filaments into a variety of sub-cellular structures such as contractile rings, [98]
protrusions [99] and the actin cortex. [100,101] This biochemical dynamic organization is in
a close interplay with the cellular biophysical processes. Therefore, actin cytoskeleton
affects many cellular processes, including, but not limited to, cell division, force gen-
eration, polarization, intracellular transport and motility. [102,103,104] This broad range of
actin-mediated processes also underscores their central physiological role, as well as their
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involvement in a wide variety of disease states. [105,106,107] Although attaining a fundamen-
tal characterization of how macroscopic cytoskeletal dynamics emerge from its molecular
constituents is a compelling goal, little understanding has yet been accomplished, mainly
due to the extensive complexity of the cytoskeleton network and difficulties inherent in
studies in vivo.
Engineering of biomimetic systems for controlled bottom-up reconstitution of sub-
cellular units in virto has become an important strategy for dissecting complex actin-
cytoskeleton systems. In principle, efficient biomimetic systems should allow full control
of the constituents for studying the effect of specific changes in molecular composition, and
their biophysical properties have to resemble as close as possible in vivo conditions. [108] In
living cells, a part of the actin cytoskeleton is coupled to membranes and thereby provides
structural integrity. Therefore, while engineering biomimetic systems, a particular focus
has to be on coupling of reconstituted actin filaments to synthetic membranes. [109,110]
The most known biomimetic system for in vitro actin-based motility and cytoskele-
tal organization in bulk is a supported lipid bilayer (SLB). SLBs are planar continuous
fluid films of uniform density that form by the spontaneous fusion and self-assembly of
liposomes and/or proteoliposomes on clean silicon oxide surfaces. The experimental data
concerning the formation of the SLBs and their chemical biofunctionalization has been
summarized and reported in detail previously. [61,111,112] SLBs provide a good model system
for mimicking the cell membrane (reduced from three to two dimensions) because the lat-
eral mobility of lipids and proteins partially resembles the situation in vivo. Furthermore,
high-resolution imaging and manipulation techniques, including laser ablation and fluores-
cence recovery after photobleaching (FRAP), [113,114]fluorescence correlation spectroscopy
(FCS), [115,116] stimulated emission depletion microscopy (STED), [117,118] and atomic force
microscopy (AFM) [119,120] can easily be applied on the flat geometry of SLB systems for
actin cytoskeleton investigation. During the last fifteen years, several groups developed
biochemical methods to couple between the actin and the SLBs. [121,122,123,124,125] The ba-
sic strategies to couple actin to SLBs in vitro were based on cell-derived or recombinant
transmembrane proteins such as ponticulin that anchor the actin network to the cell
membrane and serve as nucleation sites for actin assembly. [121,126,127] Another strategy
is based on addition of phosphatidylinositol 4,5-bisphosphate (PIP2) lipids that serve as
anchoring points for N-WASP actin nucleators. [128,129] For example, Lee et al. [125] used
PIP2 containing SLB system to generate a thin dendritic actin layer on the surface of
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the membrane, and by addition of frog egg extract to the membrane actin was able to
reconstitute long filopodia-like actin structures. Other studies added G-actin or F-actin
to ponticulin-containing SLBs and created cortex-like actin structures with the average
actin layer thickness of 15 nm as revealed by AFM measurements. [122]
Together, these studies point to a powerful role of SLBs in modulation of spatial dy-
namic organization of actin filaments. However, unlike in biological membranes, the
planar bilayers do not allow pulling of the proteins and instead are rigid in the vertical
dimensions due to the trapping at the glass surface. Therefore, the ability of actomyosin
cortex to exert forces in all three directions is restricted in studies on supported rigid
surfaces. Moreover, to emulate cortical dynamics it is essential not only to incorporate
actin turnover dynamics to soft interfaces, but also reproduce a cell-like geometry.
Lipid vesicles or droplets can overcome the aforementioned limitations due to their 3D
cell-like geometry and soft interfaces. For example, Liu et al. [110] used PIP2 containing
GUVs to show that elastic interactions between the synthetic lipid vesicle membrane and
reconstituted actin cytoskeleton can cooperate without accessory proteins to induce the
formation of actin filament protrusions (Figure I.10).
Figure I.10.: Role of membrane in formation of thin actin filament protrusions. A model of membrane-
induced formation of actin filaments. Left: Small, local deformations of the membrane induced by actin
filament polymerization against the membrane (black arrows).
Merging attractions to create a larger deformation (curly brackets). Middle: Deformations that fail to create a larger
deformation (grey arrows). Right: After bundling of filaments to overcome the resistance of the membrane.
Actin filaments bundle and can elongate without further physical constraint. Adapted with permission
from Ref. [110] Copyright 2008, Nature Physics.
Model of membrane-induced formation of a thin actin filament protrusion. Left: Small-
amplitude local deformations of the membrane arise as actin filaments polymerize against
19
4. In Vitro Reconstitution of Actin Cytoskeleton Network
the membrane (black arrows). Deformations that are within the range of attraction are
able to merge to create a larger deformation that gathers extra filaments (curly brackets).
Middle: Deformations that fail to gather extra filaments are stalled and diminish (grey
arrows). Right: After bundling enough filaments to overcome the membrane resistance to
tube formation, a ‘proto-filopodium’ can elongate without further physical constraint.
This work highlighted the mutual influence of the membrane on the actin cytoskeleton
and vice versa. To mimic better the physiological conditions of actin–lipid membrane
coupling, Merkle et al. [130] used porcine lipid extract to generate GUVs containing actin
and spectrin/ankyrin actin anchoring proteins. F-actin was found in contact with the in-
terior walls of GUVs, indicating an efficiency of membrane anchoring protein complexes.
Other studies examined morphological response of the actin networks (without linkage
to GUVs periphery) as a function of accessory proteins, such as crosslinkers or F-actin
depolymerizing agents. It was shown that the formation of randomly linked networks to
ring-like structures depends not only on different ratios of accessory proteins but also on
temperature and ion concentration. [131] Moreover, it was shown that by only changing
the dimensions (i.e. diameter) of the GUVs and keeping constant the biochemical and
biophysical conditions of an encapsulated actin system, one can easily control the mor-
phology of actin network structures. [132] However, it must be noted here that these studies
were performed with the actin concentration that is fifty times lower in comparison to
intracellular actin concentration.
One of the major drawbacks of GUVs system in the case of actin cytoskeleton in-
vestigation is that the lipid membrane is destroyed by high concentrations of salts and
actin during an electroformation. To partially overcome this obstacle, new methods for
GUVs formation have been developed. These methods include: 1) dried hybrid lipid-
agarose films, [133] 2) water-in-oil lipid monolayer droplets as precursors for GUVs for-
mation, [134] and 3) double emulsion microfluidics (see Section I.3.3). [95] For example,
Tsai et al. [133] implemented recently the dried hybrid lipid-agarose films [133] method to
reconstitute the actomyosin cortex within the GUVs. To test whether myosin-driven
contractility can cause actin membrane rupture, biotinylated lipids were used to anchor
biotinylated actin via streptavidin linkage. An important outcome of this study was that
at the high myosin/actin ratios (e.g. 1/50 and 1/100) motor-driven forces can rapture
actin-membrane attachments and no cortex structure can be observed. In a recent study
Miyazaki et al. [98] used water-in-oil lipid monolayer droplets as cell-sized compartments to
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demonstrate that actin filaments could assemble into a single ring-shaped bundle without
spatial regulatory signals. On the basis of droplet size and geometry dependencies the
authors proposed a confinement-induced assembly mechanism, which indicates a direct
contribution of cell rounding to contractile ring assembly. Another important outcome
of this study was that in addition to droplet size and geometry dependencies, myosin
concentration and its state (dimer or oligomer, controlled by KCl concentration) [135] can
regulate both actin ring assembly and its contraction. Based on the results the authors
proposed that myosin dimers promote the cytokinetic ring assembly, and myosin oligomers
could switch the ring assembly phase to the contraction phase and induce the complete
contraction.
Despite the fact that new methods for GUVs formation have improved the concentration
related limitation in the field of actin reconstitution studies, the mechanical instability
of the cell-sized GUVs and a lack of technological means for their controlled manipu-
lation still represent major drawbacks of this system. Therefore, to overcome stability
issues, polymer-stabilized water-in-oil emulsion droplets become an alternative micro-
compartment system for actin reconstitution studies. Recently Pinot et al. [136] reconsti-
tuted a dynamic, flowing F-actin network using Xenopus meiotic extracts (these extracts
ostensibly represent a full array of in vivo actin regulatory proteins) artificially confined
within the polymer-stabilized emulsion droplets. In addition, the droplets periphery was
functionalized to recruit actin nucleation promoting factors. To examine how confinement
induces the generation of symmetry breaking and F-actin flow, the authors applied bio-
chemical perturbations of actin polymerization dynamics by cytochalasin D or phalloidin
or affected the filament nucleation growth by addition of suppressor of G-protein-coupled
cyclic-AMP receptor (SCAR) domains that stimulate bulk nucleation or inhibited the
activity of myosin II. The authors showed that perturbation of actin polymerization or
filament nucleation growth lead to the inhibition of F-actin flow. On the other hand, inhi-
bition of myosin activity did not significantly affect F-actin flow dynamics in the droplet
confinement. Based on these observations the authors highlighted the primary role of
actin polymerization dynamics and nucleation in generation of actin flow. More recently,
Enas Abu Shah and Kinneret Keren used similar polymer stabilized water-in-oil droplets
to reconstitute actomyosin cortex from Xenopus laevis egg cytoplasmic extracts supple-
mented with labeled actin. [137] In contrast to previous studies they showed that symmetry
breaking is induced by myosin-driven cortical actin flow and sufficient network connectiv-
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ity, but does not depend on pre-patterned localization of actin nucleators. Moreover, it
was shown that the dynamics of artificial cortices is temperature-dependent – a shift by
a few degrees leads to a change in behavior, ranging from homogenous cortices at high
temperature (30 °C) to asymmetric actin caps at low temperature (20 °C).
The controversy in the results can be related to the fact that these studies used cell
extracts to reconstitute the actomyosin cortex within the droplets. Cell extracts reflect
better the cellular conditions, whereas the molecular composition is much less controlled
than in purified systems. Therefore, in this thesis the actomyosin cortex has been recon-
stituted from purified proteins. Towards this end, water-in-oil nano-structured droplets
as cell-size compartments and integrated microfluidic picoinjection technology were used
to achieve the functional bottom-up assembly of the minimal number of proteins required
for “synthetic actomyosin cortices”.
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Cellular interactions with the extracellular matrix or other cells are involved in nearly
every cellular event. These responses, in turn, affect almost all facets of cell’s life, includ-
ing, but not limited to, directional migration, cell proliferation, differentiation, survival
and gene expression. This broad range of adhesion/interaction-mediated processes also
underscores their central physiological roles, as well as their involvement in a wide vari-
ety of disease states. Although attaining a fundamental characterization of these cellular
functions is a compelling goal, little understanding has yet been accomplished, mainly
due to the extensive complexity of these processes. Therefore, engineering of biomimetic
systems for controlled manipulation of individual cells or subcellular units in vitro has
become an important strategy, particularly in biomedical applications.
In this thesis the primary objective was to dissect complex cellular sensory machin-
ery by means of an automated, high-throughput droplet-based microfluidic technology.
Specifically, the research was focused on the capacities of this technology in the following
topics: 1) Mimicry of the immune system cellular environment for adoptive T cell therapy;
2) bottom-up assembly of “droplet-based synthetic cells” capable to self-assemble differ-
ent sub-cellular functions, and, as a consequence, to generate signaling events including
actomyosin cortex organization, migration and self-propelling.
As described in details in the previous section, over the past decade water-in-oil emulsion
droplets created in droplet-based microfluidic devices have become widely used as a screen-
ing tool for biological and chemical applications. The soft and dynamic nature of these
biocompatible droplets, their ultra-fast generation and well-controlled environment add
up to a system that combines the necessary biophysical functions of micro-compartments
for synthetic biology applications. To generate antigen-presenting cell surrogates for T
cell stimulation and to create "synthetic cells" using a bottom-up approach the aim of
this research was to further optimize the biophysical properties and to provide droplets
with required active biochemical functions.
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In the immunological application the goal was to generate a novel antigen-presenting
interface that closely mimics in vivo conditions. The intention was to create a system
that offers: control over identity and quantity of bio-ligands; dynamic organization of
bio-ligands; T cells to exert forces in 3D; a defined environment for long-term (3 days)
monitoring of individual T cells over the course of their proliferation and differentiation.
In an attempt to dissect the complex cellular sensory machinery by means of an au-
tomated, high-throughput droplet-based microfluidic technology, the research aimed to
apply the functionalized droplets as cell-sized micro-compartments for a bottom-up as-
sembly of “minimal cells”. In this regards, particular attention was on achieving precise
control over the reconstitution of the actomyosin cortex, with the following analysis of its
dynamics.
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1. Surfactants
Surfactants were synthesized as described in chapter IV section 1 using perfluorpolypropylene-
carboxylic acid 2500 and 7000 molecular weight (PFPE-acid, DuPont, Netherlands) and
polyethylenglycol 600 and 14000 g/mol (PEG, Fluka, Germany). A representative sketch
of a micro droplet with gold-nanoparticle surfactants and triblock surfactants is presented
in figure III.1.
Figure III.1.: Schematic representation of a nano-structured surfactant-stabilized droplet water-in-oil
emulsion droplet. The structures of the triblock-copolymer surfactant, which are essential for long-
term stability, and the diblock gold-linked surfactant required for the biofunctialization are presented.
All solvents used for synthesis were purchased from Sigma-Aldrich in dry state and
stored with molecular sieve, under nitrogen or argon atmosphere. Reactions with water-
sensitive substances were performed in heated flasks under nitrogen atmosphere. Success-
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ful surfactant synthesis and their purity were confirmed using Fourier transform infrared
(FT-IR) and nuclear-magnetic-resonance (NMR) spectroscopies. Following synthesis the
surfactants were dissolved in Fluorinert®-FC40 (1.85 g cm−3, Iolitec, Germany) and fil-
tered with 0.2 µm PTFE-filters (Rotilobo®-Syringe-filter, Carl Roth GmbH, Germany) to
obtain final concentrations of 0.5 to 50 mM for stabilizing surfactants and up to 300 µM
for gold-linked surfactants.
1.1. Chemical characterization of synthesized surfactants
1.1.1. FT-IR Analysis
IR measurements were conducted on a Nicolet 6700 Nexus infrared spectrophotometer
(Thermo Electron GmbH, Dreieich, Germany) equipped with a DTGS detector. A de-
mountable path-length cell for liquid FTIR (Thermo Scientific, USA) with KBr glasses
and FC-40® perflourinated oil as solvent was used for all measurements. An average of
100 scans per analysis was collected with a resolution of 2 cm-1.
1.1.2. NMR Analysis
1H and 13C spectra were recorded using Bruker Avance III 600 with sample changer (B-
ACS 60) und cryo-unit, magnet: Bruker Ultrashield plus, 14.1 Tesla, test frequency 1H:
600.13 MHz, probehead: 5 mm QNPCryoProbeTM with ATMA (automatic tuning and
matching), inner coil 15N/13C/31P , Z- Gradient, temperature Range -10°C to 80°C.
1.2. Interfacial Tension Measurements (IFT)
OAC (Data Physics, USA) tensiometer with 90° turned CCD-camera and pendant drop
method was used to measure the surface tension of surfactant stabilizing liquids. Laplace-
Young was selected as a fitting-method. [138] Oil phase (Fluorinert® FC-40, Iolitec, Ger-
many) and aqueous phase densities were set to 1.9 g cm−3 and 0.99 g cm−3, respectively. As
aqueous phase 3ml type 1 (ISO 3696) water was used in a glass cuvette. The oil phase con-
tained the sample surfactant diluted in FC-40. Prior to measurement samples were drawn
into 1ml syringes and attached to the metal bracket via 0.4mm× 20mm BL/LB cannula
and PTFE-tubing (∅in0.32mm, ∅out0.78mm). The test cannula (0.8mm× 22mm blunt/
dull) was attached to the metal bracket and lowered into the aqueous phase. Drops were
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created manually using the syringe. All dilution series were tested starting from the lowest
concentration to reduce the effect of cross contamination. When switching to the next
higher concentration, the tubing device plus test cannula and metal bracket were washed
with 100 µl of the next sample and incubated 30min to equilibrate inner surfaces. Before
each measurement cuvettes were washed with 96% EtOH, rinsed with acetone, N2-dried,
washed with type 1 (ISO 3696) water and again filled with 3ml type 1 water. Before
measuring a new dilution series metal brackets and cuvette were ultra-sonicated 30min
in a 2:1 mixture of Extran® (Merck Millipore, Germany) and type 1 water (ISO 3696)
at room temperature, thoroughly washed with type 1 water and again ultra-sonicated
30min in type 1 water. Metal brackets were furthermore ultra-sonicated 30min in 99.9%
MeOH, rinsed with acetone and N2-dried. Before attaching the metal brackets to the
tubing device the inner surface of the test cannula was rinsed with 1ml FC-40. Droplet
interfacial tension (IFT [mNm−1]) was analyzed over time. Once IFT did not show any
change over a course of 1000 s the measurement was stopped and IFTfinal was collected
for each concentration C.
The exponential decay of IFTfinal = γ = α · e−βC + η, with surfactant concentration C,
was fitted to the data where η is IFT after reaching CMC (critical micelle concentration),
α is the surface pressure after reaching the CMC. [33] Therefore α + η is the IFT of the
oil phase without surfactant. β is a factor, which indicates the slope of the IFT. All
parameters were calculated using the Gauss-Newton Algorithm.
γCMC = η
ΠCMC = α
CMC = e
1
β
From the Gibbs-Helmholtz equation the surface excess Γ = − 1
2.303RT
· dγ
dlgC
with the gas
constant R and temperature T was derived. The area each surfactant molecule occupies
on the surface is a [A˚2] with Avogadro constant NA.
Γ =
α
RTe
a =
1
NAΓ
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For each surfactant all three parameters α, β and η were calculated for each dilution
series. All analysis was done with R (RStudio, Version 0.98.1103 – © 2009-2014 RStudio,
Inc., USA) (script in appendix).
1.3. Droplet Deformation Analysis
Droplet deformation microfluidic analysis as described by Brosseau [139] was implemented
for dynamic IFT characterization. Figure III.2 shows images of the flow cell in which
the droplets deformation occured by a sudden change in a flow regime. To detect the
deformation, high speed videos were recorded with 16000 frames per second (Phantom
v7.3, Vision Research, USA).
 0 ms      1 ms        2 ms         3 ms           4 ms             5 ms    6 ms 25 µm
Figure III.2.: Droplet deformation in flow cell chamber Time series from left to right depicting droplet deforma-
tion due to different flow rates as a reason of a sudden change in flow rate.
ImageJ was used to extract droplet shapes from the videos. Evaluation is displayed in
figure III.3. First, a time average of the video was calculated and subtracted from the raw
video. For the result (-avg) a threshold based on the video histogram was calculated using
Otsu’s method. [140] This method divides a histogram into two partitions by minimizing
the variance within each partition. The Particle Analyzer Plugin (ImageJ) was used to
extract shapes from the resulting (thresholded) binary video. Recognized shapes were
constrained to closed shapes of 1500 px2 to 5000px2 in size. Displays of extracted shapes
showed that only droplets not touching the walls of the flow cell were recognized.
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Figure III.3.: Droplets shape evaluation from deformation recordings Using ImageJ a Z-average of the raw
videos was calculated and subtracted from the raw video. For the result (-avg) a threshold for the video
histogram using Otsu’s method was calculated. This binary video (thresholded) was then analyzed with
the Particle Analyzer -Plugin and shapes were recognized (shape).
Shape information such as Feret’s diameter, minimum Feret’s diameter and slice were
saved and further analyzed with R(software) (detailed analysis program script in ap-
pendix). Deformation δ for each shape was calculated with δ = Feret−Feretmin
Feret+Feretmin
. [139] Figure
III.4 shows the deformation of each droplet entering the flow cell chamber. Total of fifty
frames (3 ms) were necessary for each droplet to reach the maximum in deformation and
to become round again. For all experiments only the entry region into the chamber was
recorded to exclude outgoing droplets. For calculating local maxima deformation values
were compared to at least 31 neighbouring values (red in figure III.3).
Figure III.4.: Representative analyses of droplets deformations as obtained in the deformation flow cell
chamber. Calculated deformation of water droplets over time [slice] in FC40 with 2.5mM of 60% Tri-
7000-PEG-1400 and 40% Di-7500-750-O-Me recorded in the last flow cell chamber. Local maxima are
displayed in red.
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2. Microfluidic Devices, and Droplet Production
All microfluidic devices used in this research were made of PDMS (Sylgard 184, Dow Corn-
ing, USA) and prepared by standard photo- and soft-lithography methods. [141] Microfluidic-
devices were designed using QCAD-pro (version 3.11.3, RibbonSoft GmbH, Germany).
The designs were printed with a high resolution printer (JD Photo-Tools, Lancs, UK) on
to a transparency (film mask). In case the resolution of less than 10 µm was required
reactive ion etching was used to create a chromium mask. The slides were used as a
mask in a photolithography process to obtain positive relief via photolithography. PDMS
(Sylgard 184, Dow Croning Corporation, USA) was used to produce via soft-lithography
the microfluidic device from the positive relief.
2.1. Photolithography
Photolithography was used to create the positive relief with structure heights ranging
from 10 to 100 µm using negative SU-8-25 photoresist on silicon wafer.
Table III.1.: Optimized photolithography experimental parameters to obtain 25 µm chan-
nel height structures with the negative SU-8-25 photoresist.
Photoresist thickness 25µm
Drying oven 180°C (30 min)
Dispense of Pothoresist 500 rpm 5 s
Tapering of Photoresist 2000 rpm 30 s
Prebaking 1 3 min at 65 °C
Prebaking 2 7 min at 95 °C
Exposure 7 s
Post baking 1 1 min at 65 °C
Postbaking 2 3 min at 95 °C
Developping 2 min
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To ensure the quality of microfluidic structures the production was carried out under
clean room conditions (class 100). First the silicon wafers were dried for 30 min at 180°C
to drive off any moisture that may be present on the wafer’s surface. Afterwards, the
wafer was covered with 1 ml photoresist by spin coating (table III.1). After spin-coating
the wafers were prebaked for 3 min at 65°C and 7 min at 95°C to remove air bubbles
and to drive off excess of photoresist solvent. The photoresist was cured 7 seconds with
UV-light and baked again at 65°C and 95°C to solidity. The remaining photoresist was
removed by Developer MR-700 (10 ml, microchem, Germany). The final structures were
analyzed with a profilometer (Veeco, Dektak 8 Advanced development, USA).
UV-light
Device design from a CAD 
file printed on a film mask
Silicon wafer
Photorersist
Developing
Cast with
PDMS
PDMS
PDMS 
polymeriation 
Pealing PDMS
of the wafer
Glas
Plasma treatment 
Fixation on glasslide
Figure III.5.: PDMS flow cell production via photo- and softlithography methods. A silicon wafer coated
with photoresist is exposed with UV light. Negative photoresist which is, exposed to UV-light is poly-
merized and following the development step form rectangular structures as a positive relief. Unexposed
photoresist is removed and the wafer is doused with PDMS. After the polymerization, the PDMS is
pealed of the wafer and after a plasma treatment covalently bound to a glass cover-slip.
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2.2. Softlithography
The manufacturing process starts with the production of the PDMS elastomer by mixing
the polymerization catalyst (cross-linking oligomers contain at least 3 silicon hydride
bonds each) with the oligomer (siloxane base oligomers contain vinyl groups) in a 1:10
(w/w) ratio. Following mixing, the polymer was degassed under vacuum in a desiccator
for 25 min, cast over the wafer and cured at 65°C for 2 hours in the oven. After curing, the
devices were pealed carefully from the wafer. A puncher (0,5 mm diameter, Ted Pella Inc.,
USA) was used to create inlet- and outlet-holes. The devices were cleaned with ethanol.
Prior to sealing the PDMS devices on the 24 x 60 mm coverslips (Carl Roth, Germany),
the glasses were cleaned with 5% Extran®-solution and twice with pure water, each for
15 min in the ultra sonic bath. To improve the sealing the coverslips and the PDMS
devices were activated with oxygen plasma (Plasma-Gerät PVA TePla100, Feldkirchen,
Germany) (0.5 mbar, 150 W, 15 sec). [31,142] After activation the devices were pressed on
the coverslips and heated 1 hour at 65°C to enhance the sealing stability.
Ombrello® (unknown substance, Motono®, Germany) or SigmaCote® (chlorinated
organopolysiloxane in heptane, Sigma-Aldrich, Germany) was used to passivate the chan-
nels with a hydrophobic layer. To test the efficiency of hydrophobic coating the PDMS
devices were treated with Ombrello® or SigmaCote® and incubated for 10 min, washed
with water and dried with N2, or, as control, only washed and dried with N2. After the
first measurement all samples were kept in ultra pure water till the second and third
analysis after 1 and 15 hours, respectively.
A B
Figure III.6.: Contact angle measurements of glass and PDMS Contact angle measurements on (A) glass and
(B) PDMS. Contact angle measured immediately after production, 1 hour and 15 hours later, respectively.
Not treated surfaces (red), Ombrello coated surfaces (green) and SigmaCote coated surfaces (blue).
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Dynamic contact angel measurements were preformed with a contact angle system OCA
(dataphysics, Germany) in Sessile Drop Mode with a Tangent-Fitting. The results are
presented in Figure III.6 and show no significant differences between SigmaCote® and
Ombrello® but a stable passivation of the treated surfaces. The values of non-passivated
PDMS devices fitted the values reported earlier. [143]
2.3. Droplet Production and Storage
All microfluidic devices used in this study were made of PDMS and prepared by photo-
and soft-lithography methods [141] as described in Section 2.1 and 2.2. [4,23] Mono-disperse
water-in-oil emulsion droplets with diameters ranging from 10 µm to 100 µm were created
with production rates ranging from 0.1 - 30 kHz by controlling the flow rates of the aqueous
phase and the oil phase from 20 to 900 µLh−1 and 50 to 1500µLh−1 respectively. All
surfactants were dissolved in FC-40 oil at concentrations, ranging from 0.5 to 50 mM. For
experiments with gold-nanostructured droplets the stabilization surfactants were mixed
with 0.1 µM to 100 µM gold-linked surfactants (Section IV.1.3).
For the droplet production the microfluidic devices were connected to 1ml syringes via
PTFE-tubing (∅in0.3mm, ∅out0.6mm) and cannula (0.4mm× 20mm BL/LB) (Portex
Fine Bore, Smiths Medical Instruments Ltd., USA). For aqueous volumes of less than
200 µL 0.3 ml syringes (BD Micro- fineTM Demi, Becton, Dickson and Company, USA)
were used. Flow rates were controlled precisely with syringe pumps (Aladdin-1000, World
Precision Instruments, USA). Figure III.7 (A and B) show a microfluidic device and the
flow focusing junction where droplets are generated. In the flow focusing junction the
aqueous phase is "cut" of by the oil phase and droplets are generated by self-assembly.
Following the droplets production droplets were collected with a PTFE-tubing in an
Eppendorf tube (for bigger volumes) or via a pipette tip at the outlet of the microfluidic
device (small volumes; 10-50 µL) and transferred immediately to an analysis chamber
(figure III.7 C and D) for further analysis and characterization. The glass slides, used
for the analysis chamber were cleaned with Extran and water as described in Section
III.2.2. To provide spacing between the coverslips two stripes of double faced sticky tape
(thickness = 80 µM , Tesa, Germany) were glued to the edges of the longer sides of a
24 x 60 mm coverslip (#1, Carl Roth, Germany) as shown in figure III.7 C. Droplets
were injected into the chamber which was wetted by 2 µL of FC-40 oil before, and a
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A 24 x 24 mm glass (#1) was glued on top. The chamber was filled completely with
FC-40 oil containing the same surfactant concentration as used for droplet creation. To
avoid evaporation the sides of the chamber were sealed by two-component glue (Twinsil,
Picodent GmbH, Germany). Droplets stored in these chambers remained stable for up to
several month. [4,144]
Cover slips
Spacer (double sided 
sticky tape 80 µm)
100 µm100 µm
A C
B D
Figure III.7.: Droplet production and storage for analysis. (A) Droplet-based microfluidic device with red and
blue colourings indicating oil and aqueous inlets, respectively. (B) Insight of a flow-focusing junction
where oil (red) and aqueous (blue) phases meet at a 20 µm wide nozzle and droplets are generated. (C)
Illustration of an analysis chamber to store droplets for analysis and characterization. (D) Phase contrast
image of 40 µm diameter droplets in an analysis chamber.
2.3.1. Different Microfluidic Operation Units
For various research purposes different microfluidic units were designed by using a QCAD-
program. Most of the designs were adapted from literature and optimized for our needs.
In the following paragraphs three main designs are described.
Deformation Measurements A droplet deformation device (figure III.8.A) was de-
signed [20] and implemented for dynamic physical analysis of surfactants and proteins ac-
cretion and actin polymerization in microfludic droplets. The results achieved by this
device are presented in Section IV.2.2. In general, two aqueous inlets (blue) and two
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 A                   B           C
100µm
Figure III.8.: Representative schematics and images of different droplet-based microfluidic units. (A)
Representation of droplet deformation devices and a magnified area of the deformation chambers. (B)
Schematic representation of spiral device for single cell encapsulation and a magnified area of dropspot
chamber. (C) Picoinjection device for controlled introduction of different bioactive components into
droplets. The inset represents an example for the injection where colored liquids were used.
oil inlets (red) for droplet production and droplet spacing, respectively, were used to ad-
just the flow rates for high throuput droplet deformation analysis, allowing high-speed
recording. Installation and recording was done as described in subsection 2.3 (Droplet
production and Storage ) and section 3 (High-speed microscopy). Flow rates were set
constant: 50 µl h−1 aqueous phase (blue), 170 µl h−1 oil phase (red) and 220 µl h−1 spacing
oil (red) (see figure III.8A).
Single cell encapsulation Single cell encapsulation and analysis experiments were per-
formed with spiral devices as shown in figure III.8 B. This device allows Dean flow-based
(De) separation of cells or particles by an inertial lift and viscous drag force and can be
calculated with the presented formula where ρ is the density of the fluid, V the axial ve-
locity scale, µ is the dynamic viscosity, d is the channel diameter for non circular channels
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and R is the curvature of the channel. [145,146,147]
De =
ρV d
µ
· ( d
R
)
1
2
The inertial force and the dean flow (created due to the spiral design) forces cells to line up
on the inner wall with equidistant spacing. [147] Flow rates were set to 700 to 900 µl h−1 for
the aqueous phase (blue), containing media (RPMI 1604) and cells (2,5 x 10 7 cells/ml)
and 1200 to 1500 µl h−1 for the oil phase (red). Droplets were analyzed in drop spot
chambers [17] for up to 4 days. As shown in figure III.8 the dropspot chamber consists of
round niches connected by narrow channels. In the absence of flow droplets are stored in
the round niches.
Picoinjection In the pico injection device an alternating electrical field induces surfac-
tant poration and allows injection of aqueous phase that contains bio-relevant material. [16]
The experiments were performed with a flow controller system (MFCS-EZ Microfluidic
flow control system, Fluigent, France) with droplet rates of about 100-500 droplets per
second. Figure III.8 C shows the device where droplets were introduced into the picoin-
jection device at the inlet and spaced with FC-40 oil (red) containing the same surfactant
concentration as used for the produced droplets (N2 pressures 100-400 mbar). The N2
pressure in the picoinjection channel was 20-250 mbar (blue). Micro indium tin electrodes
were placed at the proximity to the injection channel. To produce the electrodes the in-
dium tin was melted at 60°C on a heat plate and injected into the electrode channels.
Injection occurred only with an applied electrical field (30 KHz, 400 V). A representative
picoinjetion time-lapse is shown in figure III.8 C2. Droplets where collected with a pipette
tip at the outlet or analyzed directly in the drop-spot chamber.
3. Droplet Content Analysis
Confocal Microscopy For confocal experiments an Axiovert 200M inverted confocal
Laser-Scanning-Microscope (Zeiss, Germany) using 63× magnification water-immersions-
objective (LUMFI, NA = 1.1, working distance 1.5 mm; Olympus, Japan) and an argon
laser (458, 488 and 514 nm, Lasos LGK-7812 ML-4, Zeiss, Germany) was used. Images
were taken with the image acquisition software Pascal 5 (Zeiss, Germany).
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Fluorescence Microscopy Fluorescence intensity experiments were performed with an
upright Leica DM6000B epifluorescence microscope (Leica Microsystems, Germany) at
25°C. The droplets were excited via an external alignment free mercury metal halide lame
(EL6000, Leica Microsystems, Germany) equiped with liquid light guide and observed
with a 20x air objective (HC PLAN APO 20x/0.7; Leica Microsystems, Germany). The
field of sample excitation was limited using a rectangular aperture in the optical pathway.
Images were taken with the image acquisition LAS AF software (Leica Microsystems,
Germany) with 1392 x 1040 pixels (1 pix = 0.46 µm) resolution.
Cryo Scanning Electron Microscopy (cryo-SEM) A Zeiss Ultra 55 field emission
electron microscope (FE-SEM) equipped with in-lens, secondary electron (SE) and angle
selective backscattered electron (ASB) detectors was used for image acquisition (Zeiss
SMT, Germany). Top-view cryo-SEM imaging was performed under low temperature
conditions (Top = -115 ± 5°C) and working distances of 3 to 5 mm. Low acceleration
voltages of 1-1.5 kV were used due to the low conductivity of the investigated samples.
Signals were detected by the in-lens detector. Emulsion droplets solution (5 µL) was
dropped on 0.8 mm diameter gold specimen carriers assembled on a freeze fracture holder
(BAL-TEC AG, Balzers, Liechtenstein) and immersed immediately in liquid nitrogen.
After vitrification in liquid nitrogen, the droplets were transferred to a BAL-TECH MED
020 (BAL-TEC AG, Liechtenstein) preparation device via an evacuated liquid nitrogen-
cooled shuttle BAL-TECH VLC 100 (BAL-TEC AG, Liechtenstein). For freeze-fracture
cryo observations the droplets were fractured in the 10-6 - 10-7 mbar vacuum chamber at -
160 °C with a cooled knife. After fracturing, the stage was heated to -90 °C and kept in the
vacuum for 30 min in order to allow water in the fractured droplets to sublimate. For cryo-
SEM, the samples were transferred immediately to the SEM chamber via an evacuated
liquid nitrogen cooled shuttle. It is worth mentioning that no fixation and no cryo-
protection chemicals were used during the droplets preparation for cryo observation.
High-speed microscopy High speed videos were recorded with a Phantom v7.3 (Vision
Research, USA) CCD camera using the Observer.Z1 inverted microscope (Zeiss, Ger-
many) with 40× magnification. Videos for droplet deformation experiments and single
cell encapsulation experiments were recorded in bright-field with 60 µs exposure time and
16 000pps with a resolution of 256 × 256 pixels. Videos for pico-injection experiments
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A B C
100 µm 20 µm  5 µm
Figure III.9.: Representative cryo-SEM micrograph of freeze fractured microdroplets (A) Cryo-SEM mi-
crograph with low magnification of freeze fractured microdroplets. The droplets were fractured by the
cooled knife in the preparation device chamber in the 10-6 - 10-7 mbar vacuum chamber at -160 °C.
(B) Representative cryo-SEM micrograph of the fractured droplets obtained with higher magnification.
(C) Following the water sublimation in the preparation chamber a Cryo-SEM micrograph with a single
fractured droplet is presented.
were recorded in bright-field with 60 µs exposure time and 16 000pps with a resolution of
256× 512.
4. Retention Analysis of Fluorophores and
Biomolecules in Droplets
4.1. Fluorophores
ATTO 488 N-Hydroxysuccinimidyl ester (SE), ATTO 495 SE, ATTO 520 SE, ATTO 532
SE, ATTO 565 SE, ATTO 590 SE, ATTO 647N SE and ATTO 655 SE were purchased
from ATTO-TEC GmbH (Siegen, Germany). Alexa Fluor® 488 C5 Maleimide (M), Alexa
Fluor® 532 C5 M and Alexa Fluor® 647 SE were purchased from Thermo Fisher Scientific
(Schwerte, Germany).
The pure fluorophores were dissolved in anhydrous DMSO at a concentration of 1 mM
and stored at -20°C. In retention experiments the fluorophores were further diluted with
each buffer and both cell culture media (see next Section 4.2) to a final concentration of
5 µM and used as an aqueous phase for droplets creation.
The hydrophilicity of the fluorophores was analyzed by calculating the distribution co-
efficient, LogD, which is a measure of the expected ratio of the sum of concentrations of
all forms of the fluorophore (ionized plus un-ionized) in water and in a non-polar solvent
(octanol). Negative LogD values correspond to hydrophilic fluorophores, positive values
38
Chapter III. Materials and Methods
to hydrophobic ones. The calculations for the fluorophores with a hydrolyzed succinimidyl
ester and Saleimide reactive groups at pH 7.4 were performed by MarvinSketch version
14.10.20.0 (Chem Axon, Cambridge, MA), using the dye structures (see Appendix). Three
different calculation methods were used (VG, KLOP, PHYS) and weighted equally. Tau-
tomerization and resonance were considered and electrolyte concentrations were adapted
according to LogD (PBS): 141 mM Cl-, 141 mM Na+ & K+, pH7.4 and LogD (TRIS):
156 mM Cl-, 150 mM Na+ & K+, pH7.7. [144]
Table III.2.: Photophysical characteristics and calculated LogD values of the investigated
fluorophores.
Fluorophore LogD LogD λabs λfl MW ηfl
PBS TRIS [nm] [nm] [g/mol]
Alexa 488 M -9.47 -9.61 494 517 721 0.92
Alexa 532 M -4.43 -4.54 530 555 813 0.61
Alexa 647 M -7.75 -7.75 651 671 1250 0.33
ATTO 488 SE -7.60 -7.60 501 523 981 0.80
ATTO 495 SE -0.81 -0.71 495 527 549 0.20
ATTO 520 SE 0.59 0.45 516 538 564 0.90
ATTO 532 SE -4.49 -5.30 532 553 1082 0.90
ATTO 565 SE -0.18 -0.18 563 592 708 0.90
ATTO 590 SE 1.56 1.56 594 624 788 0.80
ATTO 633 SE n.a. n.a. 629 657 749 0.64
ATTO 647N SE 4.47 4.47 644 669 843 0.65
ATTO 655 SE -0.61 -1.46 663 684 887 0.30
λabs: maximum absorption wavelength
λfl: maximum emission wavelength
MW: Molecular weight
ηfl: Quantum yield: ratio of photons emitted and photons absorbed
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4.2. Buffers and Cell Culture Media
All buffers used for retention experiments were prepared with ultra-pure (type 1 water,
R ≥18 MΩ/cm, Millipore) water and stored at 4°C. The pH values were adjusted with
1M HCl and 1M KOH solutions. Following buffers were prepared and used in retention
experiments:
1) PBS pH 7.4 was prepared using PBS tablets according to standard protocols (Sigma
–Aldrich, Germany);
2) TRIS buffer: 50 mM TRIS, 150 mM NaCl, 2 mM MgCl2, 1 mM MnCl2, pH 7,4;
3) 30 mM HEPES, pH 7.4;
4) PIPES buffer consisted of 20 mM PIPES, 7.25 mM MgCl2, 1 mM EGTA, 3 mM
GTP, 1 mM 2-mercaptoethanol, 50 mM KCl, 1 µM paclitaxel, 31 mM glucose, 1
mg/ml glucose oxidase and 0.5 mg/ml catalase, 0.25 mg/ml beta-casein, pH 6.8. [144]
Two different cell culture media were used:
1) DMEM (Life technologies, USA) containing 4,5 g/l D-glucose, 1 mM L-glutamine,
and 1% (v/v) penicillin/streptomycin (Gibco, Darmstadt, Germany);
2) RPMI 1640 supplemented with 2 mM L-glutamine, 10% FBS (Invitrogen,
Darmstadt, Germany) and 1% (v/v) penicillin/streptomycin (Gibco, Darmstadt,
Germany).
4.3. Labelled Proteins
ATTO 647N-labeled streptavidin was purchased from Sigma–Aldrich, Germany. Alexa
Fluor® 488 goat anti-mouse IgG and Alexa Fluor® 647 goat anti-mouse IgG were pur-
chased from Thermo Fisher Scientific (Germany). Sheep anti-mouse antibodies were la-
beled with ATTO 532 SE, ATTO 565 SE, ATTO 590 SE and ATTO 647N SE according
to the protocol described in the following section.
Stock solutions of labelled streptavidin and antibodies were diluted with TRIS buffer
to final concentrations of 200 nM.
Antibody and Tubulin Labeling Anti-mouse antibodies were labeled with ATTO NHS
dyes following the protocols from ATTOtec (https://www.atto-tec.com) with some mod-
ifications. The fluorophores were dissolved in DMF (Sigma-Aldrich, Germany) in a con-
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centration of 10 mg/ml and used in a 15- to 20-fold molar excess. The AffiniPure Sheep
anti-mouse (c = 2,4 mg/ml, IgG, Dianova, Germany) was mixed with 10% (v/v) of 1
M NaHCO3 (pH 8,3 – 9,0) and stirred at RT. The fluorophore was added dropwise un-
der constant stirring, the solution was protected from light and stirred for one hour at
room temperature (RT). The crude product was purified by gel filtration with a Sephadex
G25 (PD-10) gel filter (GE Healthcare GmbH, Solingen, Germany), equilibrated with 30
ml PBS pH 6.5. Following purification step, 5 antibody-dye fractions each 0.46 µL were
collected and the protein content was determined with a Bradford Assay. The degree of
labeling of 6 was determined by UV/VIS (Lambda 25 UV/VIS Spectrometer, PerkinElmer
Precisely, USA). The labeled antibodies were stored at 20 °C. [144]
Tubulin was kindly provided by Thomas Surrey (Francis Crick Institute, London,
United Kingdom) and was purified from pig brain as previously described. [148] Tubu-
lin was labeled with ATTO 633-SE or ATTO 488-SE according to protocols described in
Hyman et. al.. [149] Tubulin concentrations were measured using UV spectroscopy (λ =
280 nm; = 115000 M-1cm-1); they are expressed as tubulin heterodimer concentrations.
The labelling ratio was determined by UV spectroscopy, using the appropriate extinction
coefficients at 280 nm and at the absorbance maximum for the dyes. Labeling ratios of
tubulin dimers labeled with ATTO 633 and ATTO 488 were 0.75 and 0.65 dye molecules
per tubular dimer respectively. [144]
4.4. Fluorophore Retention Analysis
Fluorophore retention was analyzed with brightfield and fluorescence images taken every
15 seconds for a period of 10 minutes and an additional image was taken 24 hours after
droplet production. Images were taken with a DM6000B epifluorescence microscope as
described in Section 3. The fluorescence images analysis was accomplished using Fiji (Im-
ageJ 2.0.0-rc-14, Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda,
Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014) program.
Illumination times were adjusted within 10 to 50 ms to obtain the same fluorescence in-
tensity value I0 for each tested buffer-dye-combination prior to droplet production. These
illumination times were used in further experiments to analyze the droplets within the
analysis chamber. Fluorescence intensities It0 and It24 correspond to the values obtained
immediately and 24 hours after droplet insertion in the storage device, respectively. Flu-
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orophore retention was categorized in three different groups according to Figure 4.4:
I0 ≈ It0 ≈ It24 ⇒ Stable flurophore retention
I0 ≈ It0 > It24 ⇒ Moderate fluorophore retention
I0 >> It0 ⇒ No fluorophore retention
Figure III.10.: Characterization criteria for fluorophore retention in droplets
Figure III.11 shows the fluorescence intensities It0 of droplets produced with three
different buffers and different fluorophores and representing the three different categories
of flurophore retention. [144]
Figure III.11.: Flurophore retention characterization (A, B and C) show droplets produced with 10 mM TRI7000
surfactant, containing ATTO 633 in TRIS (A), ATTO 655 in RPMI (B) and Alexa 488 in TRIS (C). The
droplets were analyzed immediately after production (Intensity It0). Upper panel: Selected fluorescence
images demonstrating different fluorescence retention in droplets. Middle panel: Intensity profiles of
cross-sections marked in upper panel. Lower panel: Red, yellow and green blocks illustrate the color
marking used in all tables.
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5. Biofunctionalization of Gold-Nanostrucured
Droplets
Gold-linked surfactants (see Section IV.1.3) were used in combination with triblock sur-
factants to generate droplets with gold nanoparticles on it’s inner periphery as anchoring
points for following biofunctionallization. Two chemical approaches (see following Sec-
tions) were used to achieve stable biofunctionalization.
5.1. NTA-Thiol coupling to Gold Nanpoarticles (One step
Approach)
His6-GFP (300 µl, 300 µM, 1 GFP was a gift of S. Gardia Addgene plasmid #29663; Pro-
tein was expressed in E.coli using standard protocols and purified by Ni-NTA chromatog-
raphy) was mixed with NiCl2 (9 µl, 100 mM, Fluka, Germany) and NTA-thiol (300 µl,
1 mM, ProChimia Surfaces Sp. z o.o., Poland) and diluted with 600 µl PBS. NTA-thiol
and NiCl2 were mixed by stirring for 20 minutes. EtOH was removed partly to a final
volume of 50 µl by pointing a nitrogen flow on the surface of the mixture. Following this
procedure the His6-GFP was added and mixed for another 1 h. PBS was added and a
final GFP concentration of 8 µM was determined using extinction coefficient  = 30000 at
395nm.
For T Cell experiments coupling procedure followed the steps as shown in GFP coupling.
25 µl His-MHC-Alexa 568- and -ICAM-1 (each 25 µM) were mixed with NiCl2 (1 µl) and
NTA-thiol (30 µl, 1 mM) and diluted with 500µl RPMI 1604 media resulting in a final
concentration of 1 µM.
5.2. RGD Biofunctionalization via Thiol Gold Interaction
To provide cells the ability to interact with the nanostructured droplet periphery, c(RGDfK)-
PEG-(cysteine)3 peptides (Peptide Speciality Laboratories GmbH, Heidelberg, Germany)
were immobilized on gold nanoparticles via the thiol residues of the cysteine linker. The
chemical structure of cRGD peptide with a PEG-spacer and a cysteine-linker is illustrated
in figure III.12. Freeze-dried Gold-PEG-PFPE copolymers synthesized as described in
Section IV 1.3 were dissolved in 100 µL FC-40 and mixed with aqueous solution of cRGD
(50 µM, 100 µL) and stirred for 1 h. The crude product solution was then centrifuged
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and the supernatant with unbound cRGD peptides were removed. The precipitant was
freeze-dried for at least 24 h to remove remained water completely. Afterwards, the
dried product was dissolved in 1 ml of fluorinated oil FC-40 (Acros Organics, Germany)
and filtered with a hydrophobic filter (PTFE 0.2 µm) to remove unreacted, hydrophilic
(11-Mercaptoundecyl)tetra(ethylene glycol) functionalized gold nanoparticles and cRGD
traces. The obtained surfactant was used in different concentrations for cell adhesion
experiments. [4]
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Figure III.12.: Chemical structure of the c(RGDfK) peptide The cyclically arranged amino acids are arginine
(R), glycine (G) and aspartate (D). A PEG spacer (6 units) was used to bridge between the peptide
and the 3 cysteine-linkers.
5.3. Rhodamine functionalization (Two step Approach)
Gold nanoparticle funtionalization with rhodamine involved two steps. First the synthesis
of PFPE-PEG-Gold surfactants linked to rhodamine B (RhB) (see Section IV.1.4) followed
by droplet creation using a mixture of TRI2500 (20 mM, PFPE2500-PEG600-PFPE2500,
synthesis described in Section IV.) and RhB-PEG-Gold-PEG-PFPE (5 µM) surfactants
as an oil phase, while PBS was used as an aqueous phase. [4]
6. Cell experiments
Mercaptoundecyl-tetra(ethylene glycol) functionalized gold nanoparticles and cRGD were
coupled in advance. The obtained surfactant was used in different concentrations for cell
adhesion experiments. [4]
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6.1. Cell Culture
All cells used were cultured in RPMI 1640 media supplemented with 2 mM L-glutamine,
10% fetal bovine serum (FBS, Invitrogen, Darmstadt, Germany or Sigma-Aldrich, Taufkirchen,
Germany) and 1% (v/v) penicillin/streptomycin (Gibco, Darmstadt, Germany) and cul-
tured in an incubator (Thermo Scientific, USA) at 37 °C and 5% CO2.
T-Cells (cell line Jurkat E6.1) The human acute T cell leukemia cell line Jurkat E6.1
clone was purchased from ATCC (American Type Culture Collection, Manassas, USA).
The cells were split every two days for not more than 20 passages. Vials that were frozen
again were taken after max three times splitting. For adhesion experiments, Jurkat E6.1
cells ( 200 µL, 2 x 107 cells/ml) were suspended in adhesion medium (RPMI 1640, 2 mM
L-glutamine, 1% (v/v) penicillin/ streptomycin, 1 % FBS) and used as an aqueous phase
for droplet creation.
T-Cells (Primary mouse T-cells) Preparation of primary T cell blasts and TCR trans-
genic mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). Cells were
deep-frozen and shipped on dry ice to the laboratory where experiments were performed.
Upon arrival cells were immediately transferred to a liquid nitrogen storage tank.
Cell culture steps were performed under a sterile flow hood (Heraeus Kendro; VWR
International GmbH, Germany). For adhesion experiments, cells were thawed 24 h prior
to the experiment. Vials contained 1.0 ml cell suspension with approximately 5.0 x 106
cells that were thawed in a water bath at 37°C. Cells were resuspended in 10 ml medium
(RPMI 1640 with phenol red and glutamine) supplemented with 10% FBS and 1% peni-
cillin/streptomycin in 15 ml falcons, centrifuged, re-suspended in 5 ml complete medium
and cultured in conventional cell culture flasks in an incubator at 37°C and 5% CO2.
After 24 h cell suspension was centrifuged, resuspended in complete medium and used for
droplet adhesion experiments. For droplet production and analysis a microscope equipped
with incubation chamber (37°C and 5% CO2) was used.
6.2. Cell Recovery and Live/Dead Staining
Cell recovery and live/dead staining followed the procedures reported earlier [150] but with
several modifications. [4] The cell containing emulsion was split equally (200 µL each) to
45
7. Actomyosin Experiments
five (1 ml) falcons (caps with punched holes) and incubated in cell culture conditions
(37°C, 5% CO2). By the addition of 5 % v/v PFO-PEG surfactants the emulsions were
broken after 1, 2, 3, 4 and 5 days respectively. The supernatant (cell containing media)
was transferred into a 15 ml centrifuge tube. The cells were washed with 10 ml PBS. After
the washing 100 µL of cells-containing buffer solution were added to a micro-plate reader
flat-bottom well which had a total capacity of 200− 300 µL. These cells were incubated
for 45 min at room temperature with 100 µL of the live/dead staining solution containing
2 µM calcein and 4 µM Ethidium homodimer-1 (Live/Dead Viability/Cytotoxicity Kit for
mammalian cells, Invitrogen Kit L-3224). After the staining procedure the percentage
of alive cells was calculated from the fluorescence measurements using the micro-plate
reader. [4]
7. Actomyosin Experiments
Actin and Myosin were purchased from Cytoskeleton, Inc.(USA) or purified by Chris-
tine Mollenhauer (technical assistant, MPI, department Spatz) by following the standard
protocols. [151,152] Actin was purified from rabbit skeletal muscle acetone powders by mod-
ifications of Spudich and Watt. [151] In general the method uses the ability of actin to
polymerize at 50 mM KCl and 2 mM MgCl2, and depolymerize when KCl and MgCl2
are removed by dialysis with a G-buffer without MgCl2, containing: 2 mM TRIS/HCl
pH 8, CaCl2 0.2 mM, NaN3 0.005%, ATP 0.2 mM (Cytoskeleton Inc., USA), DTT 0.2
mM. Final purification was preformed by gel filtration with Ge-column Hi Load 26/60
Superdex 200 prep grade (General Electric, USA). Freshly produced actin was stored on
ice and used within 2 weeks, or aliquoted, shock freezed and stored at -80 °C.
Myosin II was isolated from rabbit skeletal muscle according to the purification proto-
cols from Sarkis et al.. [152] In general, to remove unwanted proteins, the method uses the
isoelectric point of myosin II to isolate it from all other muscle proteins by centrifugation
and by salting out the desired myosin II. Freshly purified myosin II was kept on ice and
was used within 4 weeks, or was aliquoted, shock freezed and stored at -80°C.
In all the experimental conditions (see table III.3) actin concentration of 10 µM in G-
buffer was used to form actin cytoskeleton networks. Moreover, the optimal ATP concen-
tration was found to be in the range from 0.4 to 1.2 mM. To keep the ATP concentration
steady over the time of the experiment an ATP recovery buffer containing creatine phos-
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phate 50 mM mixed with creatine kinase solution (5 mg/ml) (details Section III.7.1) was
used. Additionally, a solution of oxygen scavenger, containing glucose oxidase 0.1 mg/ml,
catalase 0.018 mg/ml and glucose 5 mg/ml was added in oder to minimize bleaching and
oxidation.
To detect the dynamics of actin cytoskeleton formation 1% of Alexa Fluor 488-labeled
actin (Life Technologies, Germany) (conditions 3-7, see table III.3) or 2 % of phalloidin-
FITC (Sigma-Aldrich, Germany) (conditions 1-2, see table III.3) were mixed with non-
labeled actin. In the experiments where no phallodin was used fascin (Novus Biologicals,
USA) (conditions 4-8, see table III.3) as a cross-linking protein was added at a concen-
tration of 0.5µM if not stated differently.
In experiments where myosin II was used (conditions 2,3,6,7, see table III.3) the KCl
level for myosin II cluster length was controlled by mixing G-buffer and D-buffer at dif-
ferent ratios (detailed composition Section III.7.1). All solution mixtures were prepared
on ice, myosin solutions were incubated for 20 minutes before droplet production to allow
the myosin II to aggregate to the desired cluster length (related to the KCl concentra-
tion). [135] To inhibit myosin II activity (conditions 7, see tabel III.3) blebbistatin (0.1
mM, Sigma-Aldrich, germany) was used. In this experimental condition the myosin II
solution was incubated a second time for 30 min before the solution was used for droplet
production. All experiments were preformed at room temperature (24°C).
Table III.3.: Overview of protein used in different experimental conditions in an attempt
of actin and actomyosin network reconstitution.
Biochemistry
Experimental
condition 1 2 3 4 5 6 7
Actin x x x x x x x
Myosin x x x x
Phalloidin x x
labeled Actin x x x x x
Fascin x x x x x
PEG x x x
Blebbistatin x
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Table III.4.: Detailed experimental descriptions of buffers and proteins as used in different
experimental conditions.
Experimental condition Biochemical content
1 Pure G-buffer, (10 µM) actin, (0.2 µM) phalloidin,
20 mM MgCl2, 0.5 mM ATP, oxidation-buffer
2 Cond. 1 + D-buffer with final KCl conc. of 50 mM,
(0.5 µM) myosin II
3 Pure G-buffer, (10 µM) actin, (0.1 µM) labeled
actin, (0.5 µM) fascin
4 Cond. 3 + 2.5 w/w % PEG
5 Cond. 4 + D-buffer with final KCl conc. of 50 mM
(0.5 µM) myosin II
6 Cond. 5 + D-buffer with final KCl conc. of 50 mM
(0.5 µM) myosin II
7 Cond. 6 + (10-100µM) blebbistatin
7.1. Buffers
Buffers used for actin and actomyosin experiments were prepared with ultra-pure water
(≥18 MΩ/cm, Millipore) and stored at 4 °C. The pH-values were adjusted with HCl and
KOH solutions. Following buffers were used:
1) G-Buffer: 2.0 mM TRIS pH 7.4, 0.2 mM CaCl2, 20 mM MgCl2, 0.2 mM ATP,
0,005 % NaN3, 0.2 mM DTT;
2) D-Buffer: 50 mM K2HPO4 pH 6.5, 600 mM KCl;
3) Dilution buffer: 50 mM K2HPO4 pH 6.5;
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4) ATP recovery buffer (a): HEPES 10 mM, DABCO 0.12 mM, KCl 0.13 mM, MgCl2,
BSA 0.1%, Creatinephosphate 5 mM;
5) ATP recovery buffer (b): 0.02 % DTT, Creatine kinase 0.5 mg/ml;
6) Anti-oxidation buffer: 50 mM HEPES pH 7.4, 50 mM KCl, 1 mM ATP, 0.5 mg/ml
BSA, 10 mM DTT, 3 mg/ml glucose, 0.1 mg/ml glucose-oxidase, 0.02 mg/ml
glucose-catalase;
7.2. Actin Experimental Analysis
Investigation of actin experiments was preformed in analysis chambers (see Section III.2.3).
It is worth mentioning here that external flows could be excluded due to the completely
sealed observation system. Actin network dynamics and actomyosin motion was ana-
lyzed using confocal and fluorescence microscopy using inverted microscopes as described
in detail in Section III.3. Time-lapse analyses were preformed over periods of 30 to 60
minutes.
7.3. Motion Analysis of Actomyosin Droplets with Beads
To quantify if actomyosin activity in the droplets also affected the surfactant layer and
by this the whole droplet, a new bead-linked surfactant was synthesized. Towards this
end, a PEG passivated polystyrene bead (d= 2 µm) as the hydrophilic head group [153] was
chemically linked to a hydrophobic PFPE tail (see Section IV.1.6). Successful synthesis
was confirmed by FT-IR- and microscopy-analysis, revealing successful chemical linkage
of the beads to the PFPE molecules and the incorporation of this bead-linked surfactant
to the periphery of the droplet, respectively. A track-mate plug-in (Fiji, Image J) was
used to evaluate the motion. Data was plotted with R software (script in appendix).
In actomyosin experiments this new surfactant was added to the FC-40 oil phase which
contained triblock surfactant and gold-nanoparticle surfactant.
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1. Surfactant Synthesis and Analysis
1.1. Perfluoropolypropylene - Polyethylene glycol -
Perfluoropolypropylene (PFPE-PEG-PFPE)
Triblock-Copolymer Surfactants
This Section describes the general strategy of synthesis PFPE-PEG-PFPE triblock-co-
polymer surfactants. Three different triblock surfactants were synthesized in this the-
sis: a PFPE(2500)-PEG(600)-PFPE(2500), a PFPE(7000)-PEG(600)-PFPE(7000) and a
PFPE(7000)-PEG(1400)-PFPE(7000). In all synthesis reactions 1mmol of PEG inter-
acted with 2mmol of perfluoropolypropylene-caboxylic acid.
The synthesis of PFPE-PEG-PFPE triblock-copolymers followed the general procedure
reported earlier [15] but with several modifications as shown in Figure IV.1. [4,144] The syn-
thesis was carried out under argon atmosphere in super dry THF solvent (Acros Organics,
Germany) in a heated Schlenk flask. PEG powder was solved in 80 ml super dry THF to
a final concentration of 1mmol and cooled to -78 °C by dry ice in isopropanol. N-butyl
lithium (1.22 ml of a 1.6 M solution in hexane, 2 mmol, Sigma-Aldrich, Germany) was
added dropwise over a period of 60 min at -78 °C to the PEG solution and stirred for addi-
tional 30 min at -78 °C. Under continuous stirring the reaction was slowly heated to room
temperature followed by an additional 30 min stirring. PFPE-carboxylic acid (2 mmol)
was added dropwise over a period of 30 min and stirred for another 12 h. THF solvent with
unreacted PEG was removed by separatory funnel. Two additional washing steps with su-
per dry THF solvent were used to purify the crude product from the unreacted PEG. The
product was dissolved in methanol (Carl Roth GmbH, Germany) to separate it from unre-
acted PFPE-carboxylic acid. The PFPE2500-PEG600-PFPE2500 was completely soluble
in MeOH whereas the other two triblocks were only soluble in small concentrations. The
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PFPE-PEG-PFPE product was dissolved in the methanol, transferred to a clean flask and
dried with a rotary evaporator at 40°C. After removing the methanol and drying on the
vacuum line, the desired PFPE-PEG-PFPE triblock-copolymer surfactant was obtained.
4.61 g - 82%, 12.18 g - 87% and 11.53 -79%, of PFPE(2500)-PEG(600)-PFPE(2500),
PFPE(7000)-PEG(1400)-PFPE(7000) and PFPE(7000)-PEG(600)-PFPE(7000) triblock-
copolymer surfactants were obtained, respectively. The purity of the product was analysed
by NMR and FT-IR measurements (see following Section).
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Figure IV.1.: Synthesis schematics of PFPE-PEG-PFPE triblock-copolymer surfactants
1.1.1. NMR and FT-IR Analysis (PFPE-PEG-PFPE)
NMR
NMR data was only obtained for the triblock (PFPE2500-PEG600-PFPE2500) due to
the small solubility of the other two synthesized surfactants in MeOH-D4. Chemical shifts
are given in ppm referenced to solvent (MeOH - D4, 22°C; δ = 3.35, 4.78 for 1H, δ = 49.3
for 13C). 1H NMR δ 3,63 (CH2, s); 13C NMR δ 161.05 (Carbonyl-C); 120,2 (fluorinated
C); 113,3-118,0 (fluorinated C´s); 101,0-104,2 (fluorinated C´s); 71,13 (CH2).
FT-IR
Figure IV.2 shows a representative FT-IR spectra of the PFPE2500-carboxylic acid
reactant and the (PFPE2500-PEG600-PFPE2500) triblock surfactant product. Spec-
tra of PFPE7000-carboxylic acid reactant and (PFPE7000-PEG1400-PFPE7000) and
(PFPE7000-PEG600-PFPE7000) products are presented in appendix.
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Figure IV.2 shows seven major bands at 1705, 1775, 2883, 2934, 2920, 3031 and 3550
cm-1. The band at 1775 cm-1 is a stretching mode of the (C=O) bond of the PFPE-
carboxylic acid which is strongly blue shifted (by 50 cm-1) due to the electronegative
fluor atoms in alpha position to the carboxylic group. [154] The same blue shift of the
carboxylic (C=O) band was observed previously in the studies measuring the IR spectrum
of the trifluoroacetic acid. [155,156] The bands which appear in the PFPE spectrum in the
region 2800-3600 cm-1 are assigned to the different (OH) vibrational modes. Namely,
to the asymmetric stretching νas(OH), to symmetric stretching νs(OH) and to subbands
complex, corresponded to ν(C-O) + νb(OH) at 3550, 3031 and 2934 cm-1, respectively. [157]
The bands at 1705, 2883 and 2920 cm-1 are assigned to the PFPE-PEG-PFPE product.
The bands at 2883 and 2920 cm-1 are attributed to symmetric and asymmetric stretching
modes of the PEG (C-H) groups, respectively. [154] The band at 1705 cm-1 attributed to
the ester (C=O) stretching mode. No bands of PFPE-carboxylic acid were observed in
the product spectrum.
Figure IV.2.: Representative FT-IR spectra of a triblock-copolymer surfactant and the PFPE. Spectrum of
PFPE2500-carboxylic acid (20 mM in FC-40, red) as a reactant and the PFPE2500-PEG600-PFPE2500
triblock product (20 mM in FC-40, black).Adapted with permission from Ref. [4]
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1.2. Perfluorpolypropylene–Polyethylene glycol monoethyleter
(PFPE7000-PEG-OMe)
The surfactant was synthesized by Gerri Kannenberg. Detailed synthesis data is pub-
lished in Janiesch et al. [158] This surfactant was used in the experiments where retention
of flourophores and biomolecules was tested (see Section IV.3.4) as well as in droplet
deformation studies (see Section IV.2.2):
1.3. Gold-Linked Surfactants
Gold nanoparticle-linked surfactants were synthesized in a one step process [4] as shown in
Figure IV.3. PFPE7000-carboxylic acid or PFPE2500-carboxylic acid (2.1 mg, 0.3µmol,
molecular weight 7000 g/mol, DuPont, Netherlands; 750 mg, 0.3 µmol, molecular weight
2500 g/mol, DuPont, Netherlands) and KOH (5N, 10 µL, Sigma Aldrich, Germany) were
mixed with (11-Mercaptoundecyl)tetra(ethylene glycol) functionalized gold nanoparticles
(2 % w/w solution in water, 5 ml, Sigma Aldrich, Germany) and stirred until complete
flocculation of the PFPE-PEG-Gold product. To remove the KOH from the product the
crude product was washed three times with ultra pure water. The water was then re-
moved by freeze-drying (Piatowski Forschungsgeräte, Germany) the product for 24 hours.
Afterwards the product was dissolved in 1 ml of fluorinated oil FC-40 (Acros Organics,
Germany), filtered with a hydrophobic filter (PTFE 0.2µm, Carl Roth GmbH, Germany)
to remove unreacted, hydrophilic (11-Mercaptoundecyl)tetra(ethylene glycol) functional-
ized gold nanoparticles and stored at 4°C. The Gold-PEG-PFPE surfactant was obtained
(9.9 mg, 86 %). The final product was chemically analyzed by FT-IR. Cryo-SEM was
used to investigate the presence and density of the gold nanoparticles on the inner droplet
periphery (Section IV.4.1).
1.3.1. FT-IR Analysis of Gold-PEG-PFPE(7000) Surfactant
Figure IV.4 shows the representative IR spectra of the PFPE7000-carboxylic acid reactant
and the Gold-PEG-PFPE(7000) surfactant. The spectra in Figure IV.4 show similar
seven major bands at 1695, 1775, 2850, 2934, 2950, 3031 and 3500 cm-1 as discussed in
Section IV.1.1.1. These bands are attributed to the same vibrational modes, as previously
described. The lower intensity of the PFPE-PEG-Gold product bands is attributed to
much lower concentration of the gold-linked surfactants 3 µM vs. 20 mM (Triblock).
54
Chapter IV. Results and Discussions
Figure IV.3.: Synthesis schematics of PFPE7000-PEG-Gold diblock-copolymer surfactants Adapted with
permission from Ref. [4]
Figure IV.4.: Perpresentative FT-IR-spectra of PFPE7000-carboxylic acid and PFPE7000-PEG-Gold di-
block Comparison between PFPE7000-carboxylic acid as a reactant (20 mM) and the PFPE7000-PEG-
Gold diblock product (30 µM). Adapted with permission from Ref. [4]
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1.4. Rhodamine B-PEG-Gold-PEG-PFPE
Rhodamine B-linked (RhB-linked) surfactants were synthesized in a one step process as
shown in Figure IV.5. [4] The synthesis was carried out in dry THF solvent in a heated
Schlenk flask under argon atmosphere. Gold-PEG-PFPE solution (4.5 nmol, 15µL in FC-
40, see Section IV.1.1) and dry THF (10 ml) were cooled to -78 °C. N-butyl lithium (30 µL
of a 1.6 mM solution in hexane) were added to the Gold-PEG-PFPE solution and stirred
for 30 min at -78 °C. The solution was slowly heated to room temperature and stirred for
additional 30 min. THF solution of RhB (15 µL, 60 nmol, Sigma Aldrich, Germany) was
added and stirred for another 12 h. After the reaction was finished, the THF solvent with
unreacted RhB was removed by separatory funnel. Two additional washing steps with dry
THF solvent were used to purify the crude product from the unreacted Rhodamine(B).
The final RhB-PEG-Gold-PEG-PFPE product was dissolved in FC-40.
To characterize the success of the esterification between the PEG hydroxyl group and
the RhB carboxylic acid group (see IR measurements in next Section) a simple reaction
between the PEG(150) (molecular weight 150 g/mol, Sigma Aldrich, Germany) and RhB
was made under the same conditions to compare the shifts in the IR.
Figure IV.5.: Synthesis schematics of PFPE-PEG-Gold-RhB surfactants
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1.4.1. FT-IR analysis of Rhodamine B-PEG-Gold-PEG-PFPE(2500)
To verify the success of the RhB linked surfactants synthesis we used the information ob-
tained by attenuated total reflectance technique used in conjunction with IR spectroscopy
(ATR-IR) (Smart Orbit accessory, Thermo Electron GmbH, Germany). Figure IV.6 shows
representative ATR-IR spectra of pure RhB reactant and of the PEG(150)-RhB product
powders. This Figure presents ten major bands at 1558, 1571, 1587, 1611, 1640, 1646,
1707, 1751, 2887 and 2929 cm-1. The bands at 1571, 1587 and 1646 cm-1 are attributed
to a stretching modes of the RhB aromatic conjugated (C=C) bonds. [154,159,160] The band
at 1692 cm-1 is attributed to the stretching mode of the RhB carboxylic acid (C=O)
bond. [154,161] The bands at 1558, 1611 and 1640 cm-1 are attributed to a stretching modes
of the PEG-Rhodamine aromatic conjugated (C=C) bonds. [157,159] The band at 1751 cm-1
is attributed to the ester (C=O) stretching mode [23] and the bands at 2887 and 2929 cm-1
are attributed to symmetric and asymmetric stretching modes of the PEG (C-H) groups,
respectively. [154]
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Figure IV.6.: Representative FT-IR spectra of RhB and PEG-RhB. FT-IR spectra of the pure RhB powder
and of the PEG-RhB product powder. Adapted with permission from Ref. [4]
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1.5. Perfluoroctanyl-Triethylen glycol (PFO-PEG)
The synthesis of 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-penta-
decafluorooctanoate shown in Figure IV.7 was carried out under argon atmosphere in
dry THF solvent in a heated Schlenk flask. [4] Triethylene glycol (6.36 g, 30.6 mmol,
molecular weight 208,05 g/mol Sigma-Aldrich, Germany) was added to 200 ml dry THF
and cooled to -78 °C. N-butyl lithium (18.5 ml of a 1.6 M solution in hexane, 29,6 mmol)
was added dropwise over a period of 60 min at -78 °C to the PEG solution and stirred
for additional 30 min at -78 °C. Under continuous stirring the reaction was slowly heated
to room temperature followed by additional 30 min stirring. Pentadecafluorooctanoyl
chloride (13.23 g, 30.6 mmol, molecular weight 432.51 g/mol, Sigma-Aldrich, Germany)
was added drop wise over a period of 30 min and stirred for another 4 h. At the end
of the reaction the THF solvent with unreacted PEG was removed by separatory fun-
nel. The crude product was washed with 10 ml H2O to remove the lithium chloride.
Following the washing procedures the crude product was dried at the vacuum line and
purified using column chromatography. The column was packed with silica gel and a
mix of petroleum ether (40/60) and THF (mix 2:1) was used as mobile phase. The di-
block (Rf = 0.28) as a bright yellow color product was collected and used as emulsion
destabilizer and a colorless oil which is the triblock (Rf = 0.72) was stored for other ex-
periments. The desired 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
pentadecafluorooctanoat diblock-copolymer was obtained (7.43 g, 83%) and analyzed by
NMR and mass spectroscopy (MS).
NMR spectra were recorded using a Bruker DRX 500 (Bruker spectrometer with the
13C spectra being measured in the 1H-decoupled mode. Massachusetts, USA). Chemical
shifts are given in ppm referenced to solvent (CDClsubscript3 , 22°C ; δ = 37.26 for 1H, δ
= 77,16 for 13C) 1H NMR δ = 4.48 (tr, 2 H, CH2, C9); 3.74 (tr, 2 H, CHsubscript2, C10);
3.66 (tr, 2 H, CHsubscript2, C13/14); 3.61 (s, 4 H, CHsubscript2, C11, 12); 3.54 (tr, 2
H, CHsubscript2, C13/14); 1.37 (s, 1H, OH); 13C NMR δ = 158.3 (tr, COOR, C8); 117.0
(trq, CFsubscript2 , C1); 114-105 (m, CFsubscript2 , C2-7); 72.5(C13/14); 70.7(C11/12);
70.2(C11/12); 68.1(C10); 67.1(C9); 61.6 (C13/14).
MS was performed in the MS-department in the Organic-Chemical Institute Heidelberg
by Frau A. Seith, Herrn Dr. J. Gross and Herrn N. Nieth, using a Jeol JMS-700 (JEOL
GmbH, Germany) with an VG ZAB-F (Pfeiffer Vacuum GmbH, Germany) MS (ESI):
m/z (%) = 546.9 (43%) [M+H]+; 563.9 (100 %) [M+NH4]+
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Figure IV.7.: Synthesis schematics of PFO-PEG diblock-copolymer surfactants
1.6. PFPE(7000)-PEG-Bead Surfactant
To link polymer beads to droplets external periphery (see Section VI.3) a new type of
bead-linked surfactants was synthesized. Two reaction steps were necessary to accomplish
the synthesis of bead linked surfactants as shown in Figure IV.8 PFPE(7000)-PEG-bead
surfactant. First, the polystyrene beads (Polyscience Inc, USA) were functionalized with
Pluronic® F-127 (Sigma-Aldrich Chemie GmbH, Germany) according to the protocols
described by Kim et al. [153] and the second is the coupling of the pluronic functionalized
beads with PFPE(7000) carboxylic acid.
Polystyrene beads (d=2.077µm, SD 0.045 µm, 2.61% solids) were mixed with 2 ml of 2%
(w/v) PEG-PPG-PEG (Pluronic F-127) solution and stirred for 5 hours. 50 µL of toluene
were added and the solution was stirred for another 2 hours before the solution was heated
to 98°C to remove the toluene. The resulting milky solution was centrifuged for 12 min
at 13000 rpm (Biofuge fresco, Kendro Laboratory Products, Germany) the supernatant
was removed and the beads were resuspended 5 times in 2ml of ultra pure water and
centrifuged again to remove unbound Pluronic F-127. Following the last centrifuging step
the beads were dried in vacuum (1 x 10-2 mbar) for 12 h.
In the second step the functionalized beads were coupled to PFPE7000-carboxylic acid
via an ester bond. Towards this end, the beads were mixed with 1.5 ml of ultra pure
water and 10 µL of 5N KOH. PFPE7000-carboxylic acid (20 mg, 0.003 mol) was added to
the beads and the solution was stirred for 30 min. The functionalized beads precipitated
at the bottom and on the walls of the reaction vial. The water was removed and the
59
1. Surfactant Synthesis and Analysis
product was dried for 24 hours in vacuum (1 x 10-2 mbar). The product was solved in 2
ml of FC-40. FT-IR was used to analyze the success of the synthesis.
Polystyren-
Bead
Pluronic
F-127
PEG
PPG
PEG
adsorption Bead swelling
with toluene
Removing 
toluene (98°C)
Krytox 7000
5 N KOH
Figure IV.8.: Schematics of different experimental steps for bead surfactant synthesis. The aliphatic methy-
lene group of the polypropylene glycol (PPG) was incorporated in the swollen beads. By removing of
the toluene the beads shrink and the Pluronic F-127 is incorporated solidly in the beads.
1.6.1. FT-IR Analysis of PFPE(7000)-PEG-Bead Surfactants
The successful synthesis of PFPE(7000)-PEG-Bead Surfactants was confirmed by FT-IR
analysis. As shown in Figure IV.9. The black line represents the transmission of PFPE
carboxylic acid and the red line shows the synthesized PFPE-PEG-bead product. The
results show the same shifts of the band at 1695 cm-1 towards 1776 cm-1in the product,
as observed in synthesis in the previous section.
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Figure IV.9.: Represntative FT-IR analyses to confirm successful bead surfactant synthesis.
2. Interfacial Tension Dynamic Analysis
2.1. Pendant Drop Analysis
The pendant drop method was used to evaluate the interfacial tension at the water and oil
(FC-40) interface and the influence of various surfactants. Three independent dilutions
of surfactant containing oil phases were prepared for each experiment. Dilution series
covered concentrations ranging from 10 nM to 10mM. Data analysis was carried out as
described in Section III.1.2.
The results in table IV.1 show a significant difference of CMC values of the diblock
surfactant PFPE(7000)-PEG-OMe(750) and the two triblock surfactants PFPE(7000)-
PEG(600)-PFPE(7000) and PFPE(7000)-PEG(1400)-PFPE(7000). This implements a
better stabilization with triblock surfactants due to the lower concentration needed to
create micelles.
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Table IV.1.: Properties of surfactants as extracted from the interfacial tension experiments
and evaluated follwing the procedure described in Section III.1.2:
Surfactant CMC γCMC ΠCMC Γ a
[µM] [mN/m] [mN/m] [µmol/m2] [A˚2]
PFO(500)-PEG(150)-PFO(500) 3101.0 7.9 43.0 6.5 26.7
PFO(500)-PEG(150) 1763.0 6.0 46.0 6.9 24.1
PFPE-COO-(2500) NH4+ 202.6 5.1 48.2 7.4 22.4
PFPE(7000)-PEG-OMe(750) 148.6 21.5 29.1 3.9 43.1
PFPE(2500)-diethylamin 114.5 28.1 23.5 3.5 48.3
PFPE(7000)-PEG(600)-PFPE(7000) 48.7 23.5 28.1 3.4 48.8
PFPE(7000)-PEG(1400)-PFPE(7000) 45.1 19.5 32.5 4.0 41.1
PFPE(2500)-PEG(600)-PFPE(7000 22.7 3.1 50.0 8.1 21.4
PFPE(2500)-PEG(600) 17.2 18.1 36.8 5.4 31.6
PFPE(7000)-PEG-Gold 7.8 34.6 17.2 2.8 58.9
CMC and γCMC represent the critical micelle concentration and the corresponding final
surface tension. ΠCMC shows the minimum of surface tension of each surfactant. Γ and
a represent the surface coverage and the available area of each surfactant.
The analysis of the PFO-PEG surfactant confirm the weak stabilization with this sur-
factant that can not protect droplets from fusion. Therefore this surfactant was used as
a destabilizing surfactant to break up droplets and analyze the content afterwards.
2.2. Deformation Measurements
A droplet production and deformation device (Section III.2.3.1) was used to analyze
the deformation of the droplets in order to provide an insight on the dynamic accretion
of diblock and triblock surfactants on the oil-water interface and to evaluate the dy-
namic interfacial tension. [139] Moreover this device was used to evaluate the influence of
surfactant mixtures and protein interaction with the droplets interfaces. Both types of
surfactants were used with a concentration of 2.5mM and in all experiments ultra pure
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water was used as the aqueous phase. The surfactant mixtures composed of PFPE(7000)-
PEG(1400)-PFPE(7000) triblock and PFPE(7000)-PEG(750)-OMe diblock were mixed
at different ratios: 4:1, 3:2, 2:3 and 1:4. Analysis procedure is described in Section III.1.3.
Figure IV.10 shows the deformation results as analyzed in the first and last deformation
chamber of the deformation device.
The time it took droplets to float through the device from the first to the last chamber
was computed from high speed video recordings resulting in a flow time of one second.
The number of analyzed droplets in these videos varied from 38 to 96. An increase in
deformation between the first and last deformation chamber can be seen. Moreover, it can
be observed that the deformation is stronger in case of mixtures in comparison to pure
surfactants. This result can be explained by faster accretion and a denser organization of
the mixed surfactants on the droplet periphery. These results are in good agreement with
the data from the pendant drop measurements which already indicated the difference in
CMC values as well as the surface coverage of triblock and diblock surfactants. Through
the different structure of these two surfactants the mixture overcomes the disadvantages
of each surfactant and is offering a denser layer of surfactants on the periphery.
Figure IV.10.: Surfactant influence on droplet deformation in a deformation device. Droplet deformation
using different surfactant mixtures of Tri-7000-PEG-1400 (Tri) and Di-7500-O-Me-750 (Di) recorded in
the first and the last flow cell chamber (time differenece: 10 ms and 1.1 sec after droplet production).
The y-axes shows the deformability calculated with a ferret´s diameter. The number of droplets ana-
lyzed in each data point is shown as n in grey. Deformation increases with droplet age. No differences
with regard to surfactant mixtures are visible.
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Dynamic of Deformation In a second experiment the droplet deformation was mea-
sured for every 10th chamber. The total number of chambers was 100. 2.5mM of
PFPE7000-PEG1400-PFPE7000 in FC-40 was used as oil phase and water as aqueous
phase. Here, 8000 frames were recorded for each chamber. The time between the droplet
production and the droplet reaching the last recorded chamber was one second. The
results are shown in Figure IV.11. A constant value is reached after about 50 to 60 cham-
bers indicating that surfactants need 500 milliseconds to create a dense layer to stabilize
droplets and to shield them from fusion in case of this surfactant.
Figure IV.11.: Deformation of droplets as a functionof the time following the droplet production. Droplet
deformation of water droplets in FC40 with 2.5mM of Tri-7000-PEG-1400 recorded in chambers 1 to
100. Number of droplets recorded is shown as n in grey on top. Deformation linearly increases with
droplet age up to chamber 50.
3. Key Factors for Droplet Stability and Fluorophore
Retention
3.1. Droplet Stability
To optimize the conditions for stable mono-disperse droplet creation the range of the
surfactant concentrations for the TRI7000 and TRI7000 surfactants was investigated. [158]
For better visualization a fluorescence dye Alexa 488 was disolved in TRIS-buffer to a final
concentration of 5 µM and used as an aqueous phase. Videos of freshly produced droplets,
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created in a microfluidic device, were recorded immediately after the cross junction with
a Phantom V7.3 camera at 10000 fps.
As can be observed in Figure IV.12 surfactant concentrations below 1mM lead to droplet
coalescence as soon as droplets were in contact. At higher surfactant concentrations
(above 1mM) droplets were stable and no coalescence was observed. Figure IV.12 shows
five representative images at different concentrations for both tested surfactants.
0.75     2.5                   10     20      30 mM  
200 µm
TRI 2500
TRI 7000
Figure IV.12.: Droplet stability as a function of surfactant concentration and its molecular weight. Rep-
resentative brightfield images of water-in oil droplets immediately after production. At low surfactant
concentration (C < 1mM) coalescence of droplets is observed (left panel). At high surfactant concen-
tration creation of small droplets occurs (right panel). Monodisperse and stable droplets are produced
in a stable regime as it can be seen in the middle panel. Adapted with permission from Ref. [144]
In case of TRI2500 stable monodispers droplets creation was observed at a concentration
range of 2,5 mM < c < 10 mM. In case of the bigger surfactant TRI7000 the concentration
range was larger, ranging from 1 mM up to 20 mM surfactant concentration. Above
these surfactant concentrations small droplets were created during droplet production
due to jet-dripping and by friction of the droplets flown in the channels. When droplets
were stabilized (less than a second after production) with a dense surfactant layer no
appearance of more small droplet or a decrease in size of produced droplets was observed
any more.
To provide a detailed analysis of the droplet stability and their size distribution droplets
were collected and stored in an analysis chamber (see Section III.2.3). The results are
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presented in Figure IV.13. Size distribution was measured for large droplets (size range:
5 µm< R <40 µm) and small droplets (size: R < 5 µm). The measured size distribution at
a given surfactant concentration was normalized with the corresponding area of the large
and the small droplets, respectively. The height of the bars in Figure IV.13 represent the
percentage of occupied area.
Figure IV.13.: Droplet size distribution as a function of surfactant concentration. Left panel: small droplets
and micelles formed at high surfactant concentrations. Right panel: Size distribution of “mother-
droplets” .
Surfactant concentrations below 1mM result in a broad droplet size distribution of larger
droplets, which can be attributed to coalescence. Some droplets were larger than 50 µm
radius and are not shown in the Figure but were included in the calculated percentage of
occupied area by droplets. These findings are in good agreement with Baret et al. [32] On
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the other hand high surfactant concentrations lead to creation of small droplet, visible
with brightfield microscopy. This effect was observed at a surfactant concentration of 5mM
for TRI2500 and at 20 mM for TRI7000. For high concentrations even shrinking of the
“mother-droplets” is visible (for TRI2500) by the decrease of the average droplet radius.
In most microfluidic droplet applications this effect is undesirable since a constant volume
of all droplets is essential for quantitative analysis. Therefore in all further investigations
the surfactant concentration was always kept between 2.5 and 10 mM to ensure production
of stable droplets with low size distribution.
3.2. Effect of Droplet Size and their Formation Rate on
Fluorophore Retention
To preform long term experiments with microfluidic droplets, stable encapsulation of
particles, molecules and cells is necessary. Therefore, molecular retention in the droplets
was analyzed according to droplet size and the rate of droplets formation. [158]
First the effect of droplet formation speeds was investigated to determine fluorophore
retention. Figure IV.14 shows representative images of the fluorophore ATTO 590 SE
moderate retention as a function of formation speeds (0.5, 3, and 30 kHz) (defined as
described in Section III 4.4).
Figure IV.14.: Effect of droplet production rates on fluorophore retention Moderate retention of ATTO 590
SE fluorophores in the droplets does not depend on the droplet creation frequencies. ATTO 590 SE
fluorophores were dissolved in PIPES-buffer and used as an aqueous phase for droplets creation. The
oil phase contained 2.5 mM of TRI7000 surfactants. Adapted with permission from Ref. [144].
As can be seen in Figure IV.14 the retention was not affected due to different droplet
creation frequencies. All flurophores mentioned in Section III.4.1 were tested and showed
the same result.
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Next the effect of droplet size on fluorophore retention was investigated. The flu-
orophors were encapsulated in droplets having different sizes (Diameter = 25, 40 and
150 µm, 3 KHz production speed, 2.5 mM of TRI7000 surfactant). As shown in Figure
IV.15 the droplet diameter had no effect on the fluorophore encapsulation stability. All
investigated fluorophore retentions were not affected by the size of the droplets.
Figure IV.15.: Effect of droplet sizes on the retention of fluorophores within the droplets. Retention of
fluorophores in the droplets is not affected as a function of droplet size. ATTO 532 SE, ATTO 655
SE, ATTO 590 SE and ATTO 647N SE fluorophores were dissolved in TRIS buffer and used as an
aqueous phase for droplet creation. The oil phase contained 2.5 mM of TRI7000 surfactant. Adapted
with permission from Ref. [144]
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3.3. Effect of Buffer Type and and Cell-Culture Medium on
Fluorophore Retention in Droplets
To investigate the influence of buffers and media on dissolved fluorophore retention the
most common four buffers (TRIS, HEPES, PIPES and PBS) and to the cell culture
media (RPMI and DMEM) were used as an aqueous phase. [158] The data concerning
buffers, media and fluorphores used in this study are described in Section III.4.1. The
hydrophilicity of the tested fluorophores was analyzed using the calculated distribution
coefficient LogD (see Section III.4.1). Positive LogD values correspond to hydrophobic
fluorophores, negative values to hydrophilic ones.
The retention summary of 12 commonly used fluorophores is presented in Figure IV.17.
Fluorophores were encapsulated in droplets, produced with FC-40 oil containing 10mM
TRI2500 and 3 µM Gold-PFPE surfactant. Droplet production and analysis were pre-
formed according to Section III.4.1. The retention of fluorophores was categorized ac-
cording to:
I0 ≈ It0 ≈ It24 ⇒ Stable flurophore retention
I0 ≈ It0 > It24 ⇒ Moderate fluorophore retention
I0 >> It0 ⇒ No fluorophore retention
Figure IV.16.: Characterization criteria for fluorophore retention in droplets
Stable retention is marked green, moderate retention is marked yellow and no retention
is marked red. Stable retention (marked green) was observed for all highly-hydrophilic
fluorophores (LogD < 0). Detailed definition of these three categories is presented in
Section III.4.4.
In Figure IV.17 highly hydrophilic (LogD < -7) fluorophores as Alexa 488, Alexa 647,
and ATTO 488 show stable retention independently on buffers and media type. However,
a buffer/medium-dependent retention was observed for less hydrophilic fluorophores with
LogD values around -4. For Alexa 532 and ATTO 532 fluorophores the protonation
state of secondary amines was reduced by buffers and media with higher pH values and
consequently led to a moderate retention. All flourphores with LogD values > 0 showed
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no or in case of RPMI media moderate retention
Figure IV.17.: Fluorophores retention in the droplets Fluorophores retention in the droplets (diameter = 40 µm)
having different buffer/medium conditions. TRI2500 (10 mM) surfactants were used to generate
droplets for this experiment. Adapted with permission from Ref. [144]
Surprisingly, no retention was observed for slightly hydrophilic dyes as ATTO 495 (LogD
= -0.81), ATTO 655 (LogD= -0.61) and ATTO 565 (LogD= -0.18). In case of ATTO
495 dye this behavior can be explained by the relatively small molecular weight as well as
the planar structure which leads to a smaller energetic barrier for the transport through
the surfactant layer. [162] For ATTO 565 and 655 dyes only half of the tested buffers and
media showed moderate retention.
3.4. Retention as a Function of Surfactant Length, Structure and
Concentration
In addition to buffer and fluorophore properties the effect of the physical properties of
surfactants (i.e., geometry, concentration and molecular weight) on the fluorophore reten-
tion in the droplets were investigated. [158] Three different surfactants (TRI2500, TRI7000,
and DI7000) with 10 mM concentration each were used (see Section IV.3.1). The reten-
tion summary of the 12 fluorophores encapsulated with the three surfactants is presented
in Figure IV.18. As can be observed from Figure IV.18 droplets produced with the
TRI7000 surfactants exhibited the best retention of encapsulated fluorophores. However,
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the droplets produced with this surfactant were highly polydisperse in size due to low
droplet stability. Improved retention in the droplets produced with diblock surfactants
can be attributed to the denser surfactant layer on droplets periphery due to reduced
steric effect on comparison to triblock surfactant geometry. However, for droplet stability
it is preferable to have a dense PFPE layer on the outside droplet interface. The most
efficient layer against coalescence can be provided by triblock surfactant geometry having
two PFPE tails. [15] Due to the inherent requirement for stable monodisperse droplets,
further experiments were performed with TRI2500 and TRI7000 surfactants. As shown
in Figure IV.18, improved retention was also achieved for some of the fluorophores in
droplets produced with longer surfactants (higher molecular weight). This observation is
straightforward since dyes have to pass a higher energetic barrier due to a thicker sur-
factant layer. [162] Further optimization of fluorophore retention within the droplets was
analyzed depending on the surfactant concentration.
Figure IV.18.: Fluorophores retention in the droplets is a function of buffer/medium selection and sur-
factant physical properties. Fluorophores retention in the droplets (D = 40 µm) as a function
of buffer/medium selection and surfactant physical properties. The droplets were generated using
three different surfactants (TRI2500, TRI7000, and DI7000 (10 mM)). Adapted with permission from
Ref. [144]
The range of surfactant concentrations was chosen according to the results in Section
IV.3.1. Based on these results and considering that molecular retention might be depen-
dend on surfactant concentration, further fluorophore retention studies were preformed in
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droplets produced with 2.5 and 10 mM surfactant concentration. The retention summary
of the 12 fluorophores encapsulated in droplets made of TRI7000 and TRI2500 surfactants
at two different concentrations is presented in Figure IV.19. In both cases, improved flu-
orophore retention was observed with the lower surfactant concentration. However, this
effect is more apparent in TRIS buffer and RPMI medium. The decrease of free surfac-
tants in the oil phase reduces the formation of reverse micelles and small droplets, which
can act as carriers for the solubilized fluorophores. These results are in agreement with
previous observations where the decrease of the fluorescence intensity of fluorescein inside
droplets was observed due to increased surfactant concentration. [163]
These results emphasize that with a proper selection of the physical surfactant proper-
ties such as concentration, geometry, and molecular weight the retention of most of the
fluorophores can be controlled efficiently.
Figure IV.19.: Fluorophores retention in the droplets as a function of surfactant length and concentration
Fluorophores retention in the droplets (D = 40 µm) as a function of surfactant length and concentration.
Fluorophores were dissolved in TRIS, PIPES buffers, and RPMI medium. The oil phase contained 2.5
or 10 mM of triblock surfactants. Adapted with permission from Ref. [144]
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3.5. Retention of Biomolecules
In most biorelevant applications with microfluidic droplets, fluorescence measurements
are applied to reveal the content of biomolecules and to asses the success and efficiency
of the approach. For example, fluorescently labeled proteins were used to characterize
their localization within the droplets for amyloidosis investigations [164], protein crystal-
ization [165] and immunological applications. [4] Therefore the influence of fluorophores and
surfactants on the retention of labeled biomolecules within droplets was investigated.
20 µm
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Figure IV.20.: Retention of ATTO 633- labeled microtubules in the droplets Retention of ATTO 633-labeled
microtubules in the droplets was not observed over time. This time-lapse shows that polymerized ATTO
633-labeled microtubules diffused within minutes into the oil phase. The oil phase contained 10 mM
TRI2500 surfactants. Note: Similar results were observed with and without addition of gold-linked
surfactants.
The retention of highly hydrophilic biomolecules such as antibodies and streptavidin
was compared with less hydrophilic biomolecules such as tubulin. Towards this end labeled
streptavidin proteins and antibodies (see Section III.4.3) were dissolved in TRIS buffer to
a final concentration of 0.2 µM. For the labeled tubulin, PIPES buffer (the most common
buffer used for tubulin experiments) was used for microtubule creation (1 µM) in droplets.
The main outcome from these experiments was that the retention is strongly dependent
on the physical properties of the surfactant as well as on the hydrophilicity of the selected
dye and the hydrophilic/hydrophobic properties of the biomolecule.
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As shown in Figure IV.21 stable retention of ATTO 633-labeled microtubules in the
droplets created with 2.5mM TRI7000 surfactants was achieved. Whereas, droplets pro-
duced with 2.5mM TRI2500 surfactant showed no retention of ATTO 633-labeled tubulin
and even pre-polymerized microtubules diffused out of the droplets immediately after en-
capsulation. A representative time-lapse is presented in Figure IV.20. Additionally, stable
retention was observed for microtubules labeled with highly hydrophilic ATTO 488 dye
(Figure IV.21).
In contrast to the labeled microtubules experiments, stable retention for more than 14
days was observed for all labeled antibodies and streptavidin proteins tested in this study.
These results were independent of the hydrophilicity of the dye and surfactant selection.
In case of antibodies and streptavidin proteins their high hydrophilicity and their big
molecular weights are the major reasons for their stable retention within the droplets
independent of the dye properties. Even the most hydrophobic ATTO 647N dye (LogD
= +4.47), which showed no retention in the droplets in a pure state, did not influence the
the stable retention of sheep anti-mouse antibodies or streptavidin.
Proper surfactant selection 
Proper fluorophore selection 
ATTO 633 labeled tubulin, TRI2500 10 mM 
ATTO 633 labeled tubulin, TRI7000 10 mM 
ATTO 488 labeled tubulin, TRI2500 10 mM 
Figure IV.21.: Factors influencing the retention of microtubules in micro droplets Retention of labeled
microtubules in the droplets strongly depends on the degree of hydrophilicity of the dye and surfactant
selection. ATTO 633- and ATTO 488-labeled microtubules were polymerized in PIPES buffer and used
as an aqueous phase for droplets creation. The oil phase contained 10 mM TRI7000 and TRI2500
surfactants. Note: Similar results were observed with and without addition of gold-linked surfactants.
Adapted with permission from Ref. [144]
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Compared to antibodies, tubulin is less hydrophilic and has even been considered as an
“amphi potential” protein, i.e., a protein that has the ability to exist in both aqueous and
lipid phases (like membrane proteins). Therefore, the dyes for labeling have to be selected
very carefully if less hydrophilic proteins like tubulin or other amphiphilic molecules are
encapsulated in droplets.
In conclusion this section shows that stable droplets are produced using surfactant
concentrations in the range of 2,5-10 mM. Retention of molecules in droplets is widely
independent of the droplet production speed as well as the droplet size. Stable fluo-
rophore retention is observed for highly hydrophilic molecules. For less hydrophilic or
amphiphilic molecules and biomolecules the fluorophore selection, buffer selection (pH
and salt concentrations), surfactant length and surfactant concentration are crucial for a
stable encapsulation.
4. Gold-Nanostructured Droplets, their
Biofunctionalization and Analysis
Goldnanoparticles (GNp) are commonly used as anchoring points for biomolecules in cell
experiments due to their biocompatibility and flexible biofunctionalisation via thiol-gold
chemistry. [166] To provide the droplets with bioactive surfaces the gold-linked surfactants
were synthesized (see Section IV.1.3) and mixed with surfactants containing no GNp. [4]
4.1. Cryo-SEM Analysis
To get a quantitative estimation concerning the GNp density the nanostructured droplets
were characterized using high resolution cryo-SEM. The analysis was carried out as de-
scribed in Section III.3. Representative top-view cryo-SEM (scanning electron micro-
scope) micrographs of freeze fractured nanostructured droplets created with gold-linked
surfactant (B) 30 µM; (D) 3 µM; (F) 0 µM are presented in Figure IV.22. In all experi-
ments here a 10 mM TRI2500 oil solution was used to create stabilized droplets. Gold
nanoparticles were observed on the inner periphery of the droplets. Their density in the
periphery correlates with the Gold-PEG-PFPE concentration used for the droplet cre-
ation. As shown in Figure IV.22 a higher density and more homogeneous distribution of
gold NP’s on the inner droplet periphery was obtained using a higher concentration of
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gold-linked surfactant (30 µM) (Figure IV.22 B) compared to a lower concentration (3 µM)
(Figure IV.22 D). [4] To prove that the bright dots were gold NPs and not artifacts due to
the cryo-SEM measurements or freeze-fracture preparation, droplets without gold-linked
surfactants were created, freeze-fractured, and observed by cryo-SEM (Figure IV.22 F).
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Figure IV.22.: Cryo-SEMmicrographs of freeze-fractured nanostructured droplets Representative cryo-SEM
micrographs of freeze-fractured nanostructured droplets obtained with different magnifications. The
droplets were created using a PFPE-PEG-PFPE triblock (TRI2500) copolymer surfactant concentration
of 20 mM and PFPE-PEG-Gold-naonoparticle surfactant concentrations of (A, B) 30µM, (C, D) 3µM
and (E, F) 0 µM. Adapted with permission from Ref. [4]
4.2. Biofunctionalization of Nanostructured Droplets
In this study GNp were used as anchoring points for various biomolecules. Towards this
end, two biofunctionalization approaches were developed. The first approach was based on
functionalization of created droplets with Ni2+ mediated interaction between the (His6-
tag) proteins and nitrilotriacetic acid (NTA)-thiol linker. In the second approach the
biomolecules were coupled covalently via ester or thiol bond to the gold-linked surfactants
before droplet creation.
The results of the first approach are presented in Figure IV.23 where GNps in the
nanostructured droplets were coupled with His6-tag green fluorescence protein (His6-
GFP) via a GNp-thiol linker (detailed reaction see Section III.5.1.
Images were taken (A) 1 day, (B) 4 days, and (C) 10 days after creation. The decrease
in fluorescence intensity over the observed period can be explained due to oxidation of
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gold-sulfur bonds in the aqueous phase [167] followed by diffusion to the oil phase and by
this a solvent-induced denaturation of the GFP molecules. [168] Figure IV.23 (D and E)
show representative images of droplets having either no gold-linked surfactant (D) or no
NTA-thiol-linker (E). As expected the fluorescence signal is equally distributed over the
whole droplet.
20 µm20 µm 20 µm 
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Figure IV.23.: Representative fluorescence images of the GFP-linked goldnanostructured and nonstruc-
tural droplets (A, B, C) Gold nanostructured droplets measured (A) 1 day, (B) 4 days, and (C) 10
days after their creation. (D, E) show the negative control with images of the non-gold nanostructured
droplets (D) and nanostructured droplets where the His6GFP was used without NTA-thiol linker (E),
taken one day after creation, respectively. All images have the same intensity scale. Adapted with
permission from Ref. [4]
4.2.1. Multiple Droplet Biofunctionalization
Since in most of the biorelevant applications binary or trinary functionalization might be
required, the droplets functionalization with various proteins was examined. Method 1 is
to synthesize a surfactant with a covalently linked biomolecule and to produce droplets
with the second NTA-thiol activated biomolecule in the aqueous phase. Method 2 uses two
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bioactive molecules dissolved in the aqueous phase and linked via NTA-Thiol chemistry
to the GNp’s on the inner droplet periphery.
Rhodamine B linked surfactants and His6-GFP NTA-Thiol were used in Method 1.
Method 2 used GFP- and MHC-Alexa568-NTA-thiol linked molecules. Both methods
were successful in linking the molecules to the gold NP’s. Representative confocal images
of encapsulated GFP- and MHC-Alexa568-NTA-thiol linked molecules taken 10 min after
production are shown in Figure IV.24. The results show an even distribution of the
fluorescence biomolecules on the periphery.
50 µm
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Figure IV.24.: Representative images of encapsulated GFP- and Alexa568-MHC-NTA-thiol linked
molecules. Images were taken 10 min after production. (A) Shows GFP, (B) shows the Alexa568-MHC
molecules and (C) presents the merged fluorescence from (A) and (B).
The second approach involves two steps: synthesis of PFPE-PEG-gold surfactants
linked to rhodamine B (RhB) (Section IV.1.4) followed by droplet creation using a mix-
ture of TRI2500 (20 mM) and RhB-PEG-Gold-PEG-PFPE (5 µM) surfactants as an oil
phase, while PBS was used as an aqueous phase. The droplets were stored and observed
in the analysis chamber (see Section III.2.3). Figure IV.25 shows the distribution of the
fluorescence signal in the RhB-linked nanostructured droplets. (A - C) show a time-lapse
taken 1, 4 and 16 days after creation and (1-10) a z-stack of a droplet. All images show
that the fluorescence signal is distributed equally at the droplet periphery. Due to the
chemical bonding and the stable fluorescence dye the signal was stable for more than two
weeks. [4]
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Figure IV.25.: Representative fluorescence images of the RhB-linked gold-nanostructured droplets (A,
B, C) RhB-linked nanostructured droplets measured (A) 1 day, (B) 4 days, and (C) 16 days after their
creation. (1-10) Representative distribution of the fluorescence signal along the RhB-linked nanostruc-
tured droplet height, 3 days after creation. Stack 1 represents the top of the droplet, stack 10 the
bottom. All images have the same intensity scale. Adapted with permission from Ref. [4]
5. T Cell Experiments
As described in detail in Section I.2 the effective ex vivo T cell activation is the crucial
step for successful immune therapy. Therefore, nanostructured and biofunctionalized
droplets were used as 3D APC analogues. To provide the specific interactions with the T
cells, the nanostructured droplets were functionalized with cyclic arginine-glycine-aspartic
acid peptide (cRGDfK) or with pMHC proteins via cysteine or Ni-NTA-thiol chemistry,
respectively. Single T cell encapsulation was achieved using a microfluidic spiral device
as described in Section III.2.3.1.
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5.1. T Cell Jurkat 6.1 Experiments
The human acute T cell leukemia cell line (Jurkat E 6.1) was used to evaluate the potential
of nanostructured and biofunctionalized droplets to serve as a 3D APC analogue enabling
single cell analysis in a defined compartment. Jurkat T cells express α4β1 and α5β1
integrins and exhibit activation-dependent regulation of integrin-mediated adhesion. [169]
c(RGDfK)-PEG6-cysteine which are specific for α5β1 were linked to PFPE-PEG-gold
surfactants (Section III.5.2) [4] No significant difference between both labeling strategies
was observed. However, the two step approach was preferred to minimize the amount
of soluble c(RGDfK)-PEG6-cysteine peptides in the aqueous phase, to avoid blockage of
active sides on the cells and therefore, hindering the cell-droplet interaction. [170]
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Figure IV.26.: T cell viability and T cell-droplet-periphery interaction depending on the functionaliza-
tion. (A) Representative bright-field image of Jurkat E 6.1 cells (indicated by arrows) in the cRGD-
functionalized nanostructured droplets 6 h after their creation. (B) Quantification (adherent cell %) of
Jurkat E6.1 cell adhesion on cRGD-functionalized (pink, left bars) and nonfunctionalized (gray, right
bars) nanostructured droplets. Data is presenting mean ± standard error of the mean (n = 5). (C) T
cell proliferation time lapse. (D) T cell viability after 3 days (green= alive; orange= dead). Cells were
marked with propidium iodid. Adapted with permission from Ref. [4]
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Cell encapsulation was preformed with straight and spiral microfluidic devices using
TRI2500 (20 mM) and RGD-gold-linked surfactants (25 µM) as oil phase and 6 x106 cells
per ml in 1604 RPMI media (composition Section III.6.1) as aqueous phase. Represen-
tative droplets with encapsulated Jurkat T cells (indicated by arrows) are presented in
Figure IV.26 (A). After incubation (37°C, 5% CO2) for 1 h, 90% of T cells in cRGD func-
tionalized droplets were observed in contact with the droplet’s periphery (Figure IV.26
(A, B)) whereas cells in droplets without cRGD-linked surfactants were found randomly
distributed in the droplets, similarly to previous observevations. [23] The number of cells
per droplet was controlled by varying the initial concentration of cells added to the mi-
crofluidic channel as well as using the spiral device (Section III.2.3.1). Figure IV.26 (C)
shows the proliferation of T cells encapsulated in cRGD functionalized droplets. Cells
encapsulated in droplets with cRGD-linked surfactants showed viability for up to 3 days
of incubation (tested as described in Section III.6.2). Representative brightfield and fluo-
rescence images of cells taken after 3 days are shown in Figure IV.26 (D). This observation
is in agreement with previously published results that showed the viability of Jurkat cells
for up to 9 days after encapsulation in droplets (diameter 100 µm) made of triblock sur-
factants. [150] Considering the differences in nutrition due to the smaller droplets and by
this also a smaller volume used in our experiments a shorter viability was expected.
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Figure IV.27.: Cryo-SEM micrographs of encapsulated T cells within the freeze-fractured nano-
structured droplets. Representative cryo-SEM micrographs of freeze-fractured biofunctionalized
droplets after the Jurkat E6.1 cell adhesion experiment. Adapted with permission from Ref. [4]
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For more detailed cell-droplet interaction analysis, droplets with encapsulated T cells
were freeze-fractured and investigated by cryo-SEM (Figure IV.27). Representative cryo-
SEM micrographs with different magnifications are presented in Figure IV.27. Cells can
be observed as spherical objects with diameters of 3 to 5 µm, similarly to previous obser-
vations. [171,172] Cryo-SEM micrographs confirmed cell-droplet interactions as observed by
bright-field microscopy.
5.2. Primary Mouse T Cells
Primary mouse T cells (see Section III.6.1) were used to investigate the antigen specific
activation by nanostructured droplets. Towards this end GNp-structured droplets were
functionalised with Alexa568-labeled pMHC and Alexa568-labeled ICAM proteins via Ni-
NTA-Thiol chemistry (see Section III.5). The ability of T cells to form a SMAC during
immunological synapse was investigated. Results are presented in Figure IV.28.
Primary mouse T-cells in RPMI 1604 media were encapsulated in droplets which con-
tained Alexa568-MHC and ICAM-1-NTA-thiol linked activation and adhesion molecules.
The activation and adhesion mediated molecules were linked via NTA-thiol to the GNp.
Images were taken with the confocal microscope as described in Section III.3. In Figure
IV.28 image 1 to 3 show composed z-stacks of droplets with primary mouse T cells in
contact with the MHC-Alexa568 peptide. Images were visualized using recorded z-stacks
and a "volume viewer" plugin in FIJI (image J). The results show enhanced fluorescence
signals (brown) at the cell droplet interaction areas.
Figure IV.28 (A, B and C) shows a fluorescence (A) and a bright filed image (B)
of the cell periphery interaction. (C) shows the 3D projection of the fluorescence signal
obtained in a z-stack. These results show clearly the advantage of having mobile biolinkers
in the droplet periphery which can be concentrated for the cell-droplet-surface interaction
as needed for an optimal cell activation which also allows the T cell to exert pushing
and pulling forces. These results prove that this setup allows rearrangement and local
accumulation of biolinkers for an optimal activation of T cells.
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Figure IV.28.: Representative confocal images of the primary mouse T cells interactions with gold-
nanostructure droplets. Image 1 to 3 show composed confocal z-stacks of droplets with primary
mouse T cells in contact with their periphery. In sake of clarity of presentation the periphery of the
droplet and T cells were marked with yellow and brown colour, respectively. The fluorescence signal of
the Alexa568-labeled MHC can be observed in image (A) and (C). A brightfiled image of the related
T cell is presented in figure (B).
6. Bottom-Up Assembly of Minimal Actin Networks
This section summarizes the results of actomyosin cortex formation in droplet-based
micro-compartments. Water-in-oil nanostructured emulsion droplets as cell-sized com-
partments were used to achieve the functional bottom-up assembly of minimal number
of proteins required to reconstitute the actomyosin cortex. To analyze the dynamic actin
properties in defined compartments all actomyosin networks were created by implementa-
tion of droplet based microfluidics. All droplet experiments in this section were preformed
using 2.5 mM triblock surfactants TRI7000. In some experiments 0.3 µM gold-labeled sur-
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factants were included to provide a linkage between the actin filaments and the droplets
periphery. If not mentioned explicitly, actin was used in a final concentration of 10 µM.
Detailed information for experimental conditions can be found in Section III.7.1 and Ta-
bles III.3 and III.4.
6.1. Reconstitution of Actomyosin Networks in Bulk
Prior to the actin experiments in droplets the bioactivity of freshly purified actin (see
Section III.7) was tested in bulk (Figure IV.29). Figure IV.29 (A) and (B) present actin
networks following the experimental conditions 1 and 2 (see Table ??), respectively. In the
first experiments phalloidin-FITC was used to avoid depolymerization of actin filaments
and to provide the detection of actin network formation.
Phalloidin is a toxin found in the green amanita with LD50 of 2-3 mg/kg. In actin
experiments it is used to reduce the actin depolymerization rate. [173] With a dissociation
constant KD of 10-8 M phalloidin binds the interaction sites between the G-actin subunits
of F-actin strands, reducing the depolymerization by a factor of 30. [174]
Figure IV.29 (A) shows a typical F-actin network distribution on clean glass surfaces.
Similar homogenous distribution of phalloidin-stabilized F-actin networks was observed
in Fisher et al. [175].
Figure IV.29.: Representative images of actin and actomyosin networks on glass surfaces. (A) and (B)
show representative images of an actin and actomyosin networks labeled with phalloidin-FITC on the
glass surfaces, respectively.
To assess the activity of the motor protein a final concentration of 0.5 µM myosin II was
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added to the actin solution. KCl of 0.75mM was used to control the myosin II protein
cluster length (i.e. 50-60 myosin II proteins per cluster). [135]
Figure IV.29 (B) presents the typical morphology of actomyosin network on the clean
glass surfaces 20 min after solution preparation. The effect of myosin II can be clearly
observed due to the conformational changes associated with the myosin contraction.
The aforementioned results show clearly the polymerization and contraction activity
of actin and myosin proteins, respectively. Therefore, same actin solution (experimental
condition 1) was used to reconstitute actin networks within the microfluidic droplets (see
the following section).
6.2. Optimization and Regulation of Actin Encapsulation by
Microfluidics
To encapsulate actin within water in oil microfluidic droplets two approaches were tested.
In the first approach the actin was dissolved in complete G-buffer and the normal device for
droplets generation (one-aqueous-inlet-channel device) was used to create actin containing
droplets. The main drawback of this approach was that actin pre-polymerized already
in the syringe and therefore blockage of syringe needles or microfluidic aqueous inlet
channels was observed. To overcome this obstacle and to polymerize the actin just inside
the droplets, a new microfluidic device was generated (Figure IV.30) with two aqueous
inlet channels.
Figure IV.30.: Microfluidic droplet production device with two aqueous inlet channels. Inset (A) and (B)
show representative fluorescence images of the the two phases for actin containing droplet production.
Bright phases represent the actin solution containing the phallodidin-FITC. The second phase contains
all molecules needed for polymerization and bundling of actin. The solutions have a contact time in
the millisecond range before getting encapsulated.
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In this device one aqueous inlet channel was used to introduce actin, phalloidin-FITC
and anti-oxidation buffer in G-buffer containing no MgCl2 (bright shining phase in inset
(A) and (B) in Figure IV.30), the second aqueous channel contained ATP, MgCl2 and
myosin (when used) (dark half of the channels). By using this device the contact between
two solutions was limited to few milliseconds before droplets creation. Herby, uncontrolled
actin polymerization before encapsulation within the droplets was minimized.
Successful implementation of the two aqueous inlet channel device for encapsulation of
G-actin and controlled polymerization after encapsulation was crucial for the following
regulation of F-actin network distribution within the droplets. Polymerization of G-actin
monomers inside the droplets (experimental condition 1) and chemical immobilization of
F-actin filaments to the gold nanoparticles on the droplet periphery by means of lipoic
acid PEG succinimidyl-ester (NHS-ester) were examined. Remarkably, most of the actin
filaments were found to be in contact with the inner periphery of the droplets, compared to
randomly distributed filaments in the case of droplets without gold-linked surfactants.
It has to be mentioned here that actin can be immobilized on the periphery of the
droplets containing gold-linked surfactants also without lipoic acid linker due to the inter-
action between the cysteine on the actin filaments and the gold nanoparticles. Moreover,
analysis of images obtained by confocal microscopy revealed no difference in F actin-
droplets interaction with and without linkers. Since NHS molecules interact with the
primary amines on actin they can potentially block or affect the F-actin polymerization.
Therefore, in all further experiments, were the interaction of actin and the droplets pe-
riphery were required direct linkage was preferential.
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Figure IV.31.: Regulation of F-actin network distribution by gold-nanoparticle-linked surfactants. (A)
and (B) show a schematic and real actin network distribution (labeled with phalloidin-FITC) in
droplets having no gold-linked-surfactnat and with gold-linked surfactants, respectively. (A) non-gold-
nanostructured droplets and (B) gold-nanostructured droplets. Confocal images (A1) and (A2) show
the location of actin networks in droplets without gold-nanoparticles. (B1) 3D image of actin network
located on The periphery in gold nano-structured droplets. (B2) Slice of a confocal z-stack of actin
network located on The periphery in gold nano-structured droplets.
Next, the effect of a lipid bilayer on the actin-droplet periphery interactions was ana-
lyzed. Towards this goal, the same experimental conditions as presented before in Figure
IV.31 (B) were used. To generate a lipid bilayer within the droplets L-α-phosphatidyl-
ethanolamine-N-(lissamine rhodamine B sulfonyl) lipids (5µM) together with the G-actin
were dissolved in G-buffer and introduced as an aqueous phase. Droplets were created
using the oil phase containing triblock and gold-linked surfactants.
The results in Figure IV.32 show that following optimization of ion concentration lipids
build a GUV on the inner periphery of the droplet. Furthermore, it can be observed
(Figure IV.32 (A)) that the location of actin networks was only found in the center
of the droplets similarly to distribution observed in Figure IV.31 (A), where no gold-
linked surfactants were used. The merged 3D z-stack obtained by confocal microscopy is
presented in Figure IV.32 (B) and (C).
There are two major outcomes from these experiments: 1) The actin-gold interaction
can be prevented by the GUV formation within the droplet, which sealed completely
the inner periphery of the droplet and; 2) the most common system to mimic cellular
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membranes as a GUV can be created within the polymer stabilized droplets.
Figure IV.32.: F-Actin distribution in droplets having a GUV on its inner droplet periphery (A) cross
section image of a z-stack were actin (green, labeled with phalloidin-FITC) is located in the middle
of the droplet with no interaction with the periphery, which is sealed by the dense lipid bilayer (red,
rhodamine labeled).(B) 3D z-stack of merged confocal images with an actin network in the droplet
surrounded by a lipid bilayer on the inner droplet periphery. (C) same z-stack as presented in (B), but
with one side cropped to allow an insight view of the droplet showing that the actin is only located in
the middle of the droplet.
6.3. Actomyosin Cortex Creation
Following the ability to control the actin network distribution within the droplets, the next
step was to introduce motor proteins such as myosin II in order to create an actomyosin
cortex. Towards this end myosin II was added to the MgCl2/ATP channel solution in the
same concentration as in the bulk experiments (see Section IV.6.1, experimental conditions
2). As shown in Figure IV.33 (A) actomyosin networks can not interact with the periphery
if no gold-linked surfactants used. However, in comparison to experiments without myosin,
slight contractions were observed as represented by thicker actin bundles. Furthermore,
the actomyosin network in this experiment showed a contractile and motile behavior for
up to 20 minutes until all ATP was consumed. Figure IV.33 (B) shows time-lapse images
of the dynamic behavior of actomyosin network within the microfluidic network.
88
Chapter IV. Results and Discussions
Figure IV.33.: Representative images of actomyosin networks encapsulated in droplets without gold-
linked-surfactants. Image (A) shows a low magnification fluorescence image of the actomyosin net-
work distributed mainly in the center of the droplet. (B) represents time-lapse images of actomyosin
dynamics within the droplets.
Addition of gold-linked surfactants was necessary to create an actomyosin cortex-like
network close to the droplets periphery (Figure IV.34 A and B). These Figures show
representative image obtained with a low and high magnification of actomyosin networks
in gold-nanostructured droplets being in contact with the periphery. No dynamics and
motility of the actomyosin network was observed.
Figure IV.34.: Representative images of actomyosin networks encapsulated in droplets witht gold-linked-
surfactants. Images (A) and (B) represent actomyosin networks with gold-nanoparticles on the
periphery.
Very low dynamics of the actomyosin networks can be attributed to the non-physiological
actin network conditions due to the artificial filament stabilization provided by phalloidin.
It is known from literature that phalloidin affects the rigidity of the actin networks [175]
and perturbs the interaction of myosin with actin filaments. [176] Therefore, in the following
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experiments to detect the actomyosin network formation, phalloidin-FITC was replaced
by more physiological approach such as addition of directly labeled actin. Furthermore,
fascin was included to provide bundling of actin filaments.
6.4. Optimization of Actin Network Reconstitution in Better
Physiological Conditions
In order to mimic better the physiological conditions of the actin network reconstitution
and to overcome the afore mentioned drawbacks, phalloidin-FITC was replaced by direct
labeled G-actin. Towards this end G-actin was mixed with 1-2 % of alexa (488/568/647)-
labeled G-actin (life technologies, Germany) to provide the detection of actin network
formation. It is worth to mention here that these fluorescence dyes were chosen based on
the retention studies presented in Section IV.3.3. Furthermore, we explored the effect of
the fascin as a passive crosslinker on dynamic filament organization. Fascin is the major
actin crosslinking protein found in a wide range of sub-cellular complexes such as filopodia
and the cortex. This protein has been shown to work in concert with other crosslinkers
such as α-actin, although fascin itself is sufficient to form filopodia- and cortex-like bundles
in a reconstitution system. [177]
To reconstitute actin networks 0.1µM Alexa488-labeled G-actin (experimental con-
ditions 3, see Tables III.3 and III.4) was mixed with 9.9 µM non-labeled G-actin and
introduced in one of the two aqueous inlet channels (see Figure IV.30). Fascin (0.5µM)
was mixed together with the MgCl2/ATP solution within the G-buffer and introduced
into the second aqueous inlet channel. The concentration of fascin was adapted from the
previously reported protocols for actomyosin cortex formation on the glass surfaces. [135]
Creation of actin networks with the new experimental conditions was analyzed. Figure
IV.35 A and B present the distribution of the actin filaments within the droplets produced
without and with gold-linked surfactants, respectively. In both cases, it can be observed
that the networks formed a highly dense bundle structure. In the case of droplets con-
taining gold-linked surfactants (Figure IV.35 B) the bundles were found in contact with
the droplets periphery. This can be attributed to fast cross-linkage by fascin during the
actin filaments creation. Additionally, a partial mixture of the fascin phase and the actin
phase during droplet formation can create a local polymerization leading to high dense
bundle formation.
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Figure IV.35.: Fascin bundled actin networks encapsulated in droplets created without and with gold-
nanoparticels. (A) shows F-actin networks in droplets created without the gold-linked surfactants.
Images (B) represent the same experimental conditions but with gold-linked surfactant. (1% of G-actin
was labeled directly with Aexa488)
In an attempt to overcome the drawback of the partial mixture, a mixing channel (Fig-
ure I.2) was implemented into the microfluidic device immediately after droplets genera-
tion. Hereby, the content in the droplet is completely mixed within a few milliseconds. [178]
Figure IV.36 A shows the effect of the mixing device on the actin filament distribution.
Unfortunately, only small improvement can be observed. However, keeping the same
concentration of the actin as in the previous experiment, and observing higher volume
fraction of the actin bundles within the droplets, one can conclude that the density of the
actin network bundles is lower. Therefore, in addition to better mixture of the solutions,
more conditions were adjusted to achieve better distribution of the actin networks in the
droplets.
To optimize the G-actin polymerization rate the pH of the G-buffer was increased from
7.4 to pH 8. At elevated pH values Crevenna et. al. [179] observed decrease in the actin
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polymerization rates and increase the actin filament length.
The results for droplets containing actin networks, which polymerized at pH 8 are
presented in Figure IV.36 (B). As can be observed F-actin interacts with the whole droplet
periphery and no thick bundle structures are observed.
Figure IV.36.: Disstribution of F-actin networks created at different pH-values. (A) and (B) show the
representative fluorescence images of actin networks created in the gold-nanostructured droplets at pH
7.4 and 8, respectively.
To mimic better the biophysical condition within the droplets in terms of diffusion
coefficient and ion concentration, 2.5 % w/w of PEG (MW 10000 g/mol) was added
and the concentration of MgCl2 was reduced to 15 mM in the G-buffer solution. These
modifications were necessary to mimic better the ion concentration [180] and diffusion co-
efficient [181] as they are measured in the cellular cytosol. A representative image of actin
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networks produced with this condition is shown in Figure IV.37. It can be observed that
actin networks interact with the droplets periphery creating cortex-like structures and no
thick bundles were detected. All further experiments creating actomyosin cortexes (see
next sections) were reconstituted using the biophysical conditions according to the results
achieved in this section.
Figure IV.37.: Actin networks in droplets with the optimized biohysical and biochemical conditions. The
environment in the droplets allowed to mimic the cytosol diffusion conditions by addition of 2.5 % w/w
of PEG (MW 10000 g/mol). By this adaptation the MgCl2 could be reduced 15 mM.
6.5. Reconstitution of Actomyosin Cortex with Optimized
Biophysical and Biochemical Conditions
Following the successful optimization of biophysical and biochemical conditions, as de-
scribed in the previous Section, the next step towards the reconstitution of actomyosin
cortex was to introduce myosin II in the MgCl2/ATP channel (Experimental conditions
6, see tables III.3 and III.4). To detect the position of the myosin within the actomyosin
networks Alexa 568-labeled myosin II (ratio 1:5 to non-labeled myosin II, kind gift of
Anne Bernheim, Ben-Gurion University, Israel) was used. Additionally, an ATP recovery
buffer (see Section III.7) was introduced in both aqueous inlets to extend the activity
time of myosin II clusters.
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Figure IV.38 shows the representative combined images of actomyosin networks re-
constituted within the droplets without (Figure IV.38 A) and with (Figure IV.38 B)
gold-linked surfactants. It can be observed that in the case of droplets produced without
gold-linked surcfatants the actomyosin network distributed equally within the droplet, no
interaction with the droplet periphery was observed. Moreover, myosin II colocalized (in-
dicated by the arrows) within the actin fibers as it is expected. In the droplets produced
with gold-linked surfactants a strong interaction with the periphery of the actomyosin net-
works is observed. However, myosin II was not detected on the periphery of the droplets
but was colocalized within the actin filament network. This indicates that actin mainly
interacts during the polymerization with the gold-nanoparticles, which make sense, since
the ratio between the actin monomers and the myosin II clusters is 1000:1.
The actomyosin dynamics will be discussed and described in the following section. It is
worth mentioning here that the interaction with the periphery of the droplets was essential
to induce self-propelling of the actomyosin system within the droplet.
Figure IV.38.: Representative images of actomyosin networks encapsulated in droplets without and
with gold-linked-surfactants, respectively. (A) and (B) show representative flourescence images
of reconstitute actomyosin networks in droplets produced with and without gold-linked surfactants,
respectively.
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6.6. Analysis of Actomyosin Network Dynamics
Time-lapse images were recorded to analyze the dynamics of actomyosin networks (see
Section III.7.2) in the droplets. Figure IV.39 (A) shows representative time-lapse images
and schemes of the actomyosin contraction within a droplet containing no gold-linked
surfactants.
Figure IV.39.: Representative fluorescence time-lapse images of actomyosin network motion in droplets
and their schematics. (A) shows a schematic and real contraction of actomyosin network in a droplet
without gold-linked surfactant. (B) presents a schematic and real rotation of the actomyosin network
in droplets containing gold-linked surfactants.
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It can be observed that the contraction occures immediately after the actomyosin net-
works formation and lasts for about 8 min. The dynamics of actomyosin networks contrac-
tion is in a good agreement with the previously reported works, in which the actomyosin
dynamics was investigated on 2D surfaces [131,135] or within the 3D compartments [137,182].
More interesting, actomyosin dynamics was observed in the droplets containing gold-
linked surfactants (Figure 8 IV.39 B). In this case, no significant network contraction
was detected, as in the case were no gold linked surfactants were used, but a rotation
(self-propelling) of the actomyosin cortex was observed. It is worth mentioning here that
rotation was observed in different directions (i.e. clock-wise/counter clock-wise). This ob-
servations are similar to pervious works were polymer stabilized water-in-oil droplets were
used to reconstitute actomyosin cortex from Xenopus laevis egg cytoplasmic extracts. [137]
In this study the linkage to the droplets periphery was preformed via actin nucleation
complexes. However, in both cases, due to the spherical structure of the droplets it is not
clear if the whole droplet is rotating or only the actomyosin network.
To break the symmetry of the micro compartment droplets a new type of bead-linked
surfactants was synthesized (described in Section IV.1.6).
Figure IV.40.: Representative brigthfield and fluorescence images as well as cryo-SEM micrographs of
the bead-linked-surfactants in the contact with the droplet outside periphery. (A) shows
representative brightfield and fluorescence images of the droplet having three beads on its periphery
(indicated by arrows). (B) presents high resolution cryo-SEM micrographs of beads in contact with the
droplet periphery.
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Detailed analysis is shown in Section VI.3. These 2 µm in diameter bead-linked surfac-
tants were introduced through the oil phase. By diffusion the beads reached the droplet
outer interface where they immobilized due to the electrostatic interactions of the PFPE-
tails (for more details see Section VI.3). Figure IV.40 A and B show the representative
images and micrographs of the droplets-beads interactions as observed by light-microscopy
and cryo-SEM microscopy, respectively.
Beads linked to the outside periphery of the droplet helped to track the rotation of
the droplets and to correlate it to the motility of the actomyosin cortex. Figure IV.41
shows representative time-lapse images (total 30 min) of the droplets rotation induced by
the actomyosin cortex motility. By tracking the bead displacement it can be observed
that the droplet rotation is not limited to one plane. Moreover, the rotation speed of the
actomyosin cortex is the same as of the bead. These results confirm that the actomyosin
self-propelling can only be achieved by the interaction with the droplet interface. In
the absence of the droplet-actin networks interaction only contraction of the actomyosin
network can be detected.
Figure IV.41.: representative time-lapse images (total 30 min) of the droplets rotation induced by the
actomyosin cortex motility. (A, B and C) show the representative brightfield, fluorescence and
schematic images of the droplet rotation induced by the actomyosin cortex motility.
To provide more detailed analysis concerning the motility distribution within the droplets
a radial velocity profile was tracked and plotted (see Figure IV.42, analyzed by Marco
Linke from Ulrich Schwartz group, physical department Heidelbreg university). [183,184] Ex-
97
6. Bottom-Up Assembly of Minimal Actin Networks
cept at the edge of the droplet the profile is almost linear. This velocity profile hints on the
scenario that the actomyosin network is the driving force for movement and the droplet
rotation is induced by the frictional forces created by the surfactant layer.
Figure IV.42.: Radial velocity profile of rotating droplet.
To test if the myosin-induced contractility is the driving force for the droplets rotation,
a myosin inhibitor, blebbistatin (23 µM) [185,186] was used (experimental conditions 7, de-
tails Tables III.3 and III.4). No rotation and actomyosin motility was observed in the
droplets containing blebbistatin. To deactivate blebbistatin a 458 nm laser (1mW, ap-
plied 5 times for 100 ms) was used. [185,186] Rotation of the droplets was observed following
the deactivation of blebbistatin. The main outcome is that the myosin-driving forces are
essential for the droplets rotation.
A proposed mechanism for the rotation of actomyosin networks in defined compartments
is a spontaneous break down of discrete symmetry due myosin induced contractility. [187] In
the absence of tread-milling effects the dynamics arises solely from the contractile motion
of myosin motors as also described by Tjhung et. al. [187] In more details, myosin activity
induces a molecular scale torque, (Beusang 2008) which leads to the generation of active
torque density at larger scales, causing an isolated part of cortex to contract and rotate.
The non-symmetric immobilization of the actin cortex to the droplet periphery leads to
the generation of a force- and a torque-momentum, which in a superposition provides
a direction to the droplet rotation. [188] It is worth mentioning here, that no actomyosin
rotation was observed when using higher actin concentration (20µM) for reconstitution of
actomyosin cortexes. The lack of the droplets rotation at higher actin concentration can
be explained by symmetric distribution of the actomyosin filaments within the droplets.
Wheel gymnastics (Figure IV.43) can serve as an analogy for the aforementioned mech-
anism. Due to the stable anchoring points between the person and the wheel the ra-
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dial velocity profile within the wheel is linear. In the case of actomyosin cortex in the
droplets, the anchoring points between the actin network (i.e. the person) and the droplet
perephery (i.e. the wheel) are the gold-linked surfactants, which have certain freedom to
move. Therefore, the anchoring points between the actomyosin and the droplets have
a more frictional character and are hereby less stable. This is also a reason to slight
deviation from the linear radial velocity profile within the droplets as shown in Figure
IV.42.
Furthermore, in contrast to the wheel gymnastics, the rotation of the droplets do not
generate movement to a particular direction. This can be attributed to the lack of friction
between the outside periphery of the droplet and its external environment, like in the case
of the friction of wheel and the floor. To provide friction between the outside periphery
of the droplet and the glass surface bead-linked surfactants can be used.
Figure IV.43.: Wheel gymnastics as an analogy to actomyosin driven self propelling in droplets.
Figure IV.44 shows a hopping dynamic of the self-propelling bead-containing acto-
myosin droplets. Three major forces, including the gravity force (Fg, indicated by red
arrow), force generated by actomyosin contraction (Fc, indicated by black arrow) and the
frictional force (Ff, indicated by blue arrow) are responsible for the hopping behavior.
Gravity force is generated due to the high differences in the density between the FC-40
oil (ρ=1855 kg/m3) and the water phase (ρ=998 kg/m3). This force pushes and keeps the
droplets in the proximity to the cover glass of the analysis chamber (see section III.2.3).
Force generated by the actomyosin contraction generates the rotation of the droplets as
discussed above. The friction force is generated between the bead and the glass surface
when the bead is reaching the glass due to the droplets rotation. This frictional force
works against the rotation of the droplets, herby against the actomyosin contraction and
it is sufficient to create a failure of the powerstroke mechanism, resulting in the rupture
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of the actin-myosin interactions. Hopping of the droplets, kind of spring release effect, is
generated as a result of the instant rupture of the actin-myosin interactions.
Figure IV.44.: A representative time-lapse of hopping dynamics of the self-propelling bead containing
actomyosin droplets. The upper row shows the time-lapse images of the rotating and hopping
droplet. The lower row presents the schematics of the mechanism responsible for the self-propelling
and hopping behaviour of the droplets. Fg (red arrows), Ff (blue arrows) and Fc (black arrows)
represent the gravity, friction and contraction forces, respectively. The black dashed arrow represent
the direction of the droplet movement.
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Microfluidics is a technology that profits from minimal sample consumption, minimal
exposure to hazardous materials, increased analysis speed and data precision. Due to
these numerous advantages, the major aim of this thesis was to explore the capacities of
microfluidics, particularly droplet-based microfluidic technology in the following synthetic
biology topics: 1) Mimicry of the immune system cellular environment, with the ultimate
goal of programing T cells for adoptive T cell therapy; 2) bottom-up assembly of minimal
synthetic cells.
1. Microfluidic Droplets as Soft Nano-Structured
Biomimetic Systems for Immunological
Applications.
Despite the beneficial impact of modified T cells, the road towards broadly applicable
adoptive T cell therapy is still long and winding. The major challenge is the guidance
and exquisite regulation of immune processes ex vivo. In part, this is due to the dif-
ficulties of simulating ex vivo the intimate cellular interactions that occur between T
cells and antigen-presenting cells (APCs). The fate of T cells is not solely regulated by
the presence of certain molecules on the surface of APCs but also by their density and
spatial distribution. Moreover, mechanical properties of APCs and force-dependent gen-
eration of, so called, supramolecular activation clusters (SMACs) during the formation of
an immunological synapse (IS), play a crucial role in T cell fate regulation.
In this thesis a novel approach to the formation of nano-structured and specifically-
biofunctionalized water-in-oil emulsion droplets with the potential to serve as 3D APC
surrogates was developed (references 5-8 in publication list section VI.1). Towards this
end, a new class of gold-linked surfactants was synthesized and stable cell-size microfluidic
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droplets with various gold-nanoparticle densities were created. Two chemical approaches
were used, both to test the efficiency of the GNps inside the droplets to serve as anchoring
points and to provide the key chemical and biological functions of APCs. Remarkably,
more than 90% of encapsulated T cells were found to be in contact with the inner periph-
ery of the droplets, compared to less than 10% in the case of non-functionalized droplets.
Moreover, T cells in the functionalized droplets exhibited increased proliferation and re-
mained viable for up to 5 days of incubation without any external nutrition. Furthermore,
the dynamic properties of the droplets surfactant layer allowed formation of SMACs due
to the T cell-droplet interaction, which is a hallmark for the efficient IS.
This research highlights the advanced properties of polymer-stabilized droplets for use
in T cell stimulation. The combination of flexible biofunctialization and pliable physical
droplet properties work in tandem, providing a flexible and modular system that closely
models in situ APC-T cell interactions. Moreover, the ability to create a well-defined
picoliter environment for T cell stimulation is preeminent for long-term monitoring of
individual T cells over the course of their activation and differentiation. Therefore, in sum,
this systems bears a strong potential for clarifying individual T cell response mechanisms
triggered by collective APC-T cell molecular interactions. However, it should be noted
that many aspects were not explored in this research and warrant further investigation.
In this thesis only adhesion and stimulation ligands were used, but the generation of
productive T cell responses, such as proliferation and differentiation, requires the engage-
ment of co-stimulatory signals and adhesion complexes in addition to stimulation signals.
Therefore, combination of these signals within the droplets together with the biophysical
properties will be a necessary requirement for better understanding the force-dependent
conformational changes during IS formation. Moreover, the developed system offers the
possibility to achieve control over identity and quantity of bio-active ligands on the droplet
periphery. This advantage is crucial and opens new possibilities to understand better the
molecular mechanisms of the assembly of TCR activation clusters, and consequently to
address the following very important open questions:
i) is the T-cell activation simply dose-dependent in regards to the number of stimula-
tion microclusters; ii) what is the threshold number of stimulation microclusters required
for the T-cell activation; and iii) what is the optimal ratio between the stimulation,
co-stimulation signals and adhesive molecules required to create the best stimulation con-
ditions.
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2. Droplet-Based Microfluidics for Bottom-Up
Assembly of Minimal Synthetic Cells
Actin cytoskeleton is a very important regulator of intracellular signaling pathways.
Therefore, it affects many cellular processes, including, but not limited to, cell division,
force generation, polarization, intracellular transport and motility. This broad range of
actin-mediated processes also underscores their central physiological roles, as well as their
involvement in a wide variety of disease states. Although attaining a fundamental charac-
terization of how macroscopic cytoskeletal dynamics emerge from it molecular constituents
is a compelling goal, little understanding has yet been accomplished, mainly due to the
extensive complexity of the cytoskeleton network and difficulties inherent in studies in
vivo.
The research within this thesis focused on dissection of complex cellular sensory machin-
ery by engineering of biomimetic systems for controlled manipulation of subcellular units
in vitro. Towards this end, an automated droplet-based microfluidic system was used
to generate water-in-oil nanostructured droplets as cell-size compartments for bottom-up
assembly of the minimal number of proteins required for a “simple synthetic cell”. While
the applied methodology has a potential for assembly of a wide range of subcellular func-
tional units, the focus was on the reconstitution of the actomyosin cortex.(references 1 in
publication list section VI.1)
As a first step, to optimize the retention of labeled biomolecules and fluorophores within
emulsion droplets, key physical and chemical factors of fluorescent dyes, surfactants and
buffer conditions were investigated in details (references 4 in publication list section VI.1)
The outcomes of this investigation provide crucial information for the successful reconsti-
tution of actomyosin cortex within the nanostructured droplets (references 1 in publication
list section VI.1). Furthermore, the ability to control the filaments organization by link-
age to the droplets periphery was very important and following addition of myosin II
motor proteins allowed to achieve droplets migration and self-propulsion (references 1 in
publication list section VI.1).
The described achievements highlight the potential of the droplet-based-microfluidics
system for a bottom-up assembly of sub-cellular units. However, these results cover only
a small part of what this technology can propose. For example, pico-injection technology
has to be used more extensively in the bottom-up assembly approaches. The results as pre-
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sented in Figure V.1 can guide the perspective for further implementation of pico-injection
microfluidic unit in testing the importance of subsequent introduction of various proteins.
It can be observed that premixed differently labeled actin was distributed equally in the
droplets (Figure V.1 upper row). Figure V.1 upper row shows that premixed differently
labeled G-actins formed actin networks within the droplets combined of all three labeled
actin. In contrast, actin network created by pico-injection subsequent introduction of
differently labeled G-actin showed segregation of differently labeled F-actin (Figure V.1
lower row).
Figure V.1.: Comparison of actin network formation as a result of premixed and subsequent introduction
of differently labeled G-actin. Upper row shows representative fluorescence images of Alexa488,
Alexa568 and Alexa647 labeled actin networks. The bottom row shows the actin networks generated by
pico-injection (middle row) subsequent introduction of Alexa488, Alexa568 and Alexa647 labeled actin
monomers.
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Another experiment was perfomed to highlight the importance of implementation of
pico-injection units for the bottom-up assembly of sub-cellular units. In this experiment,
actin and myosin were introduced via pico-injection into droplets containing a GUV like
lipid bilayer on the periphery (Figure V.2). The results show that this approach can
produce large numbers of GUVs containing actomyosin networks stabilized by droplets.
In this approach actin could be linked via talin (recently purified in our group) to integrines
in the lipid bilayer. The possibilities have the potential to allow a bottom-up assembly of
focal adhesion complexes in the near future.
Figure V.2.: Actomyosin distribution in the GUVs-containing droplets. Two experimental steps were required
for stable droplets creation with F-actin and GUVs: the first is creation of droplets with GUVs (red,
rhodamine labeled POPE), and the second is an injection of these droplets with Alexa488-labled G-actin
solution by pico-injection.
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2. Structure of Used Fluorophores
O
O
N
O
O
N NH2
H
H
An SO3H SO3H
NH2N NH2
An
O
O
ON N
H
An
O O
H
O
O
N
O
O
N N
H
An
SO3H SO3H
H
O
O
NN
OH
OO
An O
O
NN
OH
OO
An
N N
N
O
O
O
An
O
N
NN
SO3
O
ATTO 488 SE ATTO 495 SE ATTO 520 SE
ATTO 532 SE ATTO 565 SE ATTO 590 SE
ATTO 647N SE ATTO 655 SE
ON NH2
H
H
An
SO3H SO3H
HO
O
H
NO N
O
O
O
An
SO3H SO3H
NHO
N
O
O
N
H
N
H
Alexa 532 Maleimide
N
N
SO3
SO3SO3
O3S
O
Alexa 647 Maleimide
N
O
O
O
N
OO
N
O
O
N
O O N
OO
N
O
O
N
O
O
N
OO
Alexa 488 Maleimide
N
O
O
O
Figure VI.1.: Overview of the chemical structures of used fluorescent dyes
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3. Bead-Surfactant Analysis
To analyze the ability of the synthesized bead-surfactant (Section IV.1.6) to serve as a
marker in the droplet periphery several experiments were preformed including confocal
microscopy, diffusion and dislocation analysis. For diffusion and dislocation experiments
the distribution of the median values of the bead-surfactant speeds in oil phase and in
the droplet interface were compared.
For confocal analysis fluorescent beads (Fluorobright PLAIN Y G, radius: 0.57 µm,
excitation max. = 441 nm, emissions max. = 486 nm, 1.08 1011 particles/ml, Polyscience
Inc, Warrington, PA, USA) were synthesized according to the reaction presented in Section
IV.1.6 and combined with droplets containing a lipid bilayer on the inner droplet periphery
to enhance the visibility of the location the bead-surfactant. The results presented in
figure VI.2 show the fluorescent signal of the beads in close contact to the lipid bilayer
proving that the bead of the bead-surfactant is incorporated in the surfactant layer on
the droplet periphery.
To create a lipid bilayer on the inner periphery of the droplets, lipids (DOPE-Rohdamin
B (80%), DOPC (10%), DOPS (10%)) solved in chlorform were mixed with a 8:1:1 ratio,
dried to remove the chloroform and resolved in ultra pure water with 20 mM MgCl2.
A B 
  5 µm 20 µm
Figure VI.2.: Representative confocal images of bead-linked-surfactant in contact to the outer lipid-
containing droplet periphery.
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In diffusion experiments preformed in an analysis chamber (Section III.2.3) a signifi-
cant difference in diffusion speeds of free bead-surfactants and in the droplet periphery
incorporated bead-surfactants could be shown (p-value: 5.87x 10-10) (Figure VI.3). This
difference in diffusion speeds decreased over time due to low density of the beads (bead ρ
= 1.05 g cm-3, FC-40 ρ = 1.85 g cm-3) resulting in a contact to the top glass of the analysis
chamber. By this friction was increasesd and no free movement was observed afterwards.
Therefore only results shortly after production were taken into consideration.
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Figure VI.3.: Analysis of beads diffusion in the oil phase. The diagrams A and B present the diffusion of the
bead-surfactant. (A) represents the diffusion of free bead-surfactant in the oil phase. Diagram B shows
the diffusion of bead-surfactant in the droplet periphery. Red line represents the median for A and B.
The diffusion for free bead surfctant was 17.21 ± 3.05 µm ms-1 before and and 1.31 ± 0.25 µm ms-1 rafter
sedimentation. The median for bead-surfactant speed in the periphery was 0.41 ± 0.36µm ms-1
In a second experiment the dislocation of beads was analyzed. In figure VI.4 the
difference of free bead-surfactants and in the periphery incorporated bead-surfactants can
be clearly seen. Here the p-value is 3.6x 10-11. The difference of the dislocation is much
higher due to the free movement of free bead-surfactant compared to the beads in the
periphery which can only move short distances due to the dense surfactant layer. The
results of these experiments together with IR-analysis and cryo-SEM images of beads in
the periphery of actin droplets (Section IV.1.6.1) show the success of the reaction and
confirm the expected behaviour of this new synthesized bead-surfactant.
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Figure VI.4.: Analysis of beads dislocation in the oil phase The diagrams A and B present the dislocation of
the bead-surfactant. (A) represents the dislocation of free bead-surfactant in the oil phase. Diagram (B)
shows the disslocation bead-surfactant in the droplet periphery. Red line represents the median for A
and B; 80.4 ± 38.7µm ms-1 and 2.7 ± 3.3 µm ms-1 respectively.
4. Proteins
4.1. Actin
Actin is a globular protein found in all eukaryotic cells with a variation of less than
5% in the sequences of amino acids between specie. [189] 1 to 5% of cell mass is actin as
monomers (length 55 A˚) or in filamentous form. The actin monomer has a weight of 42
kDa and consists of 375 amino acids in 4 subdomains called G-actin due to it´s globular
shape. F-actin has a double helical shape where each monomer has an offset of 166° and
2.75 nmwith a diameter of about 5-9 nm and up to several micrometer length. [190? ] The
persistence length of actin is about 17µm max. [191,192]
Actin polymerization is mediated by the presence of ATP which is hydrolyzed during
the actin polymerization. [193] In the first step of actin polymerization 2-4 ATP saturated
G-actins assemble. This step is the time determing step in actin polymerization. [194]
Polymerization occurs then at both ends of the actin filaments but has different kinetics
due to structural asymmetrice of the film endings. The so called (+) and (-) end have
different polymerization and depolymerization constants which are k1 = 11.6± 1.2 µM-1s-1
and k -1 = 1.4 ± 0.8µM-1s-1 for the (+) end and k2 = 1.3 ± 0.2µM-1s-1 and k -2 = 0.8
± 0.3 µM-1s-1 for the (-) end. [195] Actin filaments together with Myosin II motor proteins
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represent the major components of muscle fibers. To investigate actomyosin dynamics
in many experiments fluorescent labeled phalloidin is used although it can change the
elasticity of actin filaments. [196] In the last years more direct label actin is used to analyze
actin dynamics.
4.2. Myosin II
Myosin II protein is a sub-group of the myosin superfamily, also called motor proteins,
which in particular occurs in stress fibers and the sarcomeres of striated muscle. They
are composed of six polypeptide chains, two 220 kDa heavy chains and four modulatory
light chains, each with 20 kDa. [190,197] Clustering of the heavy chains results in an ap-
proximately 150 nm long α-helical structure having on the N-termini two globular head
regions which are about 17 nm long. The light chains are associated with the short neck
regions between the head and tail region of the myosin molecule. Myosin II molecules
can form filaments with 18 nm in diameter and up to 1- 2 µm in length, depending on
the KCl concentration. [135] The head regions of these myosin II filaments can attach to
parallel actin filaments. ATP hydrolysis and exchange leads to a conformational change,
resulting in a 5 nm power stroke and associated muscle contraction. [198]
In stress fibers non-muscle myosin II creates a complex with 10-30 actin filaments
and other actin binding proteins. Structural and functional elucidation was achieved
by fluorescence labeling of α-actinin and myosin. The case of discernible striations of
filaments led to the development of models which have great similarity with sarcomeres -
coupled with high adaptability and broad contractility of stress fibers. [199]
4.3. Phalloidin
Phalloidin is a toxin found in the green amanita with LD50 of 2-3 mg/Kg. In actin ex-
periments it is used to reduce the actin depolymerization rate. [173] With a dissociation
constant KD of 10-8 M phalloidin binds the interaction sites between the G-actin sub-
units of F-actin strands, reducing the depolymerization by a factor of 30. [174] In actin
experiments fluorescently labeled derivatives such as phalloidin TRITC/FITC are used to
stabilize actin filaments and to observe them with fluorescence microscopy. A drawback
in using phalloidin is the artificial stiffening combined with dramatically reduced depoly-
merization of F-actin which can lead to an inactivation of microfilamentous functions and
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is in stark contrast to biological bundling protein fascin. [200]
4.4. Fascin
Fascin is an actin-bundling protein that was first isolated by Kane et.al. [201] from cyto-
plasmic extracts of sea urchin eggs. Fascin is a compact protein of 55 to 58 kDa. It
bundles actin filament parallel with a distance of about 10 nm with spaced intervals (one
fascia per 4-5 actin). [202] In vivo fascin is mostly located in the filopodia to decrease actin
depolymerization by bundling. The bundling of actin filaments by fascin increases the
mechanical stiffness of the filaments whereas α-actinin increases the elasticity. Fascin has
been used before in several investigations [203] as it promotes actin polymerization creating
a nucleus from where actin filaments can elongate and bundle.
4.5. Blebbistatin
Blebbistatin (BLEBB) is a small cell permeable selective myosin II inhibitor that was
originally discovered as the result of a high throughput screen for inhibitors of nonmuscle
myosin (NMM) II.7citeTakeshiSakamoto:2005wo BLEBB, discovered by means of a high
through-put small molecule screening for inhibitors of non-muscle myosin IIA, was recently
reported to be a selective in vitro inhibitor of the myosin II isoforms expressed by striated
muscle and non-muscle cells (IC50= 0.5–5 mM) but with reported poor inhibition of
purified turkey gizzard SMM II(IC50 80 mM). [204] Thus, BLEBB, in the concentration
range of 0.5–5 mM, was found to be an ATPase inhibiting agent specific for myosin II.
Original studies showed BLEB exhibited an interesting specificity for several striated
muscle and non-muscle myosins, including Dictyosteliummyosin II, non-muscle myosins
IIA and IIB, scallop striated muscle myosin II, porcine muscle myosin II, and rabbit
skeletal muscle myosin II, whereas SM and non-conventional myosins (I, V, and X) have
been reported to be little influenced. [204]
4.6. Deformability of Droplets with Actomyosin
Droplet deformability experiments were performed in oder to compare polymerized ac-
tomyosin cortexes with droplets containing G-actin and myosin as monomers and no
ATP/MgCl2. The experiments were done using the same flow rates as in the experi-
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ments presented in Section IV.2.2. For these measurements experimental conditions 6
with and without ATP/MgCl2 (see tables III.3 and III.4) and a deformation device with
two aqueous inlets was used.
As the results of non polymerized actin and myosin at t=0 (first and last chamber) were
similar to the results of droplets where actin polymerized and because the deformation
after 30 minutes had the same value as in the last chamber (t=0), only the deformation
results of actomyosin that polymerized are represented.
The results presented in Figure VI.5 show that actomyosin encapsulation in droplets
had little to no effect on the change of deformability of droplets compared to droplets
with water (see Section IV.2.2), if values of the first and the last chamber (t=0 min)
are compared to the results in chambers 1 and 50 to 100 in Figure IV.11. The results
show that in the first second after droplet production the accretion of surfactants is the
dominating effect and that the encapsulation of proteins dose not change the deformability
of droplets.
After 30 minutes droplets with non-polymerized- and polymerized-actomyosin networks
were reintroduced into the deformation device using same flow rates as in the first measure-
ment at t=0, to be able to compare the data. Here, the results of polymerized-actomyosin
networks of the first and last chamber show deformation values which are smaller that
in the first chamber after droplet production. This indicates that actomyosin polymer-
ization stiffed the droplet and that networks were in contact with the droplet periphery.
Furthermore, the deformation in the first and last chamber have the same value indicating
that actomyosin networks are stable, even if they get squeezed 100 times in the narrow
channels between the deformation chambers.
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Figure VI.5.: Deformability of droplets within encapsulated actomyosin networks.
5. Surface Tension
Tri-7000-PEG-1400 Pendant Drop measurements characterized the influence of surfac-
tants on the FC40 water interface. For Tri-7000-PEG-1400 two dilution series were pre-
pared and tested. One showed signs of contamination as seen in figure VI.6. The other di-
lution series, shown in dark blue, showedhas an exponential decay of IFT which and yields
γCMC = (16.47± 8.47)mNm−1 after surpassing the CMC. At this point surface pressure
ΠCMC was
(27.50± 8.47)mNm−1. The CMC is extrapolated to (45.10± 113.19)µM. Surface excess
Γ is (4.04± 0.33)µM/m2 and therefore the area a one molecule occupies in the interface
is (41.11± 12.93)Å2.
Tri-7000-PEG-600 Three dilution series were tested as shown in figure VI.7. The expo-
nential decay with α, β and η yielded a γCMC of
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Figure VI.6.: Summary of surface tension measurements of droplets containing TRI7000 surfactants.
Influence of Tri-7000-PEG-1400 on IFT of FC40 in water, displayed as IFT(= y) [mNm−1] over
concentration(= x) [µM]. Measured IFTs for different dilution series are displayed in distinct colours,
the final exponential fit with α, β and η is displayed in red. The 95% confidence interval for pure FC40
in water is shown in grey. Error bars indicate 2 standard deviations. 2 dilution series were tested.
(19.55± 2.11)mNm−1 with surface pressure ΠCMC = (23.08± 2.11)mNm−1, a CMC
at (48.75± 35.52)µM and surface excess Γ of (3.40± 0.33)µM/m2 with one surfactant
molecule occupying (48.82± 4.78)Å2 in the interface. Two of three dilution series show an
increase in IFT at 1 and 10mM. In analogous measurements with sodium dodecyl sulfate
(SDS) this is usually a sign of impure SDS, which might contain hydrolysed SDS.
Di-7500-O-Me-750 Three dilution series were measured as shown in figure VI.8. One
of which, shown in light blue, seemed to be an outlier. The exponential decay with
α, β and η yielded a γCMC of (18.50± 2.98)mNm−1 with surface pressure ΠCMC =
(26.08± 2.98)mNm−1, a CMC at (148.65± 9.68)µM and surface excess Γ of (3.86± 0.46)µM/m2
with one surfactant molecule occupying (43.06± 9.69)Å2 on the interface. Measured data
however show a plateau at about 1 µM. This might indicate the presence of a polymer. If
so, the critical aggregate concentration (CAC) of this polymer would be (0.27± 0.31)µM
at a surface pressure of ΠCAC = (7.17± 5.92)mNm−1.
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Figure VI.7.: Summary of surface tension measurements of droplets containing TRI7000short surfac-
tants. Influence of Tri-7000-PEG-600 on IFT of FC40 in water, displayed as IFT(= y) [mNm−1] over
concentration(= x) [µM]. Measured IFTs for different dilution series are displayed in distinct colours,
the exponential fit with α, β and η is displayed in red. The 95% confidence interval for pure FC40 in
water is shown in grey. Error bars indicate 2 standard deviations. 3 dilution series were tested.
Figure VI.8.: Summary of surface tension measurements of droplets containing DI7000 surfactants.
Influence of Di-7500-O-Me-750 on IFT of FC40 in water, displayed as IFT(= y) [mNm−1] over
concentration(= x) [µM]. Measured IFTs for different dilution series are displayed in distinct colours, the
exponential fit with α, β and η is displayed in red. The 95% confidence interval for pure FC40 in water
is shown in grey. Error bars indicate 2 standard deviations. 3 dilution series were tested. A plateau at
1 µM might indicate presence of a polymer.
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6. FT-IR Analysis
Figure VI.9 (A) shows the representative FTIR spectra of the PFPE(7000)-carboxylic
acid reactant and the triblock surfactant product PFPE(7000)-PEG(1400)-PFPE(7000)
(TRI7000). This figure presents five major bands at 1701, 1775, 2848, 2956 and 3556 cm-1.
The band at 1701 cm-1 is attributed to the ester (C=O) stretching mode. The band at
1775 cm-1 is attributed to a stretching mode of the (C=O) bond of the PFPE-carboxylic
acid which is strongly blueshifted (by 50 cm-1) due to the electronegative fluor atoms
in alpha position to the carboxylic group. The same blueshift of the carboxylic (C=O)
band was observed previously in the studies measuring the FTIR spectrum of the trifluo-
roacetic acid. The bands at 2848 and 2956 cm-1 are assigned to symmetric and asymmetric
stretching modes of the PEG (C-H) groups of the PFPE-PEG-PFPE product.2 The band
at 3556 cm-1 is assigned to the asymmetric stretching (OH) vibrations. Figure VI.9 (B)
shows representative FTIR spectra of the DI7000 and PFPE(7000)-carboxylic acid. This
figure presents major bands at 1698, 1775, 2889, 2993 and 3556 cm-1. The band at 1698
cm-1 represents a stretching mode of the ester (C=O). The broad band at 2889 and 2993
cm-1 represents the symmetric and asymmetric stretching of PEG (CH). The band at
3556 cm-1 is assigned to the asymmetric stretching (OH) vibrations.
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Figure VI.9.: Representative FT-IR spectra of a triblock-copolymer surfactant and the PFPE. Figure.
FTIR spectra of the reactants and the products of the surfactant synthesis. FC-40 perflourinated oil was
used as a background solvent to obtain the spectra. (A) Comparison between the PFPE(7000)-carboxylic
acid (20 mM) as a reactant and the PFPE(7000)-PEG(1400)-PFPE(7000) triblock product (20 mM) .
(B) Comparison between PFPE(7000)-carboxylic acid as a reactant (20 mM) and the PFPE(7000)-PEG-
OMe(750) diblock product (20 mM).
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Chapter VI. Appendix
8. R scripts
8.1. R plot
                                        ###########
                                        # Inhalt ##
                                        ###########
## 1.   Dateien laden (11)
## 2.   Geschwindigkeite der Beads (24)
## 2.1  Beads in Öl (46)
## 2.2  Beads in Droplets (80) 
## 2.3  Signifikanz (113)
## 3.   Dislokation (124)                
                                  ####################
                                  # 1. Dateien Laden #
                                  ####################
getwd()
setwd("/Users/service/Desktop/Auswertung") # !!!!!Muss angepasst werden!!!!!
# Beads in Öl Laden
Beadsoel<-read.csv("BOELLINEAR.csv", header=TRUE, sep=";") # !!!!!Muss angepasst werden!!!!!
# Beads in Droplets Laden
Beadsdroplets<-read.csv("Beadsdroplet2.csv", header=TRUE, sep=";") # !!!!!Muss angepasst werden!!!!!
                          #######################################
                          #### 2. Geschwindigkeite der Beads ####
                          #######################################
# Definition des Vektors vBeadoel. vBeadoel ist TracK Median Speed (Spalte 21) von Beads in Öl
# vBeaddropl = TracK Median Speed (Spalte 21) von Beads im Droplet
vBeadoel<-c(Beadsoel[,21]) 
class(vBeadoel)
vBeaddropl<-c(Beadsdroplets[1:58,21]) 
class(vBeaddropl)
                                    #######################
                                    ### 2.1 Beads in Öl ###
                                    #######################
# Barplot vBeadOel #
#--------------------                                        
mp<-barplot(vBeadoel,space=2,xlim=c(0,200),ylim=c(0,25))
title(xlab="Spurnummer der Beads",mgp = c(2.5, 0, 0))
title(ylab="Geschwindigkeit der Beads [µm/ms]",mgp=c(2.5,1,0))
axis(1, at=mp, seq(from=0, 57,labels=FALSE),mgp = c(0, 0.2, 0.2), col.ticks="white")
title("Geschwindigkeiten der Beads in Öl", line = +2)
                                                                              
# Median
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# Median
m<-median(vBeadoel) 
m
# Standart Abweichung 
sd<-sd(vBeadoel)
sd
#Zeichnet horizontale Linie für Median und Standart Abweichung
  
abline(h=m, col="red") 
abline(h=m-sd,col='blue')
abline(h=m+sd,col='blue')
                                  ###############################
                                  #### 2.2 Beads in Droplets ####
                                  ###############################
# Barplot vBeaddropl #
#----------------------
mp2<-barplot(vBeaddropl,space=2,xlim=c(0,200),ylim=c(0,5),main="Geschwindigkeiten der PEG-Krytox\ngekoppelten Beads")
title(xlab="Spurnummer der Beads",mgp = c(2.5, 0, 0))
title(ylab="Geschwindigkeit der Beads [µm/ms]",mgp=c(2.5,1,0))
axis(1, at=mp2, seq(from=0, 57,labels=FALSE),mgp = c(0, 0.2, 0.2), col.ticks="white")
                                        
                                        
# Median
mdb<-median(vBeaddropl) 
mdb
# Standart Abweichung 
sdII<-sd(vBeaddropl)
sdII
#Zeichnet horizontale Linie für Median und Standart Abweichung
abline(h=mdb, col="red") 
abline(h=mdb-sdII, col='blue')
abline(h=mdb+sdII, col='blue')
                                          #####################
                                          ## 2.3.Signifikanz ##
                                          #####################
# Wilcoxon Rang-Summen-Test. Infos: http://www.ipd.uka.de/Tichy/uploads/folien/149/Emp11Wilcoxon.pdf
"p-value Beads in Oel zu Beads in Droplets"<-wilcox.test(x=vBeadoel, y=vBeaddropl, paired = TRUE)
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8.2. Deformation Anlysis R
# read the script and execute it line after line (Ctrl+Enter in RStudio)
################
#### Header ####
################
# every script starts somewhat like this
par(no.readonly=TRUE) -> paralt # save current graphic parameters as 'paralt'
basedir<-getwd() # save working directory in this variable
basedir # is '../Tutorial/Experiment 1'
#########################
#### read .txt files ####
#########################
# this loop searches the working directory and the subdirectories for '.txt' files
# each '.txt' file will be uploaded as a data frame while the first row of each '.txt' file
# will specify the names of the columns
# everything is sorted in a nested list 'input'
# 1. layer = subdirectories of working directory ("" = working directory itself)
# 2. layer = '.txt' files found
# 3. layer = columns of '.txt' file
subs<-list.dirs(".",full.names=FALSE) # Subdirectories Index 'i'
subs # here's all directories found in the working directory ("" = working directory itself)
input<-list() # creates an empty list for sorting all the data
for(i in 1:length(subs)){ # loop through working directory and subdirectories
  if(length(list.files(subs[i],pattern="*.txt"))>0){ # if a file ending with '.txt' is found
      input[[i]]<-list() # create another empty list (within the list 'input')
      files<-list.files(subs[i],pattern="*.txt") # list all found '.txt' files in 'files'
      for(j in 1:length(files)){ # loop through 'files' (with j)
        input[[i]][[files[j]]]<- # make list entry within the empty list (within 'input')
          read.table(file=paste(subs[i],files[j],sep="/"), # read '.txt' file
          sep="\t",dec=".",header=TRUE,skip=0,na.strings="1.#R",fill=TRUE) # line 1 = headder
      }
  }
}
names(input)<-subs # define first layer names of nested list = directories/ subdirectories
# 'input' is a nested list
names(input) # its first layer elements are the subdirectories ("" is the working directory) 
names(input[[2]]) # the second layer are the '.txt' files found in the subdirectory
names(input$Sample_1) # you can also call them by their name with '$name'
names(input$Sample_1$video_1.txt) # in the third layer are the actual columns of the '.txt' file
input$Sample_1$video_1.txt$Feret[1:10] # the first 10 entries for 'Feret' in 'video_1.txt'
#####################
#### Deformation ####
#####################
# we just need deformation Delta = (Feret-MinFeret)/(Feret+MinFeret) and 'Slice' from input 
# this loop creates another list 'data' which is sorted the same way as 'input'
# but it only contains 'Delta'  and 'Slice' for each '.txt' file
data<-list() # create an empty list
for(i in 1:length(input)){ # go through 'input' (first layer)
  if(length(input[[i]])>0){ # if there's stuff in (1st layer) 'input' entry
    data[[i]]<-list() # create empty list within the list 'data'
    files<-names(input[[i]]) # save names of stuff in (1st layer) 'input' entry
    for(j in 1:length(files)){ # go through these names
      attach(input[[i]][[files[j]]]) # attach: now 'Slice' will call 'input[[i]][[files[j]]]$Slice'
      data[[i]][[files[j]]]<-list("Slice"=Slice,"Delta"=(Feret-MinFeret)/(Feret+MinFeret))
      detach(input[[i]][[files[j]]]) # detach afterwards
    }
  }
}
names(data)<-subs # define names of 1st layer 'data'
rm(input) # we don't need this anymore
names(data) # this list is sorted the same way as 'input'
names(data$Sample_1)
names(data$Sample_1$video_1.txt) # but it only contains 'slice' and 'Delta' (what we need)
data$Sample_1$video_1.txt$Delta[1:10] # first 10 'Delta' entries of 'video_1.txt'
######################
#### look at data ####
######################
# if experimental procedures were new, you need to look at the deformations first
# to see how far apart the 'Delta' maxima are
# this is needed for setting the right mask size for calculating the maxima
# if the masksize if too big, not all maxima will be detected
# if it's too small, some irrelevant local maxima will be detected
# so far a mask of 21-51 was always good (I took 31)
# the function I wrote for this is 'lokex' (description within 'function_local_extrema.r' script)
# define some nice colors for plotting
colorlist<-list("firebrick1","gray85","red3","deepskyblue2","lightskyblue2","royalblue2","slateblue1")
# Now I load a .R function from basedir '../Experiment 1' because I saved it there
# if you need to use functions more often, it makes sense to save them all in one directory somewhere
# on your PC and then always load them from that directory
source(paste(basedir,"function_local_extrema.r",sep="/")) # I call the function from basedir
str(lokex) # function 'lokex' with arguments Vektor, maske, max, rand
# now try out some values for argument 'maske'
attach(data$Sample_2$video_1.txt) # 'Slice' will now call 'data$Sample_1$video_1.txt$Slice'
masksize<- 31# put in the mask size you want to test
titel<-paste("local maxima with mask size",masksize)
plot(Slice,Delta,pch=20,cex=0.2,col=colorlist[[7]], # the actual plot
     bty="l",main=titel,xlab="frame",ylab="deformation")
# now I highlight the points which would be found as local maxima
# give function 'lokex' a vector, it will calculate local maxima based on a mask
# it gives back these maxima as 'Wert' and the index of these maxima as 'Stelle'
# so now I plot these maxima over the Slices where they appeared
points(Slice[lokex(Delta,maske=masksize,rand=FALSE)$Stelle], # Slice[Stelle]
       lokex(Delta,maske=masksize,rand=FALSE)$Wert, # Wert
       pch=20,cex=0.73,col=colorlist[[1]]) # highlighting
# look at the plot, are these maxima correct? if not choose another masksize and plot again
# masksize = 11 for example is way to small (red points somewhere near 0)
# with masksize = 111 not all maxima are detected
detach(data$Sample_2$video_1.txt) # always detach afterwards
# attach another video to check. always detach afterwards
######################
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# read the script and execute it line after line (Ctrl+Enter in RStudio)
################
#### Header ####
################
# every script starts somewhat like this
par(no.readonly=TRUE) -> paralt # save current graphic parameters as 'paralt'
basedir<-getwd() # save working directory in this variable
basedir # is '../Tutorial/Experiment 1'
#########################
#### read .txt files ####
#########################
# this loop searches the working directory and the subdirectories for '.txt' files
# each '.txt' file will be uploaded as a data frame while the first row of each '.txt' file
# will specify the names of the columns
# everything is sorted in a nested list 'input'
# 1. layer = subdirectories of working directory ("" = working directory itself)
# 2. layer = '.txt' files found
# 3. layer = columns of '.txt' file
subs<-list.dirs(".",full.names=FALSE) # Subdirectories Index 'i'
subs # here's all directories found in the working directory ("" = working directory itself)
input<-list() # creates an empty list for sorting all the data
for(i in 1:length(subs)){ # loop through working directory and subdirectories
  if(length(list.files(subs[i],pattern="*.txt"))>0){ # if a file ending with '.txt' is found
      input[[i]]<-list() # create another empty list (within the list 'input')
      files<-list.files(subs[i],pattern="*.txt") # list all found '.txt' files in 'files'
      for(j in 1:length(files)){ # loop through 'files' (with j)
        input[[i]][[files[j]]]<- # make list entry within the empty list (within 'input')
          read.table(file=paste(subs[i],files[j],sep="/"), # read '.txt' file
          sep="\t",dec=".",header=TRUE,skip=0,na.strings="1.#R",fill=TRUE) # line 1 = headder
      }
  }
}
names(input)<-subs # define first layer names of nested list = directories/ subdirectories
# 'input' is a nested list
names(input) # its first layer elements are the subdirectories ("" is the working directory) 
names(input[[2]]) # the second layer are the '.txt' files found in the subdirectory
names(input$Sample_1) # you can also call them by their name with '$name'
names(input$Sample_1$video_1.txt) # in the third layer are the actual columns of the '.txt' file
input$Sample_1$video_1.txt$Feret[1:10] # the first 10 entries for 'Feret' in 'video_1.txt'
#####################
#### Deformation ####
#####################
# we just need deformation Delta = (Feret-MinFeret)/(Feret+MinFeret) and 'Slice' from input 
# this loop creates another list 'data' which is sorted the same way as 'input'
# but it only contains 'Delta'  and 'Slice' for each '.txt' file
data<-list() # create an empty list
for(i in 1:length(input)){ # go through 'input' (first layer)
  if(length(input[[i]])>0){ # if there's stuff in (1st layer) 'input' entry
    data[[i]]<-list() # create empty list within the list 'data'
    files<-names(input[[i]]) # save names of stuff in (1st layer) 'input' entry
    for(j in 1:length(files)){ # go through these names
      attach(input[[i]][[files[j]]]) # attach: now 'Slice' will call 'input[[i]][[files[j]]]$Slice'
      data[[i]][[files[j]]]<-list("Slice"=Slice,"Delta"=(Feret-MinFeret)/(Feret+MinFeret))
      detach(input[[i]][[files[j]]]) # detach afterwards
    }
  }
}
names(data)<-subs # define names of 1st layer 'data'
rm(input) # we don't need this anymore
names(data) # this list is sorted the same way as 'input'
names(data$Sample_1)
names(data$Sample_1$video_1.txt) # but it only contains 'slice' and 'Delta' (what we need)
data$Sample_1$video_1.txt$Delta[1:10] # first 10 'Delta' entries of 'video_1.txt'
######################
#### look at data ####
######################
# if experimental procedures were new, you need to look at the deformations first
# to see how far apart the 'Delta' maxima are
# this is needed for setting the right mask size for calculating the maxima
# if the masksize if too big, not all maxima will be detected
# if it's too small, some irrelevant local maxima will be detected
# so far a mask of 21-51 was always good (I took 31)
# the function I wrote for this is 'lokex' (description within 'function_local_extrema.r' script)
# define some nice colors for plotting
colorlist<-list("firebrick1","gray85","red3","deepskyblue2","lightskyblue2","royalblue2","slateblue1")
# Now I load a .R function from basedir '../Experiment 1' because I saved it there
# if you need to use functions more often, it makes sense to save them all in one directory somewhere
# on your PC and then always load them from that directory
source(paste(basedir,"function_local_extrema.r",sep="/")) # I call the function from basedir
str(lokex) # function 'lokex' with arguments Vektor, maske, max, rand
# now try out some values for argument 'maske'
attach(data$Sample_2$video_1.txt) # 'Slice' will now call 'data$Sample_1$video_1.txt$Slice'
masksize<- 31# put in the mask size you want to test
titel<-paste("local maxima with mask size",masksize)
plot(Slice,Delta,pch=20,cex=0.2,col=colorlist[[7]], # the actual plot
     bty="l",main=titel,xlab="frame",ylab="deformation")
# now I highlight the points which would be found as local maxima
# give function 'lokex' a vector, it will calculate local maxima based on a mask
# it gives back these maxima as 'Wert' and the index of these maxima as 'Stelle'
# so now I plot these maxima over the Slices where they appeared
points(Slice[lokex(Delta,maske=masksize,rand=FALSE)$Stelle], # Slice[Stelle]
       lokex(Delta,maske=masksize,rand=FALSE)$Wert, # Wert
       pch=20,cex=0.73,col=colorlist[[1]]) # highlighting
# look at the plot, are these maxima correct? if not choose another masksize and plot again
# masksize = 11 for example is way to small (red points somewhere near 0)
# with masksize = 111 not all maxima are detected
detach(data$Sample_2$video_1.txt) # always detach afterwards
# attach another video to check. always detach afterwards
######################
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################### Lokale Extremwerte finden ###############################
#################################################
# Datum:      03.05.15
# source("C:/Users/Marc/Documents/Programme/R/Skripte/Funktion Boxplot.r")
# 
# Inhalt:    Diese Funktion plottet einen Boxplot. Sie besteht aus der Funktion 'boxplot' mit einigen Einstellungen
#            die den Plot schöner aussehen lassen. Die x-Achse wird absichtlich nicht geplottet.
# 
# Anwendung:  bxplt(data,spacing,colors,title="title",ylabel="ylab",grid=TRUE,white=TRUE)
# 
# Argumente:  data        liste oder data.frame mit Einträgen aus numerischen Vektoren. Aus den Einträgen werden der
#                         Reihe nach von links nach rechts die Boxen geplottet.
#             spacing     numerisches Array. Vertikaler Abstand nach jeder Box von links nach rechts(bsp c(1,2,1))
#             colors      character Array. Farben der Boxen von links nach rechts.
#             title       character Wert. Titel des Plots
#             ylabel      character Wert. Y-Achsen Beschriftung.
#             grid        boolean. Für Gitternetz im Plot = TRUE
#             white       boolean. Für weißen Hintergrund = TRUE
# Ausgabe:    eine unbenannte Liste aus 'xticks' und 'bxplt'
#             $xticks     numerisches Array. x-Achsenstellen der Boxen von links nach rechts
#             $bxplt      liste aus allen Einträgen, welche die Funktion 'boxplot' ausgibt.
#################################################
#########################
#### Funktion: bxplt ####
#########################
#
# Pseudocode:
#
# Start Funktion
# 
bxplt<-function(data,spacing,colors,title="title",ylabel="ylab",grid=TRUE,white=TRUE,
                y.lim=c(min(unlist(data)),max(unlist(data))))
{
  Gitter<-grid # boolean
  
  #### create pos
  pos<-numeric(length(data))
  count<-1
  for(i in 1:length(data)){
    pos[i]<-count
    count<-count+spacing[i]
  }  
  
  
  if(white){  #### wenn heller Hintergrund
    par(col="gray40", # Farbe der Achsen
        cex.lab=1.2, # Größe der Achsentitel
        las=1, # Achsenbeschriftung: 0=90°gedreht an yAchse, 1=waagrecht an yAchse
        bty="l" # Ramen: l = eine yAchse links und eine xAchse unten
    )    
  } else { #### wenn dunkler Hintergrung
    par(bg='black', # Plot Hintergrundfarbe
        col.axis='white', # Achsenbeschriftung
        col.lab='white', # für Labels
        col.main='white', # für Titel
        col.sub='white', # für Untertitel
        fg='gray90', # Plot Vordergrundfarbe
        col="gray60", # Farbe der Achsen
        cex.lab=1.2, # Größe der Achsentitel
        las=1, # Achsenbeschriftung: 0=90°gedreht an yAchse, 1=waagrecht an yAchse
        bty="l" # Ramen: l = eine yAchse links und eine xAchse unten
    ) 
  }
  
  
  #### 1. Boxplot zeichnen
  boxplot(data, # richtig geordnetes data frame oder list
          ylab=ylabel, # y-Achsenbeschriftung
          main=title, # Titelei
          notch=FALSE, # Vertrauensintervall für Median darstellen
          col=colors,
          yaxt="n",xaxt="n",
          at=pos,
          ylim=y.lim
  )
  
  
  if(Gitter){    #### wenn Gitter
    if(white){
      grid(nx=NA, ny=NULL,col="gray60") #grid over boxplot
    } else {
      grid(nx=NA, ny=NULL,col="gray20") #grid over boxplot
    }    
    bxplt.data <- boxplot(data, #### 2. Boxplot zeichnen
                           ylab=ylabel, # y-Achsenbeschriftung
                           main=title, # Titelei
                           notch=FALSE, # Vertrauensintervall für Median darstellen
                           col=colors,
                           at=pos,xaxt="n",
                           add=TRUE,
                          ylim=y.lim
    )
  }else{  #### wenn kein Gitter
    bxplt.data <- boxplot(data, #### 2. Boxplot zeichnen
                          ylab=ylabel, # y-Achsenbeschriftung
                          main=title, # Titelei
                          notch=FALSE, # Vertrauensintervall für Median darstellen
                          col=colors,
                          at=pos,xaxt="n",
                          add=TRUE,
                          ylim=y.lim
    )
  } 
    
 # par(paralt.fun) # nicht aufrufen, damit plotting einstellung bleiben (zB xaxt)
  return(list("xticks"=pos,"bxplt"=bxplt.data))
}    #### Ende Funktion
##############################
#### Ende Funktion: bxplt ####
##############################
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################### Lokale Extremwerte finden ###############################
#################################################
# Datum:      03.05.15
# source("C:/Users/Marc/Documents/Programme/R/Skripte/Funktion Boxplot.r")
# 
# Inhalt:    Diese Funktion plottet einen Boxplot. Sie besteht aus der Funktion 'boxplot' mit einigen Einstellungen
#            die den Plot schöner aussehen lassen. Die x-Achse wird absichtlich nicht geplottet.
# 
# Anwendung:  bxplt(data,spacing,colors,title="title",ylabel="ylab",grid=TRUE,white=TRUE)
# 
# Argumente:  data        liste oder data.frame mit Einträgen aus numerischen Vektoren. Aus den Einträgen werden der
#                         Reihe nach von links nach rechts die Boxen geplottet.
#             spacing     numerisches Array. Vertikaler Abstand nach jeder Box von links nach rechts(bsp c(1,2,1))
#             colors      character Array. Farben der Boxen von links nach rechts.
#             title       character Wert. Titel des Plots
#             ylabel      character Wert. Y-Achsen Beschriftung.
#             grid        boolean. Für Gitternetz im Plot = TRUE
#             white       boolean. Für weißen Hintergrund = TRUE
# Ausgabe:    eine unbenannte Liste aus 'xticks' und 'bxplt'
#             $xticks     numerisches Array. x-Achsenstellen der Boxen von links nach rechts
#             $bxplt      liste aus allen Einträgen, welche die Funktion 'boxplot' ausgibt.
#################################################
#########################
#### Funktion: bxplt ####
#########################
#
# Pseudocode:
#
# Start Funktion
# 
bxplt<-function(data,spacing,colors,title="title",ylabel="ylab",grid=TRUE,white=TRUE,
                y.lim=c(min(unlist(data)),max(unlist(data))))
{
  Gitter<-grid # boolean
  
  #### create pos
  pos<-numeric(length(data))
  count<-1
  for(i in 1:length(data)){
    pos[i]<-count
    count<-count+spacing[i]
  }  
  
  
  if(white){  #### wenn heller Hintergrund
    par(col="gray40", # Farbe der Achsen
        cex.lab=1.2, # Größe der Achsentitel
        las=1, # Achsenbeschriftung: 0=90°gedreht an yAchse, 1=waagrecht an yAchse
        bty="l" # Ramen: l = eine yAchse links und eine xAchse unten
    )    
  } else { #### wenn dunkler Hintergrung
    par(bg='black', # Plot Hintergrundfarbe
        col.axis='white', # Achsenbeschriftung
        col.lab='white', # für Labels
        col.main='white', # für Titel
        col.sub='white', # für Untertitel
        fg='gray90', # Plot Vordergrundfarbe
        col="gray60", # Farbe der Achsen
        cex.lab=1.2, # Größe der Achsentitel
        las=1, # Achsenbeschriftung: 0=90°gedreht an yAchse, 1=waagrecht an yAchse
        bty="l" # Ramen: l = eine yAchse links und eine xAchse unten
    ) 
  }
  
  
  #### 1. Boxplot zeichnen
  boxplot(data, # richtig geordnetes data frame oder list
          ylab=ylabel, # y-Achsenbeschriftung
          main=title, # Titelei
          notch=FALSE, # Vertrauensintervall für Median darstellen
          col=colors,
          yaxt="n",xaxt="n",
          at=pos,
          ylim=y.lim
  )
  
  
  if(Gitter){    #### wenn Gitter
    if(white){
      grid(nx=NA, ny=NULL,col="gray60") #grid over boxplot
    } else {
      grid(nx=NA, ny=NULL,col="gray20") #grid over boxplot
    }    
    bxplt.data <- boxplot(data, #### 2. Boxplot zeichnen
                           ylab=ylabel, # y-Achsenbeschriftung
                           main=title, # Titelei
                           notch=FALSE, # Vertrauensintervall für Median darstellen
                           col=colors,
                           at=pos,xaxt="n",
                           add=TRUE,
                          ylim=y.lim
    )
  }else{  #### wenn kein Gitter
    bxplt.data <- boxplot(data, #### 2. Boxplot zeichnen
                          ylab=ylabel, # y-Achsenbeschriftung
                          main=title, # Titelei
                          notch=FALSE, # Vertrauensintervall für Median darstellen
                          col=colors,
                          at=pos,xaxt="n",
                          add=TRUE,
                          ylim=y.lim
    )
  } 
    
 # par(paralt.fun) # nicht aufrufen, damit plotting einstellung bleiben (zB xaxt)
  return(list("xticks"=pos,"bxplt"=bxplt.data))
}    #### Ende Funktion
##############################
#### Ende Funktion: bxplt ####
##############################
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################### Lokale Extremwerte finden ###############################
#################################################
# Datum:      07.04.15
# source("C:/Users/Marc/Documents/Programme/R/Skripte/Funktion lokale Extremwerte.r")
# 
# Inhalt:     Diese Funktion findet Extremwerte in einem numerischen Array. Hierbei kann Größe des Suchfensters,
#             Beachtung der Randregionen des Arrays und Suche nach Maxima oder Minima eingestellt werden.
# Komplexität: Länge('vektor') x 'maske'
# 
# Anwendung:  lokex(vektor,maske=3,max=TRUE,rand=TRUE)
# 
# Argumente:  vektor      Ein numerisches Array. Aus diesen Werten und ihrer Anordnung findet die 'lokex'
#                         lokale Maxima oder Minima (mit oder ohne Randmaxima/-minima)
#             maske       numerischer Wert. Größe des Suchfensters. Default=3. Muss ungerade Zahl >=3 sein.
#                         Bsp.: Für 'maske'=5 wird der betrachtete Wert mit den 2 Werten davor und danach ver-
#                         glichen und entschieden ob es sich um einen Extremwert handelt.
#             max         boolean. Default=TRUE sucht nach lokalen (und Rand-) Maxima. FALSE entsprechend Minima
#             rand        boolean. Default=TRUE sucht auch am Anfang und Am Ende des Arrays 'vektor', in den 
#                         Bereichen in denen das Suchfenster eigentlich über die Array-Grenzen hinaus ragen
#                         würde. Rand-Extremwerte werden somit auch gefunden.
# Ausgabe:  eine unbenannte Liste aus 'Stelle' und 'Wert'
#             $Stelle     numerisches Array. Indizes der gefundenen Extremwerte in aufsteigender Reihenfolge
#             $Wert       numerisches Array. Die zu $Stelle entsprechenden Extremwerte
#################################################
#########################
#### Funktion: lokex ####
#########################
#
# Pseudocode:
#
# Start Funktion
# 
# vektor = numerisches array mit den zu analysierenden Werten
# maske = ungerader numerischer Wert, welcher als Fenster bei Extremwertsuche benutzt wird
# max = boolean: TRUE => Maxima suchen, FALSE => Minima suchen
# rand = boolean: TRUE => Randmaxima suchen
#
# n = Länge(vektor)
# Stelle = leer (numerisches Array: Kontainer für Stelle der gefundenen Extremwerte)
# Wert = leer (numerisches Array: Kontainer für gefundene Extremwerte)
# count = 0 (numerischer Wert: Zähler für die Kontainer Arrays 'Stelle' und 'Wert') 
#
# if 'max' == TRUE
#     if 'rand' == TRUE
#         for Randbereich am Anfang von 'vektor' (bestimmt durch Fenstergröße 'maske')
#             if Maximum gefunden dann
#                 count++; 'Stelle' und 'Wert' eintragen
#     for Bereich von 'vektor' in welchem Fenster 'maske' nicht über 'vektor'-Grenzen ragt     
#         if Maximum gefunden dann
#             count++; 'Stelle' und 'Wert' eintragen
#     if 'rand' == TRUE
#         for Randbereich am Ende von 'vektor' (bestimmt durch Fenstergröße 'maske')
#             if Maximum gefunden dann
#                 count++; 'Stelle' und 'Wert' eintragen
# else
#     das ganze nur mit Minimum anstatt Maximum
#
# return Liste aus 'Stelle' und 'Wert'
# 
# Ende
lokex<-function(vektor,maske=3,max=TRUE,rand=TRUE)
{
  vektor<-as.numeric(vektor)
  maske<-as.numeric(maske)
  if(maske%%2==0)
  {
    print("Maske muss ungerade sein!")
    print(paste("Maske wird von",maske,"auf",maske+1,"geändert!"))
    maske<-maske+1
  }
  if(maske<=1)
  {
    print("Maske von <3 ist sinnlos.")
    print(paste("Maske wird von",maske,"auf 3 geändert!"))
    maske<-3
  }
  
  n<-length(vektor)
  Stelle<-numeric(0)
  Wert<-numeric(0)
  count<-0
  
  if(max==TRUE)
  {
    if(rand==TRUE){ #### Anfang Anfangsrand
    for(i in 1:((maske-1)/2))
    {
      if(vektor[i] == max(vektor[1:(i+(maske-1)/2)]))
      {
        count<-count+1
        Stelle[count]<-i
        Wert[count]<-vektor[i]  
      }
    }
    }    #### Ende Anfangsrand
    for(i in (((maske-1)/2+1):(n-(maske-1)/2)))
    {
      if(vektor[i] == max(vektor[(i-(maske-1)/2):(i+(maske-1)/2)]))
      {
        count<-count+1
        Stelle[count]<-i
        Wert[count]<-vektor[i]
      }
    }
    if(rand==TRUE){ #### Anfang Endrand
      for(i in (n-(maske-1)/2+1):n)
      {
        if(vektor[i] == max(vektor[(i-(maske-1)/2):n]))
        {
          count<-count+1
          Stelle[count]<-i
          Wert[count]<-vektor[i]  
        }
      }
    }    #### Ende Endrand
  } else {    #### Ende Maxima
    if(rand==TRUE){ #### Anfang Anfangsrand
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################### Lokale Extremwerte finden ###############################
#################################################
# Datum:      07.04.15
# source("C:/Users/Marc/Documents/Programme/R/Skripte/Funktion lokale Extremwerte.r")
# 
# Inhalt:     Diese Funktion findet Extremwerte in einem numerischen Array. Hierbei kann Größe des Suchfensters,
#             Beachtung der Randregionen des Arrays und Suche nach Maxima oder Minima eingestellt werden.
# Komplexität: Länge('vektor') x 'maske'
# 
# Anwendung:  lokex(vektor,maske=3,max=TRUE,rand=TRUE)
# 
# Argumente:  vektor      Ein numerisches Array. Aus diesen Werten und ihrer Anordnung findet die 'lokex'
#                         lokale Maxima oder Minima (mit oder ohne Randmaxima/-minima)
#             maske       numerischer Wert. Größe des Suchfensters. Default=3. Muss ungerade Zahl >=3 sein.
#                         Bsp.: Für 'maske'=5 wird der betrachtete Wert mit den 2 Werten davor und danach ver-
#                         glichen und entschieden ob es sich um einen Extremwert handelt.
#             max         boolean. Default=TRUE sucht nach lokalen (und Rand-) Maxima. FALSE entsprechend Minima
#             rand        boolean. Default=TRUE sucht auch am Anfang und Am Ende des Arrays 'vektor', in den 
#                         Bereichen in denen das Suchfenster eigentlich über die Array-Grenzen hinaus ragen
#                         würde. Rand-Extremwerte werden somit auch gefunden.
# Ausgabe:  eine unbenannte Liste aus 'Stelle' und 'Wert'
#             $Stelle     numerisches Array. Indizes der gefundenen Extremwerte in aufsteigender Reihenfolge
#             $Wert       numerisches Array. Die zu $Stelle entsprechenden Extremwerte
#################################################
#########################
#### Funktion: lokex ####
#########################
#
# Pseudocode:
#
# Start Funktion
# 
# vektor = numerisches array mit den zu analysierenden Werten
# maske = ungerader numerischer Wert, welcher als Fenster bei Extremwertsuche benutzt wird
# max = boolean: TRUE => Maxima suchen, FALSE => Minima suchen
# rand = boolean: TRUE => Randmaxima suchen
#
# n = Länge(vektor)
# Stelle = leer (numerisches Array: Kontainer für Stelle der gefundenen Extremwerte)
# Wert = leer (numerisches Array: Kontainer für gefundene Extremwerte)
# count = 0 (numerischer Wert: Zähler für die Kontainer Arrays 'Stelle' und 'Wert') 
#
# if 'max' == TRUE
#     if 'rand' == TRUE
#         for Randbereich am Anfang von 'vektor' (bestimmt durch Fenstergröße 'maske')
#             if Maximum gefunden dann
#                 count++; 'Stelle' und 'Wert' eintragen
#     for Bereich von 'vektor' in welchem Fenster 'maske' nicht über 'vektor'-Grenzen ragt     
#         if Maximum gefunden dann
#             count++; 'Stelle' und 'Wert' eintragen
#     if 'rand' == TRUE
#         for Randbereich am Ende von 'vektor' (bestimmt durch Fenstergröße 'maske')
#             if Maximum gefunden dann
#                 count++; 'Stelle' und 'Wert' eintragen
# else
#     das ganze nur mit Minimum anstatt Maximum
#
# return Liste aus 'Stelle' und 'Wert'
# 
# Ende
lokex<-function(vektor,maske=3,max=TRUE,rand=TRUE)
{
  vektor<-as.numeric(vektor)
  maske<-as.numeric(maske)
  if(maske%%2==0)
  {
    print("Maske muss ungerade sein!")
    print(paste("Maske wird von",maske,"auf",maske+1,"geändert!"))
    maske<-maske+1
  }
  if(maske<=1)
  {
    print("Maske von <3 ist sinnlos.")
    print(paste("Maske wird von",maske,"auf 3 geändert!"))
    maske<-3
  }
  
  n<-length(vektor)
  Stelle<-numeric(0)
  Wert<-numeric(0)
  count<-0
  
  if(max==TRUE)
  {
    if(rand==TRUE){ #### Anfang Anfangsrand
    for(i in 1:((maske-1)/2))
    {
      if(vektor[i] == max(vektor[1:(i+(maske-1)/2)]))
      {
        count<-count+1
        Stelle[count]<-i
        Wert[count]<-vektor[i]  
      }
    }
    }    #### Ende Anfangsrand
    for(i in (((maske-1)/2+1):(n-(maske-1)/2)))
    {
      if(vektor[i] == max(vektor[(i-(maske-1)/2):(i+(maske-1)/2)]))
      {
        count<-count+1
        Stelle[count]<-i
        Wert[count]<-vektor[i]
      }
    }
    if(rand==TRUE){ #### Anfang Endrand
      for(i in (n-(maske-1)/2+1):n)
      {
        if(vektor[i] == max(vektor[(i-(maske-1)/2):n]))
        {
          count<-count+1
          Stelle[count]<-i
          Wert[count]<-vektor[i]  
        }
      }
    }    #### Ende Endrand
  } else {    #### Ende Maxima
    if(rand==TRUE){ #### Anfang Anfangsrand
132
Chapter VI. Appendix
133

Bibliography
[1] A. C. Siegel, S. K. Y. Tang, C. A. Nijhuis, M. Hashimoto, S. T. Phillips, M. D. Dickey, and G. M.
Whitesides, “Cofabrication: a strategy for building multicomponent microsystems.,” Accounts of
chemical research, vol. 43, pp. 518–528, apr 2010.
[2] T. M. Pearce and J. C. Williams, “Microtechnology: Meet neurobiology,” Lab on a chip, vol. 7,
no. 1, pp. 30–40, 2007.
[3] A. C. Rowat, J. C. Bird, J. J. Agresti, O. J. Rando, and D. A. Weitz, “Tracking lineages of single
cells in lines using a microfluidic device,” Proceedings of the National Academy of Sciences,
vol. 106, pp. 18149–18154, Oct. 2009.
[4] I. Platzman, J.-W. Janiesch, and J. P. Spatz, “Synthesis of nanostructured and biofunctionalized
water-in-oil droplets as tools for homing T cells.,” Journal of the American Chemical Society,
vol. 135, pp. 3339–3342, Mar. 2013.
[5] A. J. deMello and R. C. R. Wootton, “Miniaturization: Chemistry at the crossroads,” Nature
Chemistry, vol. 1, pp. 28–29, Mar. 2009.
[6] L. H. Hung and A. P. Lee, “Microfluidic devices for the synthesis of nanoparticles and
biomaterials,” Journal of Medical and Biological Engineering, vol. 27, no. 1, pp. 1–6, 2007.
[7] Y. Huang, B. Agrawal, D. Sun, J. S. Kuo, and J. C. Williams, “Microfluidics-based devices: New
tools for studying cancer and cancer stem cell migration,” Biomicrofluidics, vol. 5, no. 1,
p. 013412, 2011.
[8] G. Whitesides, “Solving problems.,” Lab on a chip, vol. 10, pp. 2317–2318, Sept. 2010.
[9] J. Lederberg, “A simple method for isolating individual microbes.,” Journal of bacteriology,
vol. 68, no. 2, pp. 258–259, 1954.
[10] G. Whitesides and E. Ostuni, “Soft lithography in biology and biochemistry,” Annual Review of
Biomedical Engineering, vol. 3, pp. 335–373, 2001.
135
Bibliography
[11] G. Velve-Casquillas, M. Le Berre, M. Piel, and P. T. Tran, “Microfluidic tools for cell biological
research.,” Nano today, vol. 5, pp. 28–47, feb 2010.
[12] G. M. Whitesides, “The origins and the future of microfluidics.,” Nature, vol. 442, pp. 368–373, jul
2006.
[13] J.-u. Shim, R. T. Ranasinghe, C. A. Smith, S. M. Ibrahim, F. Hollfelder, W. T. S. Huck,
D. Klenerman, and C. Abell, “Ultrarapid generation of femtoliter microfluidic droplets for
single-molecule-counting immunoassays.,” ACS nano, vol. 7, pp. 5955–5964, July 2013.
[14] A. Theberge, F. Courtois, Y. Schaerli, M. Fischlechner, C. Abell, F. Hollfelder, and W. Huck,
“Mikrotröpfchen in Mikrofluidiksystemen: eine Technik für Entdeckungen in der Chemie und
Biologie,” Angewandte Chemie, vol. 122, pp. 5982–6005, 2010.
[15] C. Holtze, A. C. Rowat, J. J. Agresti, J. B. Hutchison, F. E. Angilè, C. H. J. Schmitz, S. Köster,
H. Duan, K. J. Humphry, R. A. Scanga, J. S. Johnson, D. Pisignano, and D. A. Weitz,
“Biocompatible surfactants for water-in-fluorocarbon emulsions,” Lab on a chip, vol. 8, no. 10,
p. 1632, 2008.
[16] A. R. Abate, T. Hung, P. Mary, J. J. Agresti, and D. A. Weitz, “High-throughput injection with
microfluidics using picoinjectors,” Proceedings of the . . . , 2010.
[17] C. H. J. Schmitz, A. C. Rowat, S. Köster, and D. A. Weitz, “Dropspots: a picoliter array in a
microfluidic device ,” Lab on a chip, vol. 9, no. 1, pp. 44–49, 2009.
[18] J.-C. Baret, O. J. Miller, V. Taly, M. Ryckelynck, A. El-Harrak, L. Frenz, C. Rick, M. L. Samuels,
J. B. Hutchison, J. J. Agresti, D. R. Link, D. A. Weitz, and A. D. Griffiths,
“Fluorescence-activated droplet sorting ( FADS ): efficient microfluidic cell sorting based on
enzymatic activity ,” Lab on a chip, vol. 9, no. 13, pp. 1850–1858, 2009.
[19] M. R. Bringer, C. J. Gerdts, H. Song, J. D. Tice, and R. F. Ismagilov, “Microfluidic systems for
chemical kinetics that rely on chaotic mixing in droplets,” Philosophical Transactions of the Royal
Society A: Mathematical, Physical and Engineering Sciences, vol. 362, pp. 1087–1104, May 2004.
[20] Q. Brosseau, J. Vrignon, and J.-C. Baret, “Microfluidic Dynamic Interfacial Tensiometry
(µDIT).,” Soft Matter, vol. 10, pp. 3066–3076, May 2014.
[21] E. W. M. Kemna, R. M. Schoeman, F. Wolbers, I. Vermes, D. A. Weitz, and A. van den Berg,
“High-yield cell ordering and deterministic cell-in-droplet encapsulation using Dean flow in a
curved microchannel.,” Lab on a chip, June 2012.
136
Bibliography
[22] M. T. Guo, A. Rotem, J. A. Heyman, and D. A. Weitz, “Droplet microfluidics for
high-throughput biological assays.,” Lab on a chip, vol. 12, pp. 2146–2155, June 2012.
[23] T. W. Hofmann, S. Hänselmann, J.-W. Janiesch, A. Rademacher, and C. H. J. Böhm, “Applying
microdroplets as sensors for label-free detection of chemical reactions.,” Lab on a chip, vol. 12,
pp. 916–922, Mar. 2012.
[24] C.-H. Choi, J.-H. Jung, T.-S. Hwang, and C.-S. Lee, “In situ microfluidic synthesis of
monodisperse PEG microspheres,” Macromolecular Research, vol. 17, pp. 163–167, Mar. 2009.
[25] N. R. Beer, B. J. Hindson, E. K. Wheeler, S. B. Hall, K. A. Rose, I. M. Kennedy, and B. W.
Colston, “On-Chip, Real-Time, Single-Copy Polymerase Chain Reaction in Picoliter Droplets,”
Analytical chemistry, vol. 79, pp. 8471–8475, Nov. 2007.
[26] A. Fallah-Araghi, J.-C. Baret, M. Ryckelynck, and A. D. Griffiths, “A completely in vitro
ultrahigh-throughput droplet-based microfluidic screening system for protein engineering and
directed evolution ,” Lab on a chip, vol. 12, no. 5, pp. 882–891, 2012.
[27] R. J. Farn, Chemistry and Technology of Surfactants. Blackwell Publishing, 2006.
[28] M. Pabon and J. M. Corpart, “Fluorinated surfactants: synthesis, properties, eﬄuent treatment,”
Journal of Fluorine Chemistry, vol. 114, pp. 149–156, Jan 2002.
[29] K. Shinoda, M. Hato, and T. Hayashi, “Physicochemical properties of aqueous solutions of
fluorinated surfactants,” The Journal of Physical Chemistry, vol. 76, pp. 909–914, Mar. 1972.
[30] L. Roach and H. Song, “Controlling nonspecific protein adsorption in a plug-based microfluidic
system by controlling interfacial chemistry using fluorous-phase surfactants,” Analytical
chemistry, 2005.
[31] G. C. Lisensky, D. J. Campbell, K. J. Beckman, C. E. Calderon, P. W. Doolan, R. M. Ottosen,
and A. B. Ellis, “Replication and Compression of Surface Structures with Polydimethylsiloxane
Elastomer,” Journal of Chemical Education, vol. 76, p. 537, Apr 1999.
[32] J.-C. Baret, F. Kleinschmidt, A. El-Harrak, and A. D. Griffiths, “Kinetic Aspects of Emulsion
Stabilization by Surfactants: A Microfluidic Analysis,” Langmuir, vol. 25, pp. 6088–6093, June
2009.
[33] D. J. Holt, R. J. Payne, W. Y. Chow, and C. Abell, “Fluorosurfactants for microdroplets:
137
Bibliography
interfacial tension analysis.,” Journal of colloid and interface science, vol. 350, pp. 205–211, oct
2010.
[34] W. Griffin, “p00311-p00326,” J. Soc. Cosmet. Chem., vol. 1, p. 249, Mar. 1949.
[35] W. Griffin, “Calculation of hlb values of non-ionic surfactants,” J. Soc. Cosmet. Chem., vol. 5,
pp. 249–256, Oct. 1954.
[36] D. J. Holt, R. J. Payne, W. Y. Chow, and C. Abell, “Fluorosurfactants for microdroplets:
Interfacial tension analysis,” Journal of Colloid and Interface Science, vol. 350, pp. 205–211, 2010.
[37] S. H. Herzfeld, M. L. Corrin, and W. D. Harkins, “THE EFFECT OF ALCOHOLS AND OF
ALCOHOLS AND SALTS OK THE CRITICAL MICELLE CONCEXTRATION OF
DODECYL,4MMOXIUM CHLORIDE,” The Journal of Physical Chemistry, vol. 54, pp. 271–283,
Feb 1950.
[38] M. Porter, “Handbook of surfactants,” 1994.
[39] A. Ray and G. Némethy, “Effects of ionic protein denaturants on micelle formation by nonionic
detergents.,” Journal of the American Chemical Society, vol. 93, pp. 6787–6793, dec 1971.
[40] M. Schick, “ScienceDirect - Journal of Colloid Science : Surface films of nonionic detergents—I.
Surface tension study*1,” Journal of Colloid Science, vol. 78, no. 801-813, 1962.
[41] J. T. K. Milton J. Rosen, SURFACTANTS AND INTERFACIAL PHENOMENA. Wiley, Sept.
2015.
[42] Chapter - 2 Critical Micelle Concentration of Surfactant, Mixed Surfactant and Polymer By
Different Methods at Room Temperature And Its Importance Abstract. Pt. Ravishankar Shukla
University, Apr. 2012.
[43] I. Platzman, J.-W. Janiesch, J. Matić, and J. P. Spatz, “Artificial Antigen-Presenting Interfaces in
the Service of Immunology,” Israel Journal of Chemistry, vol. 53, pp. 655–669, Sept. 2013.
[44] B. N. Manz and J. T. Groves, “Spatial organization and signal transduction at intercellular
junctions,” Nature Reviews Molecular Cell Biology, vol. 11, pp. 342–352, Mar. 2010.
[45] T. R. Mempel, S. E. Henrickson, and U. H. von Andrian, “T-cell priming by dendriticcells in
lymph nodes occurs in three distinct phases,” Nature Cell Biology, vol. 427, pp. 154–159, Jan.
2004.
138
Bibliography
[46] C. June, S. A. Rosenberg, M. Sadelain, and J. S. Weber, “T-cell therapy at the threshold,” Nature
biotechnology, vol. 30, pp. 611–614, July 2012.
[47] R. H. Vonderheide and C. H. June, “Engineering T cells for cancer: our synthetic future.,”
Immunological Reviews, vol. 257, pp. 7–13, Jan. 2014.
[48] S. A. Grupp, M. Kalos, D. Barrett, R. Aplenc, D. L. Porter, S. R. Rheingold, D. T. Teachey,
A. Chew, B. Hauck, J. F. Wright, M. C. Milone, B. L. Levine, and C. H. June, “Chimeric antigen
receptor-modified T cells for acute lymphoid leukemia.,” The New England journal of medicine,
vol. 368, pp. 1509–1518, Apr. 2013.
[49] S. A. Rosenberg and M. E. Dudley, “Adoptive cell therapy for the treatment of patients with
metastatic melanoma.,” Current opinion in immunology, vol. 21, pp. 233–240, Apr. 2009.
[50] M. Kalos and C. H. June, “Adoptive T cell transfer for cancer immunotherapy in the era of
synthetic biology.,” Immunity, vol. 39, pp. 49–60, July 2013.
[51] E. J. Cheadle, H. Gornall, V. Baldan, V. Hanson, R. E. Hawkins, and D. E. Gilham, “CAR T
cells: driving the road from the laboratory to the clinic.,” Immunological Reviews, vol. 257,
pp. 91–106, Jan. 2014.
[52] D. Luo and W. M. Saltzman, “Synthetic DNA delivery systems.,” Nature biotechnology, vol. 18,
pp. 33–37, Jan. 2000.
[53] P. E. Boukany, A. Morss, W.-C. Liao, B. Henslee, H. Jung, X. Zhang, B. Yu, X. Wang, Y. Wu,
L. Li, K. Gao, X. Hu, X. Zhao, O. Hemminger, W. Lu, G. P. Lafyatis, and L. J. Lee,
“Nanochannel electroporation delivers precise amounts of biomolecules into living cells.,” Nature
nanotechnology, vol. 6, pp. 747–754, Nov. 2011.
[54] M. C. Milone and L. C. Kam, “Investigative and clinical applications of synthetic immune
synapsesinvestigative and clinical applications of synthetic immune investigative and clinical
applications of synthetic immune investigative and clinical applications of synthetic immune
investigative and clinical applications of synthetic immune synapses,” © 2012 Wiley Periodicals,
Inc., vol. 5, pp. 75–85, 2013.
[55] J. B. Huppa and M. M. Davis, “T-cell-antigen recognition and the immunological synapse,”
Nature Reviews Immunology, 2003.
[56] B. F. Lillemeier, M. A. Mörtelmaier, M. B. Forstner, J. B. Huppa, J. T. Groves, and M. M. Davis,
139
Bibliography
“TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate
during activation.,” Nature Immunology, vol. 11, pp. 90–96, Dec. 2009.
[57] C. Barcia, C. E. Thomas, J. F. Curtin, G. D. King, K. Wawrowsky, M. Candolfi, W.-D. Xiong,
C. Liu, K. Kroeger, O. Boyer, J. Kupiec-Weglinski, D. Klatzmann, M. G. Castro, and P. R.
Lowenstein, “In vivo mature immunological synapses forming SMACs mediate clearance of virally
infected astrocytes from the brain.,” The Journal of experimental medicine, vol. 203,
pp. 2095–2107, Sept. 2006.
[58] K. H. Lee, “T Cell Receptor Signaling Precedes Immunological Synapse Formation,” Science (New
York, N.Y.), vol. 295, pp. 1539–1542, Feb. 2002.
[59] T. Ilani, G. Vasiliver-Shamis, S. Vardhana, A. Bretscher, and M. L. Dustin, “T cell antigen
receptor signaling and immunological synapse stability require myosin IIA,” Nature Immunology,
vol. 10, pp. 531–539, Apr. 2009.
[60] C.-h. Yu and J. T. Groves, “Engineering supported membranes for cell biology,” Medical &
Biological Engineering & Computing, vol. 48, pp. 955–963, June 2010.
[61] E. Sackmann, “Supported membranes: scientific and practical applications.,” Science (New York,
N.Y.), vol. 271, pp. 43–48, Jan. 1996.
[62] G. Campi, “Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as
scaffolds for signaling,” Journal of Experimental Medicine, vol. 202, pp. 1031–1036, Oct. 2005.
[63] J. T. Groves and M. L. Dustin, “Supported planar bilayers in studies on immune cell adhesion
and communication.,” Journal of immunological methods, vol. 278, pp. 19–32, July 2003.
[64] A. L. DeMond, K. D. Mossman, T. Starr, M. L. Dustin, and J. T. Groves, “T Cell Receptor
Microcluster Transport through Molecular Mazes Reveals Mechanism of Translocation,”
Biophysical journal, vol. 94, pp. 3286–3292, Apr. 2008.
[65] L. C. Kam, “Capturing the nanoscale complexity of cellular membranes in supported lipid
bilayers,” Journal of structural biology, 2009.
[66] K. D. Mossman, G. Campi, J. T. Groves, and M. L. Dustin, “Altered TCR signaling from
geometrically repatterned immunological synapses.,” Science (New York, N.Y.), vol. 310,
pp. 1191–1193, Nov. 2005.
[67] N. C. Hartman, J. A. Nye, and J. T. Groves, “Cluster size regulates protein sorting in the
140
Bibliography
immunological synapse,” Proceedings of the National Academy of Sciences, vol. 106,
pp. 12729–12734, Aug. 2009.
[68] R. S. O’Connor, X. Hao, K. Shen, K. Bashour, T. Akimova, W. W. Hancock, L. C. Kam, and
M. C. Milone, “Substrate rigidity regulates human t cell activation and proliferation,” The
Journal of Immunology, vol. 189, no. (3), pp. 1330–1339, 2012.
[69] Y.-C. Li, B.-M. Chen, P.-C. Wu, T.-L. Cheng, L.-S. Kao, M.-H. Tao, A. Lieber, and S. R. Roﬄer,
“Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger
TCR signaling.,” The Journal of Immunology, vol. 184, pp. 5959–5963, June 2010.
[70] R. Alon and M. L. Dustin, “Force as a Facilitator of Integrin Conformational Changes during
Leukocyte Arrest on Blood Vessels and Antigen-Presenting Cells,” Immunity, vol. 26, pp. 17–27,
Jan. 2007.
[71] N. P. Restifo, M. E. Dudley, and S. A. Rosenberg, “Adoptive immunotherapy for cancer:
harnessing the T cell response.,” Nature Reviews Immunology, vol. 12, pp. 269–281, Apr. 2012.
[72] M. F. Mescher, “Surface contact requirements for activation of cytotoxic T lymphocytes.,”
Journal of immunology (Baltimore, Md. : 1950), vol. 149, pp. 2402–2405, Oct. 1992.
[73] X. Wei, B. J. Tromberg, and M. D. Cahalan, “Mapping the sensitivity of T cells with an optical
trap: Polarity and minimal number of receptors for Ca2+ signaling,” Proceedings of the National
Academy of Sciences, vol. 96, pp. 8471–8476, July 1999.
[74] I. Zaretsky, M. Polonsky, E. Shifrut, S. Reich-Zeliger, Y. Antebi, G. Aidelberg, N. Waysbort, and
N. Friedman, “Monitoring the dynamics of primary T cell activation and differentiation using long
term live cell imaging in microwell arrays.,” Lab on a chip, vol. 12, pp. 5007–5015, Dec. 2012.
[75] M. Polonsky, I. Zaretsky, and N. Friedman, “Dynamic single-cell measurements of gene expression
in primary lymphocytes: challenges, tools and prospects,” Briefings in Functional Genomics,
vol. 12, pp. 99–108, Mar. 2013.
[76] Théorie physico-chimique de la vie et générations spontanées. Published 1910 by A. Poinat in
Paris, 1910.
[77] A. P. Liu and D. A. Fletcher, “Biology under construction: in vitro reconstitution of cellular
function.,” Nature Reviews Molecular Cell Biology, vol. 10, pp. 644–650, Sept. 2009.
141
Bibliography
[78] P. Schwille, “Bottom-up synthetic biology: engineering in a tinkerer’s world.,” Science (New York,
N.Y.), vol. 333, pp. 1252–1254, Sept. 2011.
[79] S. F. Fenz and K. Sengupta, “Giant vesicles as cell models,” Integrative Biology, vol. 4, no. 9,
pp. 982–995, 2012.
[80] M. I. Angelova and D. S. Dimitrov, “Liposome electroformation,” Faraday Discussions of the
Chemical Society, vol. 81, p. 303, 1986.
[81] P. Andrew, “Estimation of Molecular Size and Molecular Weights of Biological Compounds by
Gel Filtration,” in Methods of Biochemical Analysis, pp. 1–53, Hoboken, NJ, USA: John Wiley &
Sons, Inc., Jan. 1970.
[82] T. J. Politano, V. E. Froude, B. Jing, and Y. Zhu, “AC-electric field dependent electroformation
of giant lipid vesicles.,” Colloids and surfaces. B, Biointerfaces, vol. 79, pp. 75–82, Aug. 2010.
[83] P. Sens and H. Isambert, “Undulation Instability of Lipid Membranes under an Electric Field,”
Physical Review Letters, vol. 88, p. 128102, Mar. 2002.
[84] D. S. Dimitrov and M. I. Angelova, “Lipid swelling and liposome formation mediated by electric
fields,” Bioelectrochemistry and bioenergetics, 1988.
[85] T. Pott, H. Bouvrais, and P. Méléard, “Giant unilamellar vesicle formation under physiologically
relevant conditions.,” Chemistry and physics of lipids, vol. 154, pp. 115–119, Aug. 2008.
[86] P. M. Shaklee, S. Semrau, M. Malkus, S. Kubick, M. Dogterom, and T. Schmidt, “Protein
incorporation in giant lipid vesicles under physiological conditions.,” Chembiochem : a European
journal of chemical biology, vol. 11, pp. 175–179, Jan. 2010.
[87] D. D. Lasic, “Novel applications of liposomes,” Trends in biotechnology, 1998.
[88] M. Zagnoni, “Miniaturised technologies for the development of artificial lipid bilayer systems.,”
Lab on a chip, vol. 12, pp. 1026–1039, Mar. 2012.
[89] B. M. Discher, Y.-Y. Won, D. S. Ege, J. C.-M. Lee, F. S. Bates, D. E. Discher, and D. A.
Hammer, “Polymersomes: Tough Vesicles Made from Diblock Copolymers,” Science (New York,
N.Y.), 1999.
[90] C. LoPresti, H. Lomas, M. Massignani, and T. Smart, “Polymersomes: nature inspired nanometer
142
Bibliography
sized compartments,” ÔøºÔøºÔøºÔøºJournal of Materials Chemistry, vol. 19, pp. 3576–3590,
2009.
[91] M. Nallani, R. Woestenenk, H. P. M. de Hoog, S. F. M. van Dongen, J. Boezeman, J. J. L. M.
Cornelissen, R. J. M. Nolte, and J. C. M. van Hest, “Sorting Catalytically Active Polymersome
Nanoreactors by Flow Cytometry,” Small (Weinheim an der Bergstrasse, Germany), vol. 5,
no. 10, pp. 1138–1143, 2009.
[92] A. Graff, M. Sauer, P. Van Gelder, and W. Meier, “Virus-assisted loading of polymer
nanocontainer,” Proceedings of the National Academy of Sciences, vol. 99, pp. 5064–5068, Mar.
2002.
[93] L. Mathivet, S. Cribier, and P. F. Devaux, “Shape change and physical properties of giant
phospholipid vesicles prepared in the presence of an AC electric field.,” Biophysj, vol. 70,
pp. 1112–1121, Mar. 1996.
[94] C. Martino, S.-H. Kim, L. Horsfall, A. Abbaspourrad, S. J. Rosser, J. Cooper, and D. A. Weitz,
“Protein expression, aggregation, and triggered release from polymersomes as artificial cell-like
structures.,” Angewandte Chemie (International ed. in English), vol. 51, pp. 6416–6420, June
2012.
[95] E. Lorenceau, A. S. Utada, D. R. Link, G. Cristobal, M. Joanicot, and D. A. Weitz, “Generation
of polymerosomes from double-emulsions.,” Langmuir, vol. 21, pp. 9183–9186, Sept. 2005.
[96] A. Picker, H. Nuss, P. Guenoun, and C. Chevallard, “Polymer vesicles as microreactors for
bioinspired calcium carbonate precipitation.,” Langmuir, vol. 27, pp. 3213–3218, Apr. 2011.
[97] J. A. Ditlev, B. J. Mayer, and L. M. Loew, “There is more than one way to model an elephant.
Experiment-driven modeling of the actin cytoskeleton.,” Biophysical journal, vol. 104,
pp. 520–532, Feb. 2013.
[98] M. Miyazaki, M. Chiba, H. Eguchi, T. Ohki, and S. Ishiwata, “Cell-sized spherical confinement
induces the spontaneous formation of contractile actomyosin rings in vitro.,” Nature Cell Biology,
vol. 17, pp. 480–489, Apr. 2015.
[99] M. S. Mooseker and L. G. Tilney, “Organization of an actin filament-membrane complex.
Filament polarity and membrane attachment in the microvilli of intestinal epithelial cells.,” The
Journal of Cell Biology, 1975.
[100] J. V. Jester, P. A. Barry, G. J. Lind, W. M. Petroll, R. Garana, and H. D. Cavanagh, “Corneal
143
Bibliography
keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins.,” Investigative
Ophthalmology & Visual Science, vol. 35, no. 2, pp. 730–743, 1994.
[101] C. J. Staiger, M. B. Sheahan, P. Khurana, X. Wang, D. W. McCurdy, and L. Blanchoin, “Actin
filament dynamics are dominated by rapid growth and severing activity in the Arabidopsis
cortical array,” The Journal of Cell Biology, vol. 184, pp. 269–280, Jan. 2009.
[102] T. D. Pollard and J. A. Cooper, “Actin, a central player in cell shape and movement.,” Science
(New York, N.Y.), vol. 326, pp. 1208–1212, Nov. 2009.
[103] F. Huber, A. Boire, M. P. López, and G. H. Koenderink, “Cytoskeletal crosstalk: when three
different personalities team up.,” Current opinion in cell biology, vol. 32, pp. 39–47, Feb. 2015.
[104] G. Charras and E. Sahai, “Physical influences of the extracellular environment on cell migration.,”
Nature Reviews Molecular Cell Biology, vol. 15, pp. 813–824, Dec. 2014.
[105] H. Paz, N. Pathak, and J. Yang, “Invading one step at a time: the role of invadopodia in tumor
metastasis.,” Oncogene, vol. 33, pp. 4193–4202, Aug. 2014.
[106] R. Lamprecht, “The actin cytoskeleton in memory formation.,” Progress in neurobiology, vol. 117,
pp. 1–19, June 2014.
[107] S. Kumari, S. Curado, V. Mayya, and M. L. Dustin, “T cell antigen receptor activation and actin
cytoskeleton remodeling.,” Biochimica Et Biophysica Acta, vol. 1838, pp. 546–556, Feb. 2014.
[108] A. Upadhyaya and A. van Oudenaarden, “Biomimetic Systems for Studying Actin-Based
Motility,” Current Biology, vol. 13, pp. R734–R744, Sept. 2003.
[109] M. Tanaka and E. Sackmann, “Polymer-supported membranes as models of the cell surface,”
Nature Cell Biology, vol. 437, pp. 656–663, Sept. 2005.
[110] A. P. Liu, D. L. Richmond, L. Maibaum, S. Pronk, P. L. Geissler, and D. A. Fletcher,
“Membrane-induced bundling of actin filaments.,” Nature Physics, vol. 4, pp. 789–793, Aug. 2008.
[111] P. S. Cremer and S. G. Boxer, “Formation and Spreading of Lipid Bilayers on Planar Glass
Supports,” The Journal of Physical Chemistry B, vol. 103, pp. 2554–2559, 1999.
[112] R. P. Richter, R. Bérat, and A. R. Brisson, “Formation of solid-supported lipid bilayers: An
integrated view,” Langmuir, vol. 22, pp. 3497–3505, 2006.
144
Bibliography
[113] P. F. F. Almeida, W. L. C. Vaz, and T. E. Thompson, “Lateral diffusion in the liquid phases of
dimyristoylphosphatidylcholine/cholesterol lipid bilayers: a free volume analysis,” Biochemistry,
vol. 31, pp. 6739–6747, July 1992.
[114] K. C. Weng, J. L. Kanter, W. H. Robinson, and C. W. Frank, “Fluid supported lipid bilayers
containing monosialoganglioside GM1: a QCM-D and FRAP study.,” Colloids and surfaces. B,
Biointerfaces, vol. 50, pp. 76–84, June 2006.
[115] J. D. Unsay and A. J. García-Sáez, “Scanning fluorescence correlation spectroscopy in model
membrane systems.,” Methods in molecular biology (Clifton, N.J.), vol. 1033, pp. 185–205, 2013.
[116] T. Steinberger, R. Macháň, and M. Hof, “Z-scan fluorescence correlation spectroscopy as a tool
for diffusion measurements in planar lipid membranes.,” Methods in molecular biology (Clifton,
N.J.), vol. 1076, pp. 617–634, 2014.
[117] A. Honigmann, S. Sadeghi, J. Keller, S. W. Hell, C. Eggeling, and R. Vink, “A lipid bound actin
meshwork organizes liquid phase separation in model membranes.,” eLife, vol. 3, no. e01671,
pp. 1–16, 2014.
[118] M. Leutenegger, C. Ringemann, T. Lasser, S. W. Hell, and C. Eggeling, “Fluorescence correlation
spectroscopy with a total internal reflection fluorescence STED microscope (TIRF-STED-FCS),”
Optics Express, vol. 20, no. 5, pp. 5243–5263, 2012.
[119] A. B. García-Arribas, J. V. Busto, A. Alonso, and F. M. Goñi, “Atomic force microscopy
characterization of palmitoylceramide and cholesterol effects on phospholipid bilayers: a
topographic and nanomechanical study.,” Langmuir, vol. 31, pp. 3135–3145, Mar. 2015.
[120] S. Morandat, S. Azouzi, E. Beauvais, A. Mastouri, and K. El Kirat, “Atomic force microscopy of
model lipid membranes.,” Analytical and bioanalytical chemistry, vol. 405, pp. 1445–1461, Feb.
2013.
[121] B. R. G. Johnson, R. J. Bushby, J. Colyer, and S. D. Evans, “Self-assembly of actin scaffolds at
ponticulin-containing supported phospholipid bilayers.,” Biophysj, vol. 90, pp. L21–3, Feb. 2006.
[122] R. J. Barfoot, K. H. Sheikh, B. R. G. Johnson, J. Colyer, R. E. Miles, L. J. C. Jeuken, R. J.
Bushby, and S. D. Evans, “Minimal F-actin cytoskeletal system for planar supported phospholipid
bilayers.,” Langmuir, vol. 24, pp. 6827–6836, June 2008.
[123] M. Janke, A. Herrig, J. Austermann, V. Gerke, C. Steinem, and A. Janshoff, “Actin binding of
145
Bibliography
ezrin is activated by specific recognition of PIP2-functionalized lipid bilayers.,” Biochemistry,
vol. 47, pp. 3762–3769, Mar. 2008.
[124] S. Bosk, J. A. Braunger, V. Gerke, and C. Steinem, “Activation of F-actin binding capacity of
ezrin: synergism of PIP‚ÇÇ interaction and phosphorylation.,” Biophysical journal, vol. 100,
pp. 1708–1717, Apr. 2011.
[125] K. Lee, J. L. Gallop, K. Rambani, and M. W. Kirschner, “Self-assembly of filopodia-like structures
on supported lipid bilayers.,” Science (New York, N.Y.), vol. 329, pp. 1341–1345, Sept. 2010.
[126] A. L. Hitt, “Ponticulin is the major high affinity link between the plasma membrane and the
cortical actin network in Dictyostelium,” The Journal of Cell Biology, vol. 126, pp. 1433–1444,
Sept. 1994.
[127] E. Luna and A. Hitt, “Cytoskeleton–plasma membrane interactions,” Science (New York, N.Y.),
vol. 258, pp. 955–964, Nov. 1992.
[128] A. L. Rozelle, L. M. Machesky, M. Yamamoto, M. H. E. Driessens, R. H. Insall, M. G. Roth,
K. Luby-Phelps, G. Marriott, A. Hall, and H. L. Yin, “Phosphatidylinositol 4,5-bisphosphate
induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3,” Current Biology,
vol. 10, pp. 311–320, Mar. 2000.
[129] T. Sakisaka, T. Itoh, K. Miura, and T. Takenawa, “Phosphatidylinositol 4,5-bisphosphate
phosphatase regulates the rearrangement of actin filaments.,” . . . and Cellular Biology, 1997.
[130] D. Merkle, N. Kahya, and P. Schwille, “Reconstitution and anchoring of cytoskeleton inside giant
unilamellar vesicles.,” Chembiochem : a European journal of chemical biology, vol. 9,
pp. 2673–2681, Nov. 2008.
[131] S. K. Vogel and P. Schwille, “Minimal systems to study membrane-cytoskeleton interactions.,”
Current opinion in biotechnology, vol. 23, pp. 758–765, Oct. 2012.
[132] L. Limozin and E. Sackmann, “Polymorphism of cross-linked actin networks in giant vesicles,”
Physical Review Letters, vol. 89, pp. 168103–1–168103–4, October 2002.
[133] F.-C. Tsai, B. Stuhrmann, and G. H. Koenderink, “Encapsulation of active cytoskeletal protein
networks in cell-sized liposomes.,” Langmuir, vol. 27, pp. 10061–10071, Aug. 2011.
[134] K. Takiguchi, M. Negishi, Y. Tanaka-Takiguchi, M. Homma, and K. Yoshikawa, “Transformation
146
Bibliography
of actoHMM assembly confined in cell-sized liposome.,” Langmuir, vol. 27, pp. 11528–11535, Sept.
2011.
[135] Y. Ideses, A. Sonn-Segev, Y. Roichman, and A. Bernheim-Groswasser, “Myosin II does it all:
assembly, remodeling, and disassembly of actin networks are governed by myosin II activity,” Soft
Matter, vol. 9, no. 29, p. 7127, 2013.
[136] M. Pinot, V. Steiner, B. Dehapiot, B.-K. Yoo, F. Chesnel, L. Blanchoin, C. Kervrann, and
Z. Gueroui, “Confinement induces actin flow in a meiotic cytoplasm.,” Proceedings of the National
Academy of Sciences, vol. 109, pp. 11705–11710, July 2012.
[137] E. A. Shah, K. Keren, and M. Balasubramanian, “Symmetry breaking in reconstituted actin
cortices,” eLife, vol. 3, p. e01433, Apr. 2014.
[138] H. Girault and D. Schiffrin, “ScienceDirect - Journal of Electroanalytical Chemistry and
Interfacial Electrochemistry : Drop image processing for surface and interfacial tension
measurements,” Journal of Electroanalytical Chemistry . . . , vol. 137, no. 2, pp. 207–217, 1982.
[139] Q. Brosseau, J. Vrignon, and J.-C. Baret, “Microfluidic Dynamic Interfacial Tensiometry
(µDIT).,” Soft matter, vol. 10, no. 17, pp. 3066–76, 2014.
[140] N. Otsu, “A threshold selection method from gray-level histograms,” 2EEE TRANSACTIONS
ON SYSTREMS, vol. 9, pp. 62–66, Jan 1979.
[141] D. C. Duffy, J. C. McDonald, O. J. A. Schueller, and G. M. Whitesides, “Rapid Prototyping of
Microfluidic Systems in Poly(dimethylsiloxane),” Analytical chemistry, vol. 70, pp. 4974–4984, dec
1998.
[142] M. K. Chaudhury and G. M. Whitesides, “Correlation between surface free energy and surface
constitution.,” Science (New York, N.Y.), vol. 255, pp. 1230–1232, mar 1992.
[143] E. Delamarche, A. Bernard, H. Schmid, A. Bietsch, B. Michel, and H. Biebuyck, “Microfluidic
Networks for Chemical Patterning of Substrates: Design and Application to Bioassays,” Journal
of the American Chemical Society, vol. 120, pp. 500–508, jan 1998.
[144] J.-W. Janiesch, M. Weiss, G. Kannenberg, J. Hannabuss, T. Surrey, I. Platzman, and J. P. Spatz,
“Key factors for stable retention of fluorophores and labeled biomolecules in droplet-based
microfluidics.,” Analytical chemistry, vol. 87, pp. 2063–2067, Feb. 2015.
147
Bibliography
[145] E. S. ASMOLOV, “The inertial lift on a spherical particle in a plane Poiseuille flow at large
channel Reynolds number,” Journal of Fluid Mechanics, vol. 381, pp. 63–87, Feb. 1999.
[146] A. A. S. Bhagat, S. S. Kuntaegowdanahalli, and I. Papautsky, “Continuous particle separation in
spiral microchannels using dean flows and differential migration,” Lab on a chip, vol. 8, no. 11,
pp. 1906–1914, 2008.
[147] E. W. M. Kemna, R. M. Schoeman, F. Wolbers, I. Vermes, D. A. Weitz, and A. van den Berg,
“High-yield cell ordering and deterministic cell-in-droplet encapsulation using Dean flow in a
curved microchannel,” Lab on a chip, vol. 12, no. 16, pp. 2881–2887, 2012.
[148] M. Castoldi and A. V. Popov, “Purification of brain tubulin through two cycles of
polymerization–depolymerization in a high-molarity buffer,” Protein expression and purification,
2003.
[149] A. Hyman, D. Drechsel, D. Kellogg, S. Salser, K. Sawin, P. Steffen, L. Wordeman, and
T. Mitchison, “Preparation of modified tubulins.,” Methods in enzymology, vol. 196, pp. 478–485,
1991.
[150] J. Clausell-Tormos, D. Lieber, J.-C. Baret, A. El-Harrak, O. J. Miller, L. Frenz, J. Blouwolff,
K. J. Humphry, S. Köster, and H. Duan, “Droplet-Based Microfluidic Platforms for the
Encapsulation and Screening of Mammalian Cells and Multicellular Organisms,” Chemistry &
Biology, vol. 15, pp. 427–437, May 2008.
[151] J. A. Spudich and S. Watt, “The regulation of rabbit skeletal muscle contraction. I. Biochemical
studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic
fragments of myosin.,” The Journal of biological chemistry, vol. 246, pp. 4866–4871, Aug. 1971.
[152] R. S. Adelstein and C. B. Klee, “Purification and characterization of smooth muscle myosin light
chain kinase.,” Journal of Biological Chemistry, vol. 256, no. 7, pp. 3178–3181, 1981.
[153] A. J. Kim, V. N. Manoharan, and J. C. Crocker, “Swelling-based method for preparing stable,
functionalized polymer colloids.,” Journal of the American Chemical Society, vol. 127,
pp. 1592–1593, Feb. 2005.
[154] H. Z. B. Hesse, M. Meier, Spektroskopische Methoden in der organischen Chemie. Thieme:
Stuttgart, 2002.
[155] Z. R. H. Wierzejewska-Hant, M.; Mielke, “Infrared matrix isolation and gas phase studies of
148
Bibliography
complexes between trifluoroacetic acid and diethylether and acetone,” Spectrochimica Acta,
vol. 43, pp. 675–678, 1987.
[156] K. C. Redington, R. L.; Lin, “Tin oxide surfaces,” Spectrochimica Acta, p. 2445, Oct. 1971.
[157] R. L. Redington, “On the oh stretching and the low-frequency vibrations of carboxylic acid cyclic
dimers,” The Journal of Chemical Physics, vol. 54, no. 4111, 1971.
[158] J.-W. Janiesch, M. Weiss, G. Kannenberg, J. Hannabuss, T. Surrey, I. Platzman, and J. P. Spatz,
“Key Factors for Stable Retention of Fluorophores and Labeled Biomolecules in Droplet-Based
Microfluidics,” Analytical Chemistry, vol. 87, no. 4, pp. 2063–2067, 2015.
[159] H. Lata, S. Mor, V. K. Garg, and R. K. Gupta, “Removal of a dye from simulated wastewater by
adsorption using treated parthenium biomass.,” Journal of hazardous materials, vol. 153,
pp. 213–220, May 2008.
[160] Y. L. Pang and A. Z. Abdullah, “Comparative study on the process behavior and reaction
kinetics in sonocatalytic degradation of organic dyes by powder and nanotubes TiO2.,”
Ultrasonics sonochemistry, vol. 19, pp. 642–651, May 2012.
[161] M. Pospísil, P. Capková, H. Weissmannová, Z. Klika, M. Trchová, M. Chmielová, and Z. Weiss,
“Structure analysis of montmorillonite intercalated with rhodamine B: modeling and
experiment.,” Journal of molecular modeling, vol. 9, pp. 39–46, Feb. 2003.
[162] Y. N. Ahn, A. Gupta, A. Chauhan, and D. I. Kopelevich, “Molecular transport through
surfactant-covered oil-water interfaces: role of physical properties of solutes and surfactants in
creating energy barriers for transport.,” Langmuir, vol. 27, pp. 2420–2436, Mar. 2011.
[163] F. Courtois, L. F. Olguin, G. Whyte, A. B. Theberge, W. T. S. Huck, F. Hollfelder, and C. Abell,
“Controlling the retention of small molecules in emulsion microdroplets for use in cell-based
assays.,” Analytical chemistry, vol. 81, pp. 3008–3016, Apr. 2009.
[164] M. Meier, J. Kennedy-Darling, S. H. Choi, E. M. Norstrom, S. S. Sisodia, and R. F. Ismagilov,
“Plug-based microfluidics with defined surface chemistry to miniaturize and control aggregation of
amyloidogenic peptides.,” Angewandte Chemie (International ed. in English), vol. 48, no. 8,
pp. 1487–1489, 2009.
[165] J. E. Kreutz, L. Li, L. S. Roach, T. Hatakeyama, and R. F. Ismagilov, “Laterally Mobile,
Functionalized Self-Assembled Monolayers at the Fluorous‚àíAqueous Interface in a Plug-Based
149
Bibliography
Microfluidic System: Characterization and Testing with Membrane Protein Crystallization,”
Journal of the American Chemical Society, vol. 131, pp. 6042–6043, May 2009.
[166] R. Glass, M. M ller, and J. P. Spatz, “Block copolymer micelle nanolithography,” Nanotechnology,
vol. 14, pp. 1153–1160, Sept. 2003.
[167] C. Vericat, M. E. Vela, G. Benitez, P. Carro, and R. C. Salvarezza, “Self-assembled monolayers of
thiols and dithiols on gold: new challenges for a well-known system.,” Chemical Society Reviews,
vol. 39, pp. 1805–1834, May 2010.
[168] T. Hazelrigg and J. H. Mansfield, “Green Fluorescent Protein Applications in Drosophila,” in
Green Fluorescent Protein: . . . , pp. 227–257, Hoboken, NJ, USA: John Wiley & Sons, Inc., Nov.
2005.
[169] N. C. Romzek, E. S. Harris, C. L. Dell, J. Skronek, E. Hasse, P. J. Reynolds, S. W. Hunt, and
Y. Shimizu, “Use of a beta1 integrin-deficient human T cell to identify beta1 integrin cytoplasmic
domain sequences critical for integrin function.,” Molecular Biology of the Cell, vol. 9,
pp. 2715–2727, Oct. 1998.
[170] M. Barczyk, S. Carracedo, and D. Gullberg, “Integrins.,” Cell and tissue research, vol. 339,
pp. 269–280, Jan. 2010.
[171] C. Zhang, Y. Xu, J. Gu, and S. F. Schlossman, “A cell surface receptor defined by a mAb
mediates a unique type of cell death similar to oncosis.,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 95, pp. 6290–6295, May 1998.
[172] S. Majstoravich, J. Zhang, S. Nicholson-Dykstra, S. Linder, W. Friedrich, K. A. Siminovitch, and
H. N. Higgs, “Lymphocyte microvilli are dynamic, actin-dependent structures that do not require
Wiskott-Aldrich syndrome protein (WASp) for their morphology.,” Blood, vol. 104, pp. 1396–1403,
Sept. 2004.
[173] P. Dancker, I. Löw, W. Hasselbach, and T. Wieland, “Interaction of actin with phalloidin:,”
Biochimica et Biophysica Acta (BBA) - Protein Structure, vol. 400, pp. 407–414, Aug. 1975.
[174] T. Wieland, “Modification of actins by phallotoxins,” Naturwissenschaften, vol. 64, no. 6,
pp. 303–309, 1977.
[175] C. I. Fisher and S. C. Kuo, “Filament rigidity causes F-actin depletion from nonbinding surfaces,”
Proceedings of the National Academy of Sciences, vol. 106, pp. 133–138, Jan. 2009.
150
Bibliography
[176] R. P. Diensthuber, M. Müller, S. M. Heissler, M. H. Taft, I. Chizhov, and D. J. Manstein,
“Phalloidin perturbs the interaction of human non-muscle myosin isoforms 2A and 2C1 with
F-actin,” FEBS Letters, vol. 585, pp. 767–771, Mar. 2011.
[177] D. Vignjevic, D. Yarar, M. D. Welch, J. Peloquin, T. Svitkina, and G. G. Borisy, “Formation of
filopodia-like bundles in vitro from a dendritic network.,” The Journal of Cell Biology, vol. 160,
pp. 951–962, Mar. 2003.
[178] L. Capretto, W. Cheng, M. Hill, and X. Zhang, “Micromixing within microfluidic devices.,”
Topics in current chemistry, vol. 304, pp. 27–68, 2011.
[179] A. H. Crevenna, N. Naredi-Rainer, A. Schönichen, J. Dzubiella, D. L. Barber, D. C. Lamb, and
R. Wedlich-Söldner, “Electrostatics control actin filament nucleation and elongation kinetics.,”
The Journal of biological chemistry, vol. 288, pp. 12102–12113, Apr. 2013.
[180] T. J. Rink, R. Y. Tsien, and T. Pozzan, “Cytoplasmic pH and free Mg2+ in lymphocytes.,” The
Journal of Cell Biology, 1982.
[181] Y. Y. Kuttner, N. Kozer, E. Segal, G. Schreiber, and G. Haran, “Separating the Contribution of
Translational and Rotational Diffusion to Protein Association,” Journal of the American
Chemical Society, vol. 127, pp. 15138–15144, Nov. 2005.
[182] S. K. Vogel, Z. Petrasek, F. Heinemann, P. Schwille, and M. Balasubramanian, “Myosin motors
fragment and compact membrane-bound actin filaments,” eLife, vol. 2, pp. e00116–18, Jan. 2013.
[183] N. P. Thomas Brox, Andres Bruhn and J. Weickert, “High accuracy optical flow estimation based
on a theory for warping,” Springer-Verlag Berlin Springer-Verlag Berlin Heidelberg 2004, vol. 4,
no. 24-36, 2004.
[184] J. S. Pérez, N. M. López, and A. S. de la Nuez, “Robust Optical Flow Estimation,” IPOL
Journal, 2013.
[185] T. Sakamoto, J. Limouze, C. A. Combs, A. F. Straight, , and James R Sellers, “Blebbistatin, a
Myosin II Inhibitor, Is Photoinactivated by Blue Light,” Biochemistry, vol. 44, pp. 584–588, 2005.
[186] Y. Aratyn-Schaus, P. W. Oakes, and M. L. Gardel, “Dynamic and structural signatures of lamellar
actomyosin force generation,” Molecular Biology of the Cell, vol. 22, pp. 1330–1339, Apr. 2011.
[187] E. Tjhung, D. Marenduzzo, and M. E. Cates, “Spontaneous symmetry breaking in active droplets
151
Bibliography
provides a generic route to motility.,” Proceedings of the National Academy of Sciences, vol. 109,
pp. 12381–12386, July 2012.
[188] S. R. Naganathan, S. Fürthauer, M. Nishikawa, F. Jülicher, S. W. Grill, and J. Ferrell, “Active
torque generation by the actomyosin cell cortex drives left–right symmetry breaking,” eLife,
vol. 3, p. e04165, Dec. 2014.
[189] M.-F. . P. D. Korn, E. D. ; Carlier, “Actin polymerization and atp hydrolysis,” Advances in
Bophysics, vol. 26, no. 4827, pp. 51–73, 1987.
[190] A. M. Gordon, E. Homsher, and M. Regnier, “Regulation of contraction in striated muscle.,”
Physiological reviews, vol. 80, pp. 853–924, Apr. 2000.
[191] F. Gittes, “Flexural rigidity of microtubules and actin filaments measured from thermal
fluctuations in shape,” The Journal of Cell Biology, vol. 120, pp. 923–934, Feb. 1993.
[192] M. . S. A. . L. A. Ott, A. ; Magnasco, “Measurement of the persistence length of polymerized
actin using fluorescence microscopy,” Physical Review E, vol. 48, no. 3, pp. 1642–1645, 1993.
[193] T. D. Pollard, “Rate constants for the reactions of atp- and adp-actin with the ends of actin
filaments.,” The Journal of Cell Biology, vol. 103, no. 6 Pt 2, pp. 2747–2754, 1986.
[194] J. a. Sept, D. McCammon, “Thermodynamics and kinetics of actin filament nucleation.,”
Biophysical Journal, vol. 81, no. 2, pp. 667–674, 2001.
[195] R. F. Ismagilov, “Integrated microfluidic systems,” Angewandte Chemie, vol. 42, no. 35,
pp. 4130–4132, 2003.
[196] A. I. H Kojima and T. Yanagida, “Direct measurement of stiffness of single actin filaments with
and without tropomyosin by in vitro nanomanipulation,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 91, no. 26, pp. 12962–12966, 1994.
[197] T. Ober, “Molekulares Tuning des Aktin-Myosin-Motors : Entwicklung und Anwendung eines
Motility Assays zur Messung maximaler Verkürzungsgeschwindigkeiten intakter Muskelfasern in
einem in vitro Modell,” 2006.
[198] M. J. Tyska and D. M. Warshaw, “The myosin power stroke,” Cell Motility and the Cytoskeleton,
2002.
152
Bibliography
[199] S. Pellegrin and H. Mellor, “Actin stress fibres.,” Journal of cell science, vol. 120, pp. 3491–3499,
Oct. 2007.
[200] M. Frimmer, “What we have learned from phalloidin,” Toxicology Letters, vol. 35, pp. 169–182,
Feb. 1987.
[201] R. E. Kane, “Preparation and purification of polymerized actin from sea urchin egg extracts,” The
Journal of Cell Biology, vol. 66, pp. 305–315, Aug. 1975.
[202] J. Bryan and R. E. Kane, “Separation and interaction of the major components of sea urchin
actin gel,” Journal of Molecular Biology, vol. 125, pp. 207–224, Oct. 1978.
[203] L. Haviv, N. Gov, Y. Ideses, and A. Bernheim-Groswasser, “Thickness distribution of actin
bundles in vitro,” European biophysics journal : EBJ, vol. 37, pp. 447–454, Nov. 2007.
[204] X. Zhang, A. Seftel, and M. E. DiSanto, “Blebbistain, a myosin II inhibitor, as a novel strategy to
regulate detrusor contractility in a rat model of partial bladder outlet obstruction.,” PloS one,
vol. 6, no. 10, p. e25958, 2011.
153

Acknowledgment
Im Verlaufe der Erstellung der Doktorarbeit hat sich mein Fokus von der reinen chemis-
chen Fragestellung zu einer weit gefächerten interdisziplinären Sichtweise erweitert. An-
regende Gespräche mit meinen Kolleginnen und Kollegen aus dem Arbeitskreis haben mir
sehr geholfen mich in neue Gebiete der Medizin und Biologie einzuarbeiten. Die pro-
duktive und kollegiale Arbeitsatmosphäre war eine große Unterstützung, für die ich allen
Mitgliedern des Arbeitskreises danke.
Ermöglicht wurde diese Arbeit durch Herrn Professor Spatz, dem ich insbesondere
für die anregenden Gespräche und die stete Unterstützung bei der Umsetzung neuer
Forschungsrichtungen zu großem Dank verpflichtet bin.
Herrn Professor Dahint danke ich, dass er das Zweitgutachten der vorliegenden Arbeit
übernommen hat.
Dr. Ilia Platzman, der meine Faszination für die Anwendung der Mikrofluidik in biolo-
gischen und medizinischen Fragestellungen teilt und mich bei meiner Doktorarbeit betreut
hat, danke ich nicht nur für stetige wissenschaftliche Unterstützung, sondern insbesondere
auch für das offene und menschliche Verhältnis.
Professor Jean-Christophe Baret danke ich für die Zusammenarbeit im Bereich der
Mikrofluidik.
Professor Anne Bernheim danke ich für die Zusammenarbeit und ihr Fachwissen im
Bereich der Rekonstruktion von Aktomyosinnetzwerken.
Für die interessanten Diskussionen zur Erklärung der Rotation von Aktomyosin Tropfen
danke ich Professor Ulrich Schwarz.
Gerri Kannenberg, Marian Weiss, Lucia Benk und Johannes Frohnmayer waren im
Mikrofluidik-Team treue Wegbegleiter, denen ich für die gute Zusammenarbeit danke. Se-
bastian Weber, Gerri und Marian danke ich besonders, sie waren nicht nur gute Kollegen,
sondern auch gute Freunde außerhalb des Labors. Die Skitouren bei den Gruppensem-
inaren in Antholz waren legendär.
155
Bibliography
Christine Mollenhauer danke ich für die Aufreinigung von Aktin und Myosin und die
Unterstützung bei der Benutzung der Labore in Stuttgart.
Meinen Freunden Marcus Böhm, Phillip Nägele, Gerri Kannenberg und Julian Anton
aus dem Studium danke ich für die gute Zeit in den letzten Jahren. Mit euch war das
Studium stets anregend.
Meiner Familie danke ich für den Rückhalt und die Unterstützung. Danke, dass ihr
immer für mich da seid. Meinen Eltern, Dr. Willi und Heide Janiesch möchte ich an
dieser Stelle für das häufige und schnelle Korrekturlesen danken
Ein besonderer Dank gilt meiner Freundin Julia Ziegler, die während meiner Doktorar-
beit immer für mich da war. Speziell in der Zeit des Schreibens der Arbeit hatte sie viel
Verständnis für mich.
156
Bibliography
Eidesstattliche Versicherung gemäß § 8 der Promotionsordnung
der Naturwissenschaftlich-Mathematischen Gesamtfakultät der
Universität Heidelberg
1. Bei der eingereichten Dissertation zu dem Thema "Development of Droplet-
Based Microfluidics for Synthetic Biology Applications" handelt es sich um
meine eigenständig erbrachte Leistung.
2. Ich habe nur die angegebenen Quellen und Hilfsmittel benutzt und mich keiner
unzulässigen Hilfe Dritter bedient. Insbesondere habe ich wörtlich oder sinngemäß
aus anderen Werken übernommene Inhalte als solche kenntlich gemacht.
3. Die Arbeit oder Teile davon habe ich bislang nicht an einer Hochschule des In- oder
Auslandes als Bestandteil einer Prüfungs- oder Qualifikationsleistung vorgelegt.
4. Die Richtigkeit der vorstehenden Erklärung bestätige ich.
5. Die Bedeutung der eidesstattlichen Versicherung und die strafrechtlichen Folgen
einer unrichtigen oder unvollständigen eidesstattlichen Versicherung sind mir bekannt.
Ich versichere an Eides statt, dass ich nach bestem Wissen die reine Wahrheit erklärt und
nichts verschwiegen habe.
Ort und Datum Unterschrift
157
3. Bottom-Up Assembly of Minimal Synthetic Cells
These drawbacks are mainly due to complications related to controlled permeability of
the traditional polymersomes [96] and due to the lack of technological means that allow
precise and efficient injection of different biological components into polymersomes. To
overcome these obstacles, a new highly innovative and creative approach in bottom-up
synthetic biology had to be created, as described in the following section.
3.4. Droplets
Microfluidic block copolymers-stabilized water-in-oil droplets can also be classified as
polymersomes, but due to the continuous oil phase they are considered in the scientific
community as emulsion droplets. The advantages of water-in-oil emulsion droplets for
biological applications have been described in details in Section I.1.1. In the context of
bottom-up assembly of artificial cells droplet-based compartment systems represent the
advantages of the polymersomes, but can also be easily adapted to the droplet-based
microfluidic technologies for precise delivery of bio-relevant ingredients. The continuous
oil phase can play an important role in preserving the droplet material content (see Section
IV.3). Moreover, a continuous oil phase is required to control an injection (details see
Section I.1.1) of precise amounts of high-value biomaterials exclusively into the droplets
Figure I.9.
Figure I.9.: A droplet based pico-injection unit. (A) Shows a junction to control the spacing between the droplets
through addition of oil via the second oil channel. Figure (B) shows a injection channel and the electrodes
of an alternating electric field with 30kHz and 600V used to reduce the stability of the surfactants in the
droplet periphery for an aqueous injection of other cellular components (injection volume can range between
2 to 100 pL dependend on the applied pressure) from a pico-injection channel.
Due to the variety of required cellular components in the droplets the microfluidic device
with small and compact electric systems was integrated to apply electric fields in micro-
16
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the membrane, and by addition of frog egg extract to the membrane actin was able to
reconstitute long filopodia-like actin structures. Other studies added G-actin or F-actin
to ponticulin-containing SLBs and created cortex-like actin structures with the average
actin layer thickness of 15 nm as revealed by AFM measurements. [122]
Together, these studies point to a powerful role of SLBs in modulation of spatial dy-
namic organization of actin filaments. However, unlike in biological membranes, the
planar bilayers do not allow pulling of the proteins and instead are rigid in the vertical
dimensions due to the trapping at the glass surface. Therefore, the ability of actomyosin
cortex to exert forces in all three directions is restricted in studies on supported rigid
surfaces. Moreover, to emulate cortical dynamics it is essential not only to incorporate
actin turnover dynamics to soft interfaces, but also reproduce a cell-like geometry.
Lipid vesicles or droplets can overcome the aforementioned limitations due to their 3D
cell-like geometry and soft interfaces. For example, Liu et al. [110] used PIP2 containing
GUVs to show that elastic interactions between the synthetic lipid vesicle membrane and
reconstituted actin cytoskeleton can cooperate without accessory proteins to induce the
formation of actin filament protrusions (Figure I.10).
Figure I.10.: Role of membrane in formation of thin actin filament protrusions. A model of membrane-
induced formation of actin filaments. Left: Small, local deformations of the membrane induced by actin
filament polymerization against the membrane (black arrows).
Merging attractions to create a larger deformation (curly brackets). Middle: Deformations that fail to create a larger
deformation (grey arrows). Right: After bundling of filaments to overcome the resistance of the membrane.
Actin filaments bundle and can elongate without further physical constraint. Adapted with permission
from Ref. [110] Copyright 2008, Nature Physics.
Model of membrane-induced formation of a thin actin filament protrusion. Left: Small-
amplitude local deformations of the membrane arise as actin filaments polymerize against
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2. Microfluidic Devices, and Droplet Production
A 24 x 24 mm glass (#1) was glued on top. The chamber was filled completely with
FC-40 oil containing the same surfactant concentration as used for droplet creation. To
avoid evaporation the sides of the chamber were sealed by two-component glue (Twinsil,
Picodent GmbH, Germany). Droplets stored in these chambers remained stable for up to
several month. [4,144]
Cover slips
Spacer (double sided 
sticky tape 80 µm)
100 µm100 µm
A C
B D
Figure III.7.: Droplet production and storage for analysis. (A) Droplet-based microfluidic device with red and
blue colourings indicating oil and aqueous inlets, respectively. (B) Insight of a flow-focusing junction
where oil (red) and aqueous (blue) phases meet at a 20 µm wide nozzle and droplets are generated. (C)
Illustration of an analysis chamber to store droplets for analysis and characterization. (D) Phase contrast
image of 40 µm diameter droplets in an analysis chamber.
2.3.1. Different Microfluidic Operation Units
For various research purposes different microfluidic units were designed by using a QCAD-
program. Most of the designs were adapted from literature and optimized for our needs.
In the following paragraphs three main designs are described.
Deformation Measurements A droplet deformation device (figure III.8.A) was de-
signed [20] and implemented for dynamic physical analysis of surfactants and proteins ac-
cretion and actin polymerization in microfludic droplets. The results achieved by this
device are presented in Section IV.2.2. In general, two aqueous inlets (blue) and two
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 A                   B           C
100µm
Figure III.8.: Representative schematics and images of different droplet-based microfluidic units. (A)
Representation of droplet deformation devices and a magnified area of the deformation chambers. (B)
Schematic representation of spiral device for single cell encapsulation and a magnified area of dropspot
chamber. (C) Picoinjection device for controlled introduction of different bioactive components into
droplets. The inset represents an example for the injection where colored liquids were used.
oil inlets (red) for droplet production and droplet spacing, respectively, were used to ad-
just the flow rates for high throuput droplet deformation analysis, allowing high-speed
recording. Installation and recording was done as described in subsection 2.3 (Droplet
production and Storage ) and section 3 (High-speed microscopy). Flow rates were set
constant: 50µl h−1 aqueous phase (blue), 170µl h−1 oil phase (red) and 220µl h−1 spacing
oil (red) (see figure III.8A).
Single cell encapsulation Single cell encapsulation and analysis experiments were per-
formed with spiral devices as shown in figure III.8 B. This device allows Dean flow-based
(De) separation of cells or particles by an inertial lift and viscous drag force and can be
calculated with the presented formula where ρ is the density of the fluid, V the axial ve-
locity scale, µ is the dynamic viscosity, d is the channel diameter for non circular channels
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A B C
100 µm 20 µm  5 µm
Figure III.9.: Representative cryo-SEM micrograph of freeze fractured microdroplets (A) Cryo-SEM mi-
crograph with low magnification of freeze fractured microdroplets. The droplets were fractured by the
cooled knife in the preparation device chamber in the 10-6 - 10-7 mbar vacuum chamber at -160 °C.
(B) Representative cryo-SEM micrograph of the fractured droplets obtained with higher magnification.
(C) Following the water sublimation in the preparation chamber a Cryo-SEM micrograph with a single
fractured droplet is presented.
were recorded in bright-field with 60µs exposure time and 16 000pps with a resolution of
256× 512.
4. Retention Analysis of Fluorophores and
Biomolecules in Droplets
4.1. Fluorophores
ATTO 488 N-Hydroxysuccinimidyl ester (SE), ATTO 495 SE, ATTO 520 SE, ATTO 532
SE, ATTO 565 SE, ATTO 590 SE, ATTO 647N SE and ATTO 655 SE were purchased
from ATTO-TEC GmbH (Siegen, Germany). Alexa Fluor® 488 C5 Maleimide (M), Alexa
Fluor® 532 C5 M and Alexa Fluor® 647 SE were purchased from Thermo Fisher Scientific
(Schwerte, Germany).
The pure fluorophores were dissolved in anhydrous DMSO at a concentration of 1 mM
and stored at -20°C. In retention experiments the fluorophores were further diluted with
each buffer and both cell culture media (see next Section 4.2) to a final concentration of
5 µM and used as an aqueous phase for droplets creation.
The hydrophilicity of the fluorophores was analyzed by calculating the distribution co-
efficient, LogD, which is a measure of the expected ratio of the sum of concentrations of
all forms of the fluorophore (ionized plus un-ionized) in water and in a non-polar solvent
(octanol). Negative LogD values correspond to hydrophilic fluorophores, positive values
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orophore retention was categorized in three different groups according to Figure 4.4:
I0 ≈ It0 ≈ It24 ⇒ Stable flurophore retention
I0 ≈ It0 > It24 ⇒ Moderate fluorophore retention
I0 >> It0 ⇒ No fluorophore retention
Figure III.10.: Characterization criteria for fluorophore retention in droplets
Figure III.11 shows the fluorescence intensities It0 of droplets produced with three
different buffers and different fluorophores and representing the three different categories
of flurophore retention. [144]
Figure III.11.: Flurophore retention characterization (A, B and C) show droplets produced with 10 mM TRI7000
surfactant, containing ATTO 633 in TRIS (A), ATTO 655 in RPMI (B) and Alexa 488 in TRIS (C). The
droplets were analyzed immediately after production (Intensity It0). Upper panel: Selected fluorescence
images demonstrating different fluorescence retention in droplets. Middle panel: Intensity profiles of
cross-sections marked in upper panel. Lower panel: Red, yellow and green blocks illustrate the color
marking used in all tables.
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6. Cell experiments
and the supernatant with unbound cRGD peptides were removed. The precipitant was
freeze-dried for at least 24 h to remove remained water completely. Afterwards, the
dried product was dissolved in 1 ml of fluorinated oil FC-40 (Acros Organics, Germany)
and filtered with a hydrophobic filter (PTFE 0.2 µm) to remove unreacted, hydrophilic
(11-Mercaptoundecyl)tetra(ethylene glycol) functionalized gold nanoparticles and cRGD
traces. The obtained surfactant was used in different concentrations for cell adhesion
experiments. [4]
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Figure III.12.: Chemical structure of the c(RGDfK) peptide The cyclically arranged amino acids are arginine
(R), glycine (G) and aspartate (D). A PEG spacer (6 units) was used to bridge between the peptide
and the 3 cysteine-linkers.
5.3. Rhodamine functionalization (Two step Approach)
Gold nanoparticle funtionalization with rhodamine involved two steps. First the synthesis
of PFPE-PEG-Gold surfactants linked to rhodamine B (RhB) (see Section IV.1.4) followed
by droplet creation using a mixture of TRI2500 (20 mM, PFPE2500-PEG600-PFPE2500,
synthesis described in Section IV.) and RhB-PEG-Gold-PEG-PFPE (5 µM) surfactants
as an oil phase, while PBS was used as an aqueous phase. [4]
6. Cell experiments
Mercaptoundecyl-tetra(ethylene glycol) functionalized gold nanoparticles and cRGD were
coupled in advance. The obtained surfactant was used in different concentrations for cell
adhesion experiments. [4]
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created in a microfluidic device, were recorded immediately after the cross junction with
a Phantom V7.3 camera at 10000 fps.
As can be observed in Figure IV.12 surfactant concentrations below 1mM lead to droplet
coalescence as soon as droplets were in contact. At higher surfactant concentrations
(above 1mM) droplets were stable and no coalescence was observed. Figure IV.12 shows
five representative images at different concentrations for both tested surfactants.
0.75     2.5                   10     20      30 mM  
200 µm
TRI 2500
TRI 7000
Figure IV.12.: Droplet stability as a function of surfactant concentration and its molecular weight. Rep-
resentative brightfield images of water-in oil droplets immediately after production. At low surfactant
concentration (C < 1mM) coalescence of droplets is observed (left panel). At high surfactant concen-
tration creation of small droplets occurs (right panel). Monodisperse and stable droplets are produced
in a stable regime as it can be seen in the middle panel. Adapted with permission from Ref. [144]
In case of TRI2500 stable monodispers droplets creation was observed at a concentration
range of 2,5 mM < c < 10 mM. In case of the bigger surfactant TRI7000 the concentration
range was larger, ranging from 1 mM up to 20 mM surfactant concentration. Above
these surfactant concentrations small droplets were created during droplet production
due to jet-dripping and by friction of the droplets flown in the channels. When droplets
were stabilized (less than a second after production) with a dense surfactant layer no
appearance of more small droplet or a decrease in size of produced droplets was observed
any more.
To provide a detailed analysis of the droplet stability and their size distribution droplets
were collected and stored in an analysis chamber (see Section III.2.3). The results are
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the other hand high surfactant concentrations lead to creation of small droplet, visible
with brightfield microscopy. This effect was observed at a surfactant concentration of 5mM
for TRI2500 and at 20 mM for TRI7000. For high concentrations even shrinking of the
“mother-droplets” is visible (for TRI2500) by the decrease of the average droplet radius.
In most microfluidic droplet applications this effect is undesirable since a constant volume
of all droplets is essential for quantitative analysis. Therefore in all further investigations
the surfactant concentration was always kept between 2.5 and 10 mM to ensure production
of stable droplets with low size distribution.
3.2. Effect of Droplet Size and their Formation Rate on
Fluorophore Retention
To preform long term experiments with microfluidic droplets, stable encapsulation of
particles, molecules and cells is necessary. Therefore, molecular retention in the droplets
was analyzed according to droplet size and the rate of droplets formation. [158]
First the effect of droplet formation speeds was investigated to determine fluorophore
retention. Figure IV.14 shows representative images of the fluorophore ATTO 590 SE
moderate retention as a function of formation speeds (0.5, 3, and 30 kHz) (defined as
described in Section III 4.4).
Figure IV.14.: Effect of droplet production rates on fluorophore retention Moderate retention of ATTO 590
SE fluorophores in the droplets does not depend on the droplet creation frequencies. ATTO 590 SE
fluorophores were dissolved in PIPES-buffer and used as an aqueous phase for droplets creation. The
oil phase contained 2.5 mM of TRI7000 surfactants. Adapted with permission from Ref. [144].
As can be seen in Figure IV.14 the retention was not affected due to different droplet
creation frequencies. All flurophores mentioned in Section III.4.1 were tested and showed
the same result.
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Next the effect of droplet size on fluorophore retention was investigated. The flu-
orophors were encapsulated in droplets having different sizes (Diameter = 25, 40 and
150µm, 3 KHz production speed, 2.5 mM of TRI7000 surfactant). As shown in Figure
IV.15 the droplet diameter had no effect on the fluorophore encapsulation stability. All
investigated fluorophore retentions were not affected by the size of the droplets.
Figure IV.15.: Effect of droplet sizes on the retention of fluorophores within the droplets. Retention of
fluorophores in the droplets is not affected as a function of droplet size. ATTO 532 SE, ATTO 655
SE, ATTO 590 SE and ATTO 647N SE fluorophores were dissolved in TRIS buffer and used as an
aqueous phase for droplet creation. The oil phase contained 2.5 mM of TRI7000 surfactant. Adapted
with permission from Ref. [144]
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no or in case of RPMI media moderate retention
Figure IV.17.: Fluorophores retention in the droplets Fluorophores retention in the droplets (diameter = 40 µm)
having different buffer/medium conditions. TRI2500 (10 mM) surfactants were used to generate
droplets for this experiment. Adapted with permission from Ref. [144]
Surprisingly, no retention was observed for slightly hydrophilic dyes as ATTO 495 (LogD
= -0.81), ATTO 655 (LogD= -0.61) and ATTO 565 (LogD= -0.18). In case of ATTO
495 dye this behavior can be explained by the relatively small molecular weight as well as
the planar structure which leads to a smaller energetic barrier for the transport through
the surfactant layer. [162] For ATTO 565 and 655 dyes only half of the tested buffers and
media showed moderate retention.
3.4. Retention as a Function of Surfactant Length, Structure and
Concentration
In addition to buffer and fluorophore properties the effect of the physical properties of
surfactants (i.e., geometry, concentration and molecular weight) on the fluorophore reten-
tion in the droplets were investigated. [158] Three different surfactants (TRI2500, TRI7000,
and DI7000) with 10 mM concentration each were used (see Section IV.3.1). The reten-
tion summary of the 12 fluorophores encapsulated with the three surfactants is presented
in Figure IV.18. As can be observed from Figure IV.18 droplets produced with the
TRI7000 surfactants exhibited the best retention of encapsulated fluorophores. However,
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the droplets produced with this surfactant were highly polydisperse in size due to low
droplet stability. Improved retention in the droplets produced with diblock surfactants
can be attributed to the denser surfactant layer on droplets periphery due to reduced
steric effect on comparison to triblock surfactant geometry. However, for droplet stability
it is preferable to have a dense PFPE layer on the outside droplet interface. The most
efficient layer against coalescence can be provided by triblock surfactant geometry having
two PFPE tails. [15] Due to the inherent requirement for stable monodisperse droplets,
further experiments were performed with TRI2500 and TRI7000 surfactants. As shown
in Figure IV.18, improved retention was also achieved for some of the fluorophores in
droplets produced with longer surfactants (higher molecular weight). This observation is
straightforward since dyes have to pass a higher energetic barrier due to a thicker sur-
factant layer. [162] Further optimization of fluorophore retention within the droplets was
analyzed depending on the surfactant concentration.
Figure IV.18.: Fluorophores retention in the droplets is a function of buffer/medium selection and sur-
factant physical properties. Fluorophores retention in the droplets (D = 40 µm) as a function
of buffer/medium selection and surfactant physical properties. The droplets were generated using
three different surfactants (TRI2500, TRI7000, and DI7000 (10 mM)). Adapted with permission from
Ref. [144]
The range of surfactant concentrations was chosen according to the results in Section
IV.3.1. Based on these results and considering that molecular retention might be depen-
dend on surfactant concentration, further fluorophore retention studies were preformed in
71
3. Key Factors for Droplet Stability and Fluorophore Retention
droplets produced with 2.5 and 10 mM surfactant concentration. The retention summary
of the 12 fluorophores encapsulated in droplets made of TRI7000 and TRI2500 surfactants
at two different concentrations is presented in Figure IV.19. In both cases, improved flu-
orophore retention was observed with the lower surfactant concentration. However, this
effect is more apparent in TRIS buffer and RPMI medium. The decrease of free surfac-
tants in the oil phase reduces the formation of reverse micelles and small droplets, which
can act as carriers for the solubilized fluorophores. These results are in agreement with
previous observations where the decrease of the fluorescence intensity of fluorescein inside
droplets was observed due to increased surfactant concentration. [163]
These results emphasize that with a proper selection of the physical surfactant proper-
ties such as concentration, geometry, and molecular weight the retention of most of the
fluorophores can be controlled efficiently.
Figure IV.19.: Fluorophores retention in the droplets as a function of surfactant length and concentration
Fluorophores retention in the droplets (D = 40 µm) as a function of surfactant length and concentration.
Fluorophores were dissolved in TRIS, PIPES buffers, and RPMI medium. The oil phase contained 2.5
or 10 mM of triblock surfactants. Adapted with permission from Ref. [144]
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As shown in Figure IV.21 stable retention of ATTO 633-labeled microtubules in the
droplets created with 2.5mM TRI7000 surfactants was achieved. Whereas, droplets pro-
duced with 2.5mM TRI2500 surfactant showed no retention of ATTO 633-labeled tubulin
and even pre-polymerized microtubules diffused out of the droplets immediately after en-
capsulation. A representative time-lapse is presented in Figure IV.20. Additionally, stable
retention was observed for microtubules labeled with highly hydrophilic ATTO 488 dye
(Figure IV.21).
In contrast to the labeled microtubules experiments, stable retention for more than 14
days was observed for all labeled antibodies and streptavidin proteins tested in this study.
These results were independent of the hydrophilicity of the dye and surfactant selection.
In case of antibodies and streptavidin proteins their high hydrophilicity and their big
molecular weights are the major reasons for their stable retention within the droplets
independent of the dye properties. Even the most hydrophobic ATTO 647N dye (LogD
= +4.47), which showed no retention in the droplets in a pure state, did not influence the
the stable retention of sheep anti-mouse antibodies or streptavidin.
Proper surfactant selection 
Proper fluorophore selection 
ATTO 633 labeled tubulin, TRI2500 10 mM 
ATTO 633 labeled tubulin, TRI7000 10 mM 
ATTO 488 labeled tubulin, TRI2500 10 mM 
Figure IV.21.: Factors influencing the retention of microtubules in micro droplets Retention of labeled
microtubules in the droplets strongly depends on the degree of hydrophilicity of the dye and surfactant
selection. ATTO 633- and ATTO 488-labeled microtubules were polymerized in PIPES buffer and used
as an aqueous phase for droplets creation. The oil phase contained 10 mM TRI7000 and TRI2500
surfactants. Note: Similar results were observed with and without addition of gold-linked surfactants.
Adapted with permission from Ref. [144]
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gold-linked surfactant (30 µM) (Figure IV.22 B) compared to a lower concentration (3 µM)
(Figure IV.22 D). [4] To prove that the bright dots were gold NPs and not artifacts due to
the cryo-SEM measurements or freeze-fracture preparation, droplets without gold-linked
surfactants were created, freeze-fractured, and observed by cryo-SEM (Figure IV.22 F).
A
B
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Figure IV.22.: Cryo-SEMmicrographs of freeze-fractured nanostructured droplets Representative cryo-SEM
micrographs of freeze-fractured nanostructured droplets obtained with different magnifications. The
droplets were created using a PFPE-PEG-PFPE triblock (TRI2500) copolymer surfactant concentration
of 20 mM and PFPE-PEG-Gold-naonoparticle surfactant concentrations of (A, B) 30 µM, (C, D) 3µM
and (E, F) 0µM. Adapted with permission from Ref. [4]
4.2. Biofunctionalization of Nanostructured Droplets
In this study GNp were used as anchoring points for various biomolecules. Towards this
end, two biofunctionalization approaches were developed. The first approach was based on
functionalization of created droplets with Ni2+ mediated interaction between the (His6-
tag) proteins and nitrilotriacetic acid (NTA)-thiol linker. In the second approach the
biomolecules were coupled covalently via ester or thiol bond to the gold-linked surfactants
before droplet creation.
The results of the first approach are presented in Figure IV.23 where GNps in the
nanostructured droplets were coupled with His6-tag green fluorescence protein (His6-
GFP) via a GNp-thiol linker (detailed reaction see Section III.5.1.
Images were taken (A) 1 day, (B) 4 days, and (C) 10 days after creation. The decrease
in fluorescence intensity over the observed period can be explained due to oxidation of
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Figure IV.25.: Representative fluorescence images of the RhB-linked gold-nanostructured droplets (A,
B, C) RhB-linked nanostructured droplets measured (A) 1 day, (B) 4 days, and (C) 16 days after their
creation. (1-10) Representative distribution of the fluorescence signal along the RhB-linked nanostruc-
tured droplet height, 3 days after creation. Stack 1 represents the top of the droplet, stack 10 the
bottom. All images have the same intensity scale. Adapted with permission from Ref. [4]
5. T Cell Experiments
As described in detail in Section I.2 the effective ex vivo T cell activation is the crucial
step for successful immune therapy. Therefore, nanostructured and biofunctionalized
droplets were used as 3D APC analogues. To provide the specific interactions with the T
cells, the nanostructured droplets were functionalized with cyclic arginine-glycine-aspartic
acid peptide (cRGDfK) or with pMHC proteins via cysteine or Ni-NTA-thiol chemistry,
respectively. Single T cell encapsulation was achieved using a microfluidic spiral device
as described in Section III.2.3.1.
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5.1. T Cell Jurkat 6.1 Experiments
The human acute T cell leukemia cell line (Jurkat E 6.1) was used to evaluate the potential
of nanostructured and biofunctionalized droplets to serve as a 3D APC analogue enabling
single cell analysis in a defined compartment. Jurkat T cells express α4β1 and α5β1
integrins and exhibit activation-dependent regulation of integrin-mediated adhesion. [169]
c(RGDfK)-PEG6-cysteine which are specific for α5β1 were linked to PFPE-PEG-gold
surfactants (Section III.5.2) [4] No significant difference between both labeling strategies
was observed. However, the two step approach was preferred to minimize the amount
of soluble c(RGDfK)-PEG6-cysteine peptides in the aqueous phase, to avoid blockage of
active sides on the cells and therefore, hindering the cell-droplet interaction. [170]
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Figure IV.26.: T cell viability and T cell-droplet-periphery interaction depending on the functionaliza-
tion. (A) Representative bright-field image of Jurkat E 6.1 cells (indicated by arrows) in the cRGD-
functionalized nanostructured droplets 6 h after their creation. (B) Quantification (adherent cell %) of
Jurkat E6.1 cell adhesion on cRGD-functionalized (pink, left bars) and nonfunctionalized (gray, right
bars) nanostructured droplets. Data is presenting mean ± standard error of the mean (n = 5). (C) T
cell proliferation time lapse. (D) T cell viability after 3 days (green= alive; orange= dead). Cells were
marked with propidium iodid. Adapted with permission from Ref. [4]
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Figure IV.28.: Representative confocal images of the primary mouse T cells interactions with gold-
nanostructure droplets. Image 1 to 3 show composed confocal z-stacks of droplets with primary
mouse T cells in contact with their periphery. In sake of clarity of presentation the periphery of the
droplet and T cells were marked with yellow and brown colour, respectively. The fluorescence signal of
the Alexa568-labeled MHC can be observed in image (A) and (C). A brightfiled image of the related
T cell is presented in figure (B).
6. Bottom-Up Assembly of Minimal Actin Networks
This section summarizes the results of actomyosin cortex formation in droplet-based
micro-compartments. Water-in-oil nanostructured emulsion droplets as cell-sized com-
partments were used to achieve the functional bottom-up assembly of minimal number
of proteins required to reconstitute the actomyosin cortex. To analyze the dynamic actin
properties in defined compartments all actomyosin networks were created by implementa-
tion of droplet based microfluidics. All droplet experiments in this section were preformed
using 2.5 mM triblock surfactants TRI7000. In some experiments 0.3 µM gold-labeled sur-
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In diffusion experiments preformed in an analysis chamber (Section III.2.3) a signifi-
cant difference in diffusion speeds of free bead-surfactants and in the droplet periphery
incorporated bead-surfactants could be shown (p-value: 5.87x 10-10) (Figure VI.3). This
difference in diffusion speeds decreased over time due to low density of the beads (bead ρ
= 1.05 g cm-3, FC-40 ρ = 1.85 g cm-3) resulting in a contact to the top glass of the analysis
chamber. By this friction was increasesd and no free movement was observed afterwards.
Therefore only results shortly after production were taken into consideration.
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Figure VI.3.: Analysis of beads diffusion in the oil phase. The diagrams A and B present the diffusion of the
bead-surfactant. (A) represents the diffusion of free bead-surfactant in the oil phase. Diagram B shows
the diffusion of bead-surfactant in the droplet periphery. Red line represents the median for A and B.
The diffusion for free bead surfctant was 17.21 ± 3.05 µm ms-1 before and and 1.31 ± 0.25 µm ms-1 rafter
sedimentation. The median for bead-surfactant speed in the periphery was 0.41 ± 0.36 µm ms-1
In a second experiment the dislocation of beads was analyzed. In figure VI.4 the
difference of free bead-surfactants and in the periphery incorporated bead-surfactants can
be clearly seen. Here the p-value is 3.6x 10-11. The difference of the dislocation is much
higher due to the free movement of free bead-surfactant compared to the beads in the
periphery which can only move short distances due to the dense surfactant layer. The
results of these experiments together with IR-analysis and cryo-SEM images of beads in
the periphery of actin droplets (Section IV.1.6.1) show the success of the reaction and
confirm the expected behaviour of this new synthesized bead-surfactant.
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Figure VI.4.: Analysis of beads dislocation in the oil phase The diagrams A and B present the dislocation of
the bead-surfactant. (A) represents the dislocation of free bead-surfactant in the oil phase. Diagram (B)
shows the disslocation bead-surfactant in the droplet periphery. Red line represents the median for A
and B; 80.4 ± 38.7 µm ms-1 and 2.7 ± 3.3 µm ms-1 respectively.
4. Proteins
4.1. Actin
Actin is a globular protein found in all eukaryotic cells with a variation of less than
5% in the sequences of amino acids between specie. [189] 1 to 5% of cell mass is actin as
monomers (length 55 A˚) or in filamentous form. The actin monomer has a weight of 42
kDa and consists of 375 amino acids in 4 subdomains called G-actin due to it´s globular
shape. F-actin has a double helical shape where each monomer has an offset of 166° and
2.75 nmwith a diameter of about 5-9 nm and up to several micrometer length. [190? ] The
persistence length of actin is about 17µm max. [191,192]
Actin polymerization is mediated by the presence of ATP which is hydrolyzed during
the actin polymerization. [193] In the first step of actin polymerization 2-4 ATP saturated
G-actins assemble. This step is the time determing step in actin polymerization. [194]
Polymerization occurs then at both ends of the actin filaments but has different kinetics
due to structural asymmetrice of the film endings. The so called (+) and (-) end have
different polymerization and depolymerization constants which are k1 = 11.6 ± 1.2 µM-1s-1
and k -1 = 1.4 ± 0.8 µM-1s-1 for the (+) end and k2 = 1.3 ± 0.2 µM-1s-1 and k -2 = 0.8
± 0.3 µM-1s-1 for the (-) end. [195] Actin filaments together with Myosin II motor proteins
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6. FT-IR Analysis
Figure VI.9 (A) shows the representative FTIR spectra of the PFPE(7000)-carboxylic
acid reactant and the triblock surfactant product PFPE(7000)-PEG(1400)-PFPE(7000)
(TRI7000). This figure presents five major bands at 1701, 1775, 2848, 2956 and 3556 cm-1.
The band at 1701 cm-1 is attributed to the ester (C=O) stretching mode. The band at
1775 cm-1 is attributed to a stretching mode of the (C=O) bond of the PFPE-carboxylic
acid which is strongly blueshifted (by 50 cm-1) due to the electronegative fluor atoms
in alpha position to the carboxylic group. The same blueshift of the carboxylic (C=O)
band was observed previously in the studies measuring the FTIR spectrum of the trifluo-
roacetic acid. The bands at 2848 and 2956 cm-1 are assigned to symmetric and asymmetric
stretching modes of the PEG (C-H) groups of the PFPE-PEG-PFPE product.2 The band
at 3556 cm-1 is assigned to the asymmetric stretching (OH) vibrations. Figure VI.9 (B)
shows representative FTIR spectra of the DI7000 and PFPE(7000)-carboxylic acid. This
figure presents major bands at 1698, 1775, 2889, 2993 and 3556 cm-1. The band at 1698
cm-1 represents a stretching mode of the ester (C=O). The broad band at 2889 and 2993
cm-1 represents the symmetric and asymmetric stretching of PEG (CH). The band at
3556 cm-1 is assigned to the asymmetric stretching (OH) vibrations.
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Figure VI.9.: Representative FT-IR spectra of a triblock-copolymer surfactant and the PFPE. Figure.
FTIR spectra of the reactants and the products of the surfactant synthesis. FC-40 perflourinated oil was
used as a background solvent to obtain the spectra. (A) Comparison between the PFPE(7000)-carboxylic
acid (20 mM) as a reactant and the PFPE(7000)-PEG(1400)-PFPE(7000) triblock product (20 mM) .
(B) Comparison between PFPE(7000)-carboxylic acid as a reactant (20 mM) and the PFPE(7000)-PEG-
OMe(750) diblock product (20 mM).
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